10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

x     ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2013

Or

¨      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from   ___________ to ___________

Commission file number: 333-147980

ORIGINOIL, INC.

(Exact name of registrant as specified in charter)

Nevada	26-0287664
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

5645 West Adams Blvd, Los Angeles, CA 90016

(Address of principal executive offices) (Zip Code)

Registrant's telephone Number: (323) 939-6645

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

¨ Yes x  No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

¨ Yes x No

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x  Yes  ¨  No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, “non-accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer ¨	Accelerated Filer  ¨
Non-accelerated Filer ¨ (Do not check if a smaller reporting company)	Smaller Reporting Company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ¨ Yes x No

The aggregate market value of the voting stock held by non-affiliates of the registrant was approximately $11,707,942 based upon the closing sales price of the registrant’s common stock on June 28, 2013 of $0.32 per share.  At April 14, 2014, 73,365,231 shares of the registrant’s common stock were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE: NONE

1

TABLE OF CONTENTS

		Page
	PART I
Item 1.	Business		3
Item 1A	Risk Factors		13
Item 1B	Unresolved Staff Comments		20
Item 2.	Properties		20
Item 3.	Legal Proceedings		20
Item 4.	Mine Safety Disclosures		20
	PART II
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities		20
Item 6	Selected Financial Data		21
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations		21
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk		24
Item 8.	Financial Statements and Supplementary Data		24
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure		24
Item 9A.	Controls and Procedures		24
Item 9B.	Other Information		26
	PART III
Item 10.	Directors, Executive Officers and Corporate Governance		27
Item 11.	Executive Compensation		29
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters		32
Item 13.	Certain Relationship and Related Transactions, and Director Independence		34
Item 14.	Principal Accountant Fees and Services		34
Item 15.	Exhibits, Financial Statement Schedules		35
SIGNATURES			36

2

PART I

This Form 10-K contains forward-looking statements that are subject to a number of risks and uncertainties, many of which are beyond our control, which may include statements about our:

● business strategy;

● financial strategy;

● intellectual property;

● production;

● future operating results; and

● plans, objectives, expectations and intentions contained in this report that are not historical.

All statements, other than statements of historical fact included in this report, regarding our strategy, intellectual property, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used in this report, the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. All forward-looking statements speak only as of the date of this report. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this report are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved.  These statements may be found under “Management's Discussion and Analysis of Financial Condition and Results of Operations,”  “Business,” “Properties,” as well as in this report generally.  Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the risks outlined under “Risk Factors” and matters described in this report generally.  In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur.

ITEM 1. BUSINESS.

Organizational History

OriginOil, Inc. (“we”, “us”, “our”, the “Company” or “OriginOil”) was incorporated on June 1, 2007 under the laws of the State of Nevada.  We have only been engaged in our business operations since June 2007, and to date, we have been primarily involved in research and development activities.  Our principal offices are located at 5645 West Adams Blvd., Los Angeles, California 90016. Our telephone number is (323) 939-6645. Our website address is www.originoil.com.  Our website and the information contained on our website are not incorporated into this Form 10-K.

Overview of Business

OriginOil has developed a breakthrough water cleanup technology for the algae, oil & gas and other water-intensive industries.

Unlike other technologies, our patent-pending Electro Water Separation™ process rapidly and efficiently removes organic material from large quantities of water without the need for chemicals.

OriginOil is a pure technology company. We are neither a producer nor a service company. Our technology integrates easily with other industry processes. We have begun to embed our technology into larger systems through licensing and joint ventures.

To develop these markets, we rent, sell and showcase smaller-scale equipment such as the EWS Model A12™ (the Algae Appliance™). However, we are not in the business of developing sales distribution networks or engaging in volume manufacturing, and our long-term business model is based on licensing our technology to original equipment manufacturers (OEMs), engineering service firms, and specialty operators, as well as fuel refiners, chemical and oil companies. 

We have only been engaged in our business operations since June 2007, and to date, we have been primarily involved in research and development activities, and sales of pilot and demonstration equipment, beginning in June of 2010.

In October of 2012, we announced that we signed our first OEM agreement with oil and gas water treatment firm Pearl H20, LLC (Pearl), a Pacific Advanced Civil Engineering, Inc. (PACE) spinoff now branded as PearlBlue. In October 2013, Colorado-based Industrial Systems Inc. (ISI) agreed to become our pioneer customer for our Pay per Barrel program. Subsequently, ISI also became an OEM licensee. In January, 2014, we named our third active OEM, Orca Vision Inc., a new East Asian urban farming venture.

We are a joint venture partner in Ennesys, a system integrator focused on algae production to meet the European Union’s environmental regulations. In mid-2013, we installed a prototype EWS Waste unit at the Ennesys demonstration site which can process liquid waste, generating clean, nitrate-rich water to feed algae grown on the building’s roof as an energy source. In late 2013, we transferred three of our non-core patent applications to Ennesys.

3

OriginOil’s Technology Platform: Electro Water Separation™

OriginOil’s breakthrough water cleanup technology, called Electro Water Separation™ (EWS), is a high-speed, chemical free process that efficiently extracts organic contaminants from very large quantities of water.  Because of its capabilities, we believe EWS is valuable in water-intensive industries such as algae, oil & gas, aquaculture and waste water.

EWS works in two stages:

·   Stage1- Electro-Coagulation: contaminated water enters the first stage, which is a proprietary electro-coagulation process. In this stage, mild electrical impulses are applied in long tubes, causing the organic contaminants to coagulate, or “clump” together.

·   Stage 2 - Electro-Flotation: the clumped-up material travels into a second stage where low power electrical pulses generate a cloud of micro-bubbles that gently lifts the concentrate to the surface for harvesting.

The harvested concentrate can be made up of chemical waste, valuable petroleum, or useful algae feedstock.

For the emerging algae industry, EWS can reduce bacterial contamination, and concentrate algae without chemicals, making large-scale harvest possible.

For the oil & gas industry, EWS can help clean up produced water and recycle fracking water, to reduce harm to the environment and lower costs.

In aquaculture, EWS can help improve yields and make seafood healthier by dramatically reducing the levels of toxic ammonia and bacteria in water.

EWS has also been shown to help clean up contaminated farm and sewage water quickly and cheaply, without chemicals, for recycling and further purification.

Our Strategy

We are currently marketing our EWS systems at the demonstration scale, as a way to penetrate markets and prove the technology for these markets, and create future customers. This process is intended to lead to wide distribution of our technology through OEM (Original Equipment Manufacturer) and licensing “Powered by OriginOil” deals with distributors, manufacturers, engineering service firms, and specialty operators, as well as fuel refiners, and chemical and oil companies.

We believe our OEM/licensing model offers a host of potential advantages to us, including:

●	limited capital requirements;
● ●	no capital cost for volume manufacturing, no time or expense wasted on building distribution channels;
●	collaboration with major players instead of competing with them;
●	an opportunity to make the core EWS technology a de facto standard in the multiple industries where it has applications.

4

We currently manufacture our demonstration equipment in-house, with engineering support from PACE Engineering of Fountain Valley, California. Additionally, we have chosen Clean Water Technology as our contract manufacturer for larger scale demonstration systems, where required.

Given the number of potential industries in which EWS can be applied, we believe it is impractical for us to enter into each market and exploit them all effectively at once. Therefore, our market strategy is to build, rent and showcase demonstration units only. For larger systems, we seek OEMs, who will embed the technology in their own end-to-end systems, and ultimately, master licensees for each industry of application.

Our Product Offerings

The Algae Industry

Much of the petroleum that powers our world comes from ancient algae that decomposed hundreds of millions of years ago. Like petroleum, algae can be turned into transportation fuels, chemicals, pharmaceuticals and plastics; but unlike petroleum, algae absorbs CO2 in the process, about two tons of CO2 for every ton of algae produced.

Algae is one of nature′s most efficient and versatile photosynthetic factories. It has a short growing cycle and does not require arable land or fresh water, which makes it very attractive as an energy feedstock, or as a healthy and natural feed or fertilizer. But a major barrier to commercialization is the difficulty in extracting small amounts of algae biomass from very large quantities of water at a reasonable cost and without using more energy than can be created. And the quantities of water required can be very large indeed: algae-to-water ratio can be as high as 1-to-1000.

Conventional water separation technologies such as centrifuges and membranes may work on a limited basis, but are believed to be too expensive for large-scale use. Additionally, centrifuges can damage algae in what is called the “windshield bug-splatter” effect, making the crop useless for applications where it is needed intact.

Early Harvesting Technology: Single Step Extraction™

OriginOil’s early algae harvesting technology is Single Step Extraction™ (SOS). Today, it is the first stage in EWS and it powers our sanitation and growth optimizing applications.

In 2010, SOS was sold as an experimental research system to Melbourne-based MBD Energy (MBD) for its James Cook University (JCU) proving site. Based on success there, MBD ordered a series of progressively larger systems. But on September 25, 2012, before those systems could be put into operation, we filed a complaint in the US District Court Central District of California against MBD to protect our intellectual property. On December 20, 2012, we entered into a Settlement Agreement with Mutual Releases and Covenants (the “Settlement Agreement”) with MBD pursuant to which we agreed to a final settlement and release of claims in connection with the complaint. Under the Settlement Agreement, MBD agreed, among other things, to withdraw its patent application that related to certain company technology and provide us with certain assurances of non-infringement of our technology and we agreed, among other things, to file a dismissal of the complaint, which was entered on March 1, 2013, and to withdraw our notice of default of the Master Project Agreement (“MPA”) previously entered into with MBD. The Settlement Agreement provided that the MPA would terminate in its entirety on June 30, 2013. The parties agreed to review their relationship further at that time. The Settlement Agreement also provided for a standard mutual release, denial of liability and covenant not to sue. As called for in the Settlement Agreement, OriginOil provided an updated demonstration system for MBD’s research site at James Cook University (JCU Upgrade). The JCU Upgrade incorporated the full EWS process and was delivered in the third quarter of 2013. Under the settlement, we also agreed to provide an updated demonstration system at MBD’s proof of concept site at Tarong Power Station (Tarong Upgrade). However, the MPA terminated without obligation to either party before the Tarong Upgrade could be carried out. The parties continue to discuss possible collaboration opportunities.

Current Offering: EWS Algae™

Today, EWS Algae™ is our standardized, low energy, chemical-free, algae processing technology. Powered by EWS, we offer two EWS Algae™ product lines, solving two major barriers in the commercialization of the algae industry:

· Algae Growth Optimization: a continuous process to optimize microalgae growth water by improving productivity and preventing competing microorganism invasion related “crashes”.

· Algae Harvesting: a continuous flow ‘wet harvest’ system to efficiently dewater and concentrate the microscopic algae harvest. The process can deliver a concentrate with the algae cells substantially intact, or ruptured, as desired.

5

Algae Growth Optimization - Algae Screen ™ S60

EWS Algae Screen Model S60

Our standard demonstration system is the Algae Screen™ S60, which we believe is an important algae growth tool for lowering the bacterial load in growth water to improve productivity and prevent invader-related crashes. The Algae Screen™ S60 provides a continuous, chemical free, low energy process, which sanitizes up to 60 liters (16 gallons) per minute of microalgae growth water, improving productivity and preventing competing microorganism invasion related crashes.

Based on our core platform, EWS, the Model S60 is attached to an algae production system, where it continuously lowers the bacterial load in growth water to improve productivity and prevent invader-related crashes.

The Model S60 was announced on November 25, 2013. A test unit has been sold to an algae industry customer.

Algae Harvesting: EWS Algae

EWS Algae demonstrator, the Model A12

EWS Algae models are rated by their maximum capacity to process algae dilute continuously, shown in liters per minute.

Our standard demonstration models are:

· EWS Algae Model A12, marketed as an R&D tool for ongoing monitoring and development of strains and growth methodologies and as a Phase I harvester;

· EWS Algae Model A60, positioned as a mid-sized system designed for distributed pond or bioreactor architectures;

· EWS Algae Model A200, designed for full-scale production, either singly or in parallel configuration.

The Model A12 is commercially available. A12s are also on loan or placed at showcases in St Cloud State University (MN), New Mexico State University, and at the National Algae Association’s Center for Harvesting Demonstrations near Houston (TX).

The larger Model A60 was first demonstrated publicly on December 18, 2013 at the launch of our Permanent Showcase in Thermal, California.

We intend to build at least one Model A200 in 2014, to prove scale.

6

In December 2013, Orca Vision Inc. ordered three Model A12 algae harvesters from us for testing and demonstration. These were shipped and installed in the first quarter of 2014. We agreed to enable Orca Vision to begin operating as a non-exclusive OEM in East Asia integrating our algae harvesters and water treatment systems into its own hydroponic systems, “Powered by OriginOil”.

The Oil and Gas Industry

The oil and gas industry is one of the most water-intensive industries in the world. It is both a large consumer of fresh water and a large producer of contaminated water. Water is produced and used in large quantities in oil and gas operations. According to the U.S. Department of Energy, an average of 3 barrels of contaminated water is generated for each 1 barrel of oil produced. In the United States, the average is 7 barrels of water. Greentech Media reports that energy companies pay between $3 – $12 to dispose of each barrel of produced water, implying a potential world market value between $300 billion and $1 trillion per year.

We believe OriginOil’s high speed, lower energy and chemical free Electro Water Separation™ technology is ideally suited to clean up the large quantities of water used in oil and gas operations.

A 2009 report on modern shale gas by the Groundwater Protection Council, "Modern Shale Gas Development in the United States: A Primer," stated that “[t]he amount of water needed to drill and fracture a horizontal shale gas well generally ranges from about 2 million to 4 million gallons, depending on the basin and formation characteristics.” While fracking technology promises to unleash an abundant supply of inexpensive natural gas to power the modern world, water is quickly becoming a serious limiting factor. Additionally, the water returns as “frac flowback” laced with petroleum and contaminants that require rapid and efficient removal for disposal and recycling.

Our EWS Petro™ P160 is designed to efficiently remove organics, such as crude oil, and suspended solids and bacteria from process water such as produced or ‘frac flowback’ water at a continuous flow rate of 1 barrel per minute or 160 liters per minute in continuous, chemical free operation. EWS Petro can be used as a standalone system for the separation of organics from produced or frac flowback water, enabling clients to reuse their process water for further fracturing or drilling fluids operations. Reusing the water significantly reduces trucking and disposal costs.

Unlike the algae market which at its developmental stage requires primarily research or test scale equipment, the oil and gas market requires commercial scale equipment. Due to these requirements of scale, we bypassed the sale of demonstration units and are licensing our EWS system to OEMs with the intent that they will build the commercial units that will integrate EWS and provide all the necessary deployment tools.  

To date, we have active OEM relationships with Pearl Blue (previously Pearl H2O), and Industrial Systems, Inc. (ISI).  Pearl Blue, a subsidiary of PACE Engineering, is in construction of an integrated one barrel per minute system with installation planned in the second quarter of 2014.  The system, which utilizes EWS as its first stage, is designed to treat frac flowback water to allow it to be recycled as new frac water. ISI is a manufacturer of portable tanks of up to 53,000 barrels of capacity that are used in hydraulic fracking operations.  ISI is in the process of building a 5,000 barrel per day water treatment system utilizing EWS as its first stage.  It is to be installed in the third quarter of 2014 in the intermountain area of Colorado or Utah.

In February 2014, we announced the opening of a Houston, Texas office for the oil and gas division of our business.

The Aquaculture Industry

Fish farming is threatened by its own expansion. Bio-security is a continuing problem, with potentially high mortality rates for fish populations. And where water is re-used, removing ammonia is a major and expensive challenge. Fish farms are also heavy contributors to pollution of rivers, lakes and oceans.

7

We believe EWS technology presents a triple answer to the problem of aquaculture:

· It can sanitize water by cost-effectively removing ammonia and killing bacteria and aquatic animal pathogens.

· It can cost effectively harvest algae for use as nutritious fish feed.

· It can effectively clean both supply and discharge waters.

 

Our primary system is called EWS Aqua  Q60™, a commercial fish farming pond water treatment system, which reduces levels of ammonia and pathogens by continuously recirculating pond water through a low-voltage electrical field.

If an operator wants to grow algae for economical and healthy feed, then EWS Aqua may be able to generate fertile effluent to feed the algae ponds.

Like the oil and gas market, the aquaculture market requires commercial scale equipment. Surveys have shown that the existence of a field proven system is critical to sales and licensing.  Accordingly, on December 18, 2013, we launched our Permanent Showcase at Aqua Farming Tech, a working fish farm in Thermal, California. This Showcase features a working Model S60 as well as a Model A60 to demonstrate the algae feed application to growers.

Following this launch, on January 28, 2014, we announced our first commercial relationship in aquaculture: we will collaborate with Israel’s AquaGreen Fish Farms, Ltd to help streamline zero-discharge aquaculture systems for the production of chemical free seafood. AquaGreen stated it would integrate OriginOil water treatment technology into its systems.

Organic Waste Industry

In many applications such as agriculture, fish farming and animal farming, it is important to clean up the water supply coming in and the wastewater going out of those facilities. Our breakthrough EWS technology is a high-speed, high volume, and chemical-free process that can efficiently remove organic contaminants and pathogens from incoming or outgoing water supplies.  The EWS Waste™ system is currently under development for this purpose.

A prototype EWS Waste unit (the Waste Appliance™) now processes liquid human waste at the Ennesys urban algae demonstration site near Paris, generating clean, nitrate-rich water to feed algae grown on the building’s roof.  The algae is then converted onsite into energy for the building’s use. In this case, EWS Waste is turning liquid sewage into nutrition for algae that, in turn, can help make commercial buildings self-sufficient for energy.

Where there are issues with pollution of incoming water, EWS technology has also been shown to effectively clean organics such as petroleum, achieving up to 99.9% reduction in free oil and a 99.5% reduction in suspended solids, and reduction of up to 99% of bacteria and other invaders, for clean and sanitized pond inflows and discharges.

Competitors

The Algae Industry

Companies in the new algae fuels industry tend to organize themselves as integrated producers and to keep their intellectual property to themselves.  Our strategy, on the other hand, is to share our technology widely.

8

With respect to our algae harvesting and sanitizing applications, we are aware that Algae Ventures, Cavitation Technologies, Diversified Technologies, Evodos, New Oil Resources, Open Algae LLC, Phycal, SRS Energy (aka Solution Recovery Services), Unitel Technologies, Inc., Pall Energy Group, Alfa Laval, Westfalia and Smartflow Technologies, among others, offer competing or possibly complementary technologies.  

The Oil and Gas Industry

Historically the solution to the treatment of produced and frac flowback water has primarily been disposal in injection wells.  Many technologies existed for the “filtering” of these waters and were used in certain situations driven by particular needs.  More recently, because of environmental concerns and regulatory requirements, these “filtering” technologies are being used to replace or at least minimize disposal.  The industry is increasingly recycling its produced and frac flowback waters for use in water flooding, enhanced oil recovery, new hydraulic fracturing operations, irrigation and even drinking water.  As the technologies have developed and the cost of disposal has risen, recycling is becoming the economic choice. In addition, intense lobbying by environmental groups in front-line regions like California and New York is driving recycling adoption as a way to make fracking more acceptable.

The “filtering” technologies range from simple decanting to distillation.  These technologies are used to create a multi-stage process to remove contaminants to the extent that is necessary to meet the quality standards necessary for the planned reuse.  The first stage of any of these multi-stage processes, which can include our EWS technology, is to remove oil and suspended solids from the water stream.  Subsequent stages could remove the heavy metals, scaling chemicals, salts and other natural and introduced chemicals.  Many of the subsequent or downstream processes are in fact complementary to EWS and offer significant opportunity.

Other companies using similar technologies include:  Halliburton, Bosque, Ecolotron, Quantum-ionics, Kaselco, Baker Hughes, RecylClean and Ecosphere.  Other technologies also compete with EWS, but are differentiated by their use of other technologies, chemical coagulants, batch operation or high level of consumables. Those include:  Aqua-Tech, Aqua-Pure, CTI, Purifics, HydroZonics, Myclex, Osmonics, Filterboxx, MECO, Layne, 212 Resources, Veolia, Fountain Quail, Pall and Altela.

The Aquaculture Industry

The aquaculture industry faces challenges from its own expansion relating to water management and toxin management. Solutions to these problems include chemicals, filtration and antibiotics. We believe our EWS technology may present dramatically better alternatives in water and toxin management.

With respect to competition, we are aware that Pentair (Aquatic Eco Systems), Aqua Logic, Aquaneering, Emperor Aquatics, PR Aqua, Krüger Kaldnes, among others, offer competing or possibly complementary technologies.  

The Organic Waste Industry

As our potential offering is in prototype stage, the Organic Waste industry does not figure in our competitive planning.

In general, we believe that OriginOil has one or more advantages over some of the potential competitors, in that our process is free of the use of any chemicals, is highly scalable on a continuous flow process, and may be significantly lower in energy consumption. We believe our technology may, in some cases, complement these companies’ offerings, however there is no guarantee that our technology will produce more efficiently or cost-effectively than these other technologies.

Government and Environmental Regulation

We are not aware of any existing or probable government regulations that would negatively impact on our operations.  As a licensor and/or provider of water treatment equipment, we are not subject to government regulations of algae production, other than normal safety standards and certifications (such as UL or CE) for goods that we manufacture for demonstrations and joint ventures.However, our prospective customers are subject to local, state and federal laws and regulations governing environmental quality and pollution control. To date, our compliance with government regulations has had no material effect on our operations, capital, earnings, or competitive position, and the cost of such compliance has not been material. We are unable to assess or predict at this time what effect additional regulations or legislation could have on our activities.

Our long-term business model is based on licensing our technology to distributors, manufacturers, engineering firms and specialty operators. We are not in the business of producing and marketing end products, nor of developing sales distribution networks or engaging in volume manufacturing. As a result, we are not currently required to obtain government approval for the production, distribution, and/or use of our technology

9

Intellectual Property

Our business is also based on developing a strong intellectual property portfolio and establishing a network of OEM distributors and core technology licensees.  We have filed the following patent and trademark applications: 

· On July 28, 2007 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Algae Growth System for Oil Production”. The inventors listed on the patent application are Nicholas Eckelberry and Riggs Eckelberry, our founders. We are listed as the assignee. On January 29, 2009 the application published with the publication number US 2009-0029445 A1.

· On May 23, 2008 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Apparatus And Method For Optimizing Photosynthetic Growth In a Photo Bioreactor”. The inventors listed on the patent application are Steven Shigematsu and Nicholas Eckelberry. We are listed as the assignee. On November 26, 2009 the application published with the publication number US 2009-0291485 A1.

· On July 26, 2009 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Procedure For Extraction Of Lipids From Algae Without Cell Sacrifice”. The inventors listed on the patent application are Paul Reep and Michael Green. We are listed as the assignee. This application was re-filed as a provisional application on August 13, 2010.

· On April 20, 2010 we filed a PCT application with the USPTO to protect the intellectual property rights for “Systems, Apparatus and Methods for Obtaining Intracellular Products and Cellular Mass and Debris from Algae and Derivative Products and Process Use Thereof”. The inventors are Nicholas Eckelberry, Michael Green, and Scott Fraser. We are listed as the assignee. On October 10, 2010 the application published with the publication number WO/2010/123903.

· On June 18, 2010 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Bio-Energy Reactor”. The inventors listed on the patent application are Michael Green, and Nicholas Eckelberry. On December 22, 2011, the application was published with the publication number US 2011-0308962 A1. We are listed as the assignee.

· On October 17, 2010 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Methods and Apparatus for Dewatering, Flocculation and Harvesting of Algae Cells”. The inventors listed on the patent application are Michael Green, Nicholas Eckelberry, Scott Fraser and Brian Goodall. We are listed as the assignee. On May 24, 2012, the application was published with the publication number US 2012-0129244 A1. The application was converted to a utility application on October 14, 2011.

· On October 19, 2010 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Methods and Apparatus for Dewatering, Flocculation and Harvesting Algae Cells”. The inventors listed on the patent application are Michael Green, Nicholas Eckelberry, Scott Fraser, and Brian Goodall. We are listed as the assignee. The application was converted to a utility application on October 18, 2011. On April 28, 2011, the application was published with the publication number US 2011-0095225 A1.

· On October 19, 2010 we filed a PCT application with the Korean Receiving Office to protect the intellectual property rights for “Systems and Methods for Extracting Non-Polar Lipids from an Aqueous Algae Slurry and Lipids Produced There from”. The inventors are Nicholas Eckelberry, Michael Green, and Scott Fraser. We are listed as the assignee. On April 28, 2011, the application published with the publication number WO/2011/133181.

· On March 18, 2011 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Enhancing Algae Growth by Reducing Competing Microorganisms in a Growth Medium”. The inventors listed on the patent application are Michael Green, Scott Fraser, Nicholas Eckelberry, and Jose Sanchez Pina. We are listed as the assignee.

10

· On May 20, 2011 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Systems and Methods for Monitoring and Controlling Process Chemistry Associated with Biomass Growth, Oil Product and Oil Separation in Aqueous Mediums”. The inventors listed on the patent application are Paul Reep and Gavin Grey. We are listed as the assignee.

· On June 16, 2011 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Bio-Energy Reactor”. The inventors listed on the patent application are Michael Green and Nicholas Eckelberry. On April 28, 2011 the application published with the publication number US 2011-0095225 A1. We are listed as the assignee.

· On August 10, 2011 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Procedure for Extracting of Lipids from Algae without Cell Sacrifice”. The inventors listed on the patent application are Michael Green and Paul Reep. We are listed as the assignee.

· On August 12, 2011 we filed a PCT application with the Korean Receiving Office to protect the intellectual property rights for “Procedure for Extracting of Lipids from Algae Without Cell Sacrifice”. The inventors listed on the patent application are Michael Green and Paul Reep. On February 16, 2012 the application published with the publication number WO/2012/021831. We are listed as the assignee.

· On September 7, 2011 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Apparatuses, Systems and Methods for Increasing Contact Between Solutes and Solvents in an Aqueous Medium”. The inventors listed on the patent application are Nicholas Eckelberry, Gavin Gray, Jose L Sanchez Pina and Maxwell Roth. We are listed as the assignee.

· On October 10, 2011 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Systems and Methods For Increasing Growth Of Biomass Feedstocks”. The inventors listed on the patent application are Nicholas Eckelberry, Jose L Sanchez Pina and Michael Green. We are listed as the assignee.

· On October 14, 2011 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Systems and Methods For Developing Terrestrial and Algal Biomass Feedstocks and Bio-Refining the Same”. The inventor listed on the patent application was Paul Reep. We are listed as the assignee.

· On October 14, 2011 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Systems, Methods And Apparatuses For Dewatering, Flocculating And Harvesting Algae Cells”. The inventors listed on the patent application are Michael Green, Scott Frasier, Brian Goodall and Nickolas Eckelberry.  On May 24, 2012 the application published with the publication number US 2012/0129244 A1. We are listed as the assignee.

· On October 18, 2011 we filed a PCT application with the Korean Receiving Office to protect the intellectual property rights for “Systems, Methods and Apparatuses For Dewatering, Flocculating and Harvesting Algae Cells”. The inventors listed on the patent application are Michael Green, Scott Frasier, Brian Goodall and Nickolas Eckelberry.  On April 26, 2012 the application published with the publication number WO/2012/054404. We are listed as the assignee.

· On November 11, 2011 we filed a trademark application with the USPTO to protect the intellectual property rights for our company logo “O”. On February 11, 2013 the trademark was issued with Certificate Number 4,284,801.

· On November 11, 2011 we filed a trademark application with the USPTO to protect the intellectual property rights for our company logo “OriginOil”. On February 11, 2013 the trademark was issued with Certificate Number 4,284,800.

· On January 30, 2012 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Systems and Methods for Harvesting and Dewatering Algae”. The inventor listed on the patent application is Nicholas Eckelberry. We are listed as the assignee.

· On March 12, 2012 we filed a utility patent application and PCT applications with the Korean Receiving Office to protect the intellectual property rights for “Enhancing Algae Growth by Reducing Competing Microorganisms in a Growth Medium”. The inventors listed on the patent application are Michael Green, Scott Fraser, Nicholas Eckelberry, and Jose Sanchez Pina. We are listed as the assignee. On November 27, 2012, the application published with the publication number WO/2012/129031.

· On April 17, 2012 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Solute Extraction From an Aqueous Medium Using a Modular Device”. The inventor listed on the patent application is Nicholas Eckelberry. We are listed as the assignee.

· On May 18, 2012 we filed a provisional patent application with the USPTO to protect the intellectual property rights for “Modular Systems and Methods for Extracting a Contaminant from a Solution”. The inventor listed on the patent application is Nicholas Eckelberry. We are listed as the assignee.

· On May 18, 2012 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Monitoring Systems for Biomass Processing Systems”. The inventors listed on the patent application are Paul Reep and Gavin Grey. We are listed as the assignee.

· On May 21, 2012 we filed a PCT application with the Korean Receiving Office to protect the intellectual property rights for “Monitoring Systems for Biomass Processing Systems”. The inventors listed on the patent application are Paul Reep and Gavin Grey. We are listed as the assignee.

· On September 6, 2012 the Australian Patent Office issued patent 2010239380 titled “Systems, Apparatus and Methods for Obtaining Intracellular Products and Cellular Mass and Debris from Algae and Derivative Products and Process of Use Thereof”. This application was nationalized from PCT application PCT/US2010/031756.

11

· On September 7, 2012 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Increasing Contact Between Solutes and Solvents in an Aqueous Medium”. The inventors listed on the patent application are Nicholas Eckelberry, Gavin Grey, Jose Sanchez Pina, and Maxwell Roth. We are listed as the assignee.

· On September 9, 2012 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Systems and Methods for Increasing Growth of Biomass Feedstocks”. The inventors listed on the patent application are Nicholas Eckelberry, Mike Green, and Jose Sanchez Pina. We are listed as the assignee.

· On October 10, 2012 we filed a PCT application with the Korean Receiving Office to protect the intellectual property rights for “Systems and Methods for Increasing Growth of Biomass Feedstocks”. The inventors listed on the patent application are Nicholas Eckelberry, Mike Green, and Jose Sanchez Pina.  We are listed as the assignee.

· On October 15, 2012 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Systems and methods for Developing Terrestrial and Algal Biomass Feedstocks and Bio-refining the Same”. The inventor listed on the patent application is Paul Reep. We are listed as the assignee.

· On October 18, 2012 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Systems and methods for Extracting Non-polar Lipids from an Aqueous Algae Slurry and Lipids Produced There from”. The inventors listed on the patent application are Nicholas Eckelberry, Michael Green and Scott Fraser. We are listed as the assignee.

· On October 19, 2012 we filed national stage  application with the EPO to protect the intellectual property rights for “Systems and methods for Extracting Non-polar Lipids from an Aqueous Algae Slurry and Lipids Produced There from”. The inventors listed on the patent application are Nicholas Eckelberry, Michael Green and Scott Fraser. We are listed as the assignee.

· On January 29, 2013 we filed a utility patent application with the USPTO to protect the intellectual property rights for “Systems and Methods for Harvesting and Dewatering Algae”. The inventor listed on the patent application is Nicholas Eckelberry. We are listed as the assignee.

· On January 30, 2013 we filed a PCT application with the Korean Receiving Office to protect the intellectual property rights for “Systems and Methods for Harvesting and Dewatering Algae”. The inventor listed on the patent application is Nicholas Eckelberry. We are listed as the assignee.

· On April 17, 2013 we filed a patent application with the USPTO to protect the intellectual property rights for “Harvesting and Dewatering Algae Using a Two-Stage Process”. The inventors listed on the patent application are Nicholas Eckelberry and Jose L. Sanchez Pina. We are listed as the assignee.  

· On April 17, 2013 we filed a PCT application with the USPTO to protect the intellectual property rights for “Harvesting and Dewatering Algae Using a Two-Stage Process”. The inventors listed on the patent application are Nicholas Eckelberry and Jose L. Sanchez Pina. We are listed as the assignee.

· On April 26, 2013 we filed a patent application with the USPTO to protect the intellectual property rights for “Producing Algae Biomass Having Reduced Concentration of Contaminants”. The inventor listed on the patent application is Jose L. Sanchez Pina. We are listed as the assignee.

· On July 15, 2013 we filed a patent application with the USPTO to protect the intellectual property rights for “Removing Ammonia from Water”. The inventors listed on the patent application are Nicholas Eckelberry, Jose L. Sanchez Pina and Andrew Davies. We are listed as the assignee.

· On September 9, 2013 we filed a patent application with the EPO, to protect the intellectual property rights for “Removing Compounds from Water Using a Series of Reactor Tubes Containing Cathodes Comprised of a Mixed Metal Oxide”. The inventors listed on the patent application are Nicholas Eckelberry, Jose L. Sanchez Pina and Scott Alexander Fraser. We are listed as the assignee.

· On December 17, 2013 we filed a patent application with the USPTO to protect the intellectual property rights for “Removing Compounds from Water Using a Series of Reactor Tubes Containing Cathodes Comprised of a Mixed Metal Oxide”. The inventors listed on the patent application are Nicholas Eckelberry, and Jose L. Sanchez Pina. We are listed as the assignee.

In 2008 we abandoned the pursuit of two provisional patent filings filed in relating to “In-Line Lysing And Extraction System for Microorganisms” and “Renewable Carbon Sequestering Method of Producing Pollution Free Electricity”. 

In 2009 we abandoned the pursuit of a provisional patent related to “Modular Portable Photobioreactor System”.

12

In 2010 we abandoned the pursuit of utility patent application related to “Device and Method for Separation, Cell Lysing and Flocculation of Algae from Water” and provisional patent application “Methods and Apparatus for Growing Algae on a Solid Surface”.

In 2011 we abandoned the pursuit of provisional patent application related to “Algae Growth Lighting and Control System”.

In 2012 we abandoned the pursuit of provisional patent filings related to “Multi-Plane Growth Apparatus and Method”, “Systems and Methods for Monitoring and Controlling Algae Growth and Harvesting Cellular Mass and Intracellular Products”, “Method for Extracting Intracellular Products from Microorganisms Using Gas Embolism”, “Algae Harvest Appliance”, “A System, Method And Apparatus To Produce Dewatered And Densified Algae Biomass” and foreign rights for “Bio-Energy Reactor”.

In 2013, we transferred the rights to the patents related to "Bio Energy Reactor", "Algae Growth System for Oil Production" and "Apparatus and Method for Optimizing Photosynthetic Growth in a Photo Bioreactor " to our partner Ennesys in France.

None of these abandoned or transferred patents are required for our business or products and we are focusing our efforts on the patent applications listed above.

Research and Development

During the years ended December 31, 2013 and 2012, we invested $1,072,548, and $980,170, respectively, on research and development of our technologies.  Research and development costs include activities related to development and innovations in the core Electro Water Separation™ (EWS) technology, fabrication and scale-up of products based on this technology, development of firmware and process automation, development of new applications in industries such as aquaculture, technical support of customers, agents, joint venture partners and licensees, on-site consulting and training activities, and miscellaneous research.

Employees

As of March 31, 2014, we have 10 full-time employees.  We have not experienced any work stoppages and we consider relations with our employees to be good. 

ITEM 1A. RISK FACTORS

Risks Relating to Our Business

We have a limited operating history which makes it difficult to evaluate our business and prospects.

We were formed in June 2007 and are currently developing a new technology that has not yet gained market acceptance. As such, we have a limited operating history upon which you can base an evaluation of our business and prospects. Since we have not been profitable, there are substantial risks, uncertainties, expenses and difficulties that we are subject to. To address these risks and uncertainties, we must do among the following:

● Successfully execute our business strategy;

● Respond to competitive developments; and

● Attract, integrate, retain and motivate qualified personnel;

There can be no assurance that at this time we will operate profitably or that we will have adequate working capital to meet our obligations as they become due. Investors must consider the risks and difficulties frequently encountered by early stage companies, particularly in rapidly evolving markets. We cannot be certain that our business strategy will be successful or that we will successfully address these risks. In the event that we do not successfully address these risks, our business, prospects, financial condition, and results of operations could be materially and adversely affected.

We have a history of losses and can provide no assurance of our future operating results.

We currently have limited product revenues, and may not succeed in commercializing any products which will generate product or licensing revenues. Until recently, our primary activity has been research and development. We have experienced net losses and negative cash flows from operating activities since inception and we expect such losses and negative cash flows to continue in the foreseeable future. As of December 31, 2013 and 2012, we had working capital (deficit) of ($1,535,766) and $(961,099), respectively, and shareholders' equity (deficit) of $(1,513,199) and $(540,896), respectively.  For the years ended December 31, 2013 and 2012, we incurred net losses of $(8,762,991) and $(10,570,029).  As of December 31, 2013, we had an aggregate accumulated deficit of $(36,330,103).  We may never achieve profitability.  The opinion of our independent registered public accountants on our audited financial statements as of and for the year ended December 31, 2013 contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern.  Our ability to continue as a going concern is dependent upon raising capital from financing transactions and future sales.

13

We will need significant additional capital, which we may be unable to obtain.

Revenues generated from our operations are not presently sufficient to sustain our operations. Therefore, we will need to raise additional capital to continue our operations. There can be no assurance that additional funds will be available when needed from any source or, if available, will be available on terms that are acceptable to us. We may be required to pursue sources of additional capital through various means, including debt or equity financings. Future financings through equity investments are likely to be dilutive to existing stockholders. Also, the terms of securities we may issue in future capital transactions may be more favorable for our new investors. Newly issued securities may include preferences, superior voting rights, the issuance of warrants or other derivative securities, and the issuances of incentive awards under equity employee incentive plans, which may have additional dilutive effects. Further, we may incur substantial costs in pursuing future capital and/or financing, including investment banking fees, legal fees, accounting fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we may issue, such as convertible notes and warrants, which will adversely impact our financial condition. Our ability to obtain needed financing may be impaired by such factors as the capital markets and our history of losses, which could impact the availability or cost of future financings. If the amount of capital we are able to raise from financing activities, together with our revenues from operations, is not sufficient to satisfy our capital needs, even to the extent that we reduce our operations accordingly, we may be required to cease operations.

We have incurred substantial indebtedness.

As of March 31, 2014, we have convertible notes with outstanding principal and accrued but unpaid interest of approximately $2,401,526. All such debt is payable within the following twelve months and is convertible at a significant discount to our market price of stock. Our level of indebtedness increases the possibility that we may be unable to generate cash sufficient to pay, when due, the principal of, interest on or other amounts due in respect of the indebtedness. Our indebtedness, combined with other financial obligations and contractual commitments, could:

·in the case of convertible debt that is converted into equity, result in a reduction in the overall percentage holdings of our stockholders, put downward pressure on the market price of our common stock, result in adjustments to conversion and exercise prices of outstanding notes and warrants and obligate us to issue additional shares of common stock to certain of our stockholders;

·make it more difficult for us to satisfy our obligations with respect to the indebtedness and any failure to comply with the obligations under any of our debt instruments, including restrictive covenants, could result in events of default under the loan agreements and instruments governing the indebtedness;

·require us to dedicate a substantial portion of our cash flow from operations to payments on  indebtedness, thereby reducing funds available for working capital, capital expenditures, acquisitions, research and development and other corporate purposes;

·increase our vulnerability to adverse economic and industry conditions, which could place us at a competitive disadvantage compared to competitors that have relatively less indebtedness;

·limit our flexibility in planning for, or reacting to, changes in business and the industry in which we operate; and

·limit our ability to borrow additional funds, or to dispose of assets to raise funds, if needed, for working capital, capital expenditures, acquisitions, research and development and other corporate purposes.

We may incur significant additional indebtedness in the future. If we incur a substantial amount of additional indebtedness, the related risks that we face could become more significant. Additionally, the terms of any future debt that we may incur may impose requirements or restrictions that further affect our financial and operating flexibility or subject us to other events of default.

Our revenues are dependent upon acceptance of our technology and products by the market; the failure of which would cause us to curtail or cease operations.

We believe that most of our future revenues will come from the sale or license of our technology and systems. As a result, we will continue to incur substantial operating losses until such time as we are able to generate revenues from the sale or license of our technology and systems. There can be no assurance that businesses and prospective customers will adopt our technology and systems, or that businesses and prospective customers will agree to pay for or license our technology and systems. In the event that we are not able to develop a customer base that purchases or licenses our technology and systems, or if we are unable to charge the necessary prices or license fees, our financial condition and results of operations will be materially and adversely affected.

14

We will need to increase the size of our organization, and may experience difficulties in managing growth.

We are a small company with a minimal number of employees. With the start of our planned principal activities, we expect to experience a period of significant expansion in headcount, facilities, infrastructure and overhead and anticipate that further expansion will be required to address potential growth and market opportunities. Future growth will impose significant added responsibilities on members of management, including the need to identify, recruit, maintain and integrate managers. Our future financial performance and our ability to compete effectively will depend, in part, on our ability to manage any future growth effectively.

We may not be able to successfully develop and commercialize our technology and systems which would result in continued losses and may require us to curtail or cease operations.

We are currently commercializing our technology. We are unable to project when we will achieve profitability, if at all. As is the case with any new technology, we expect the research and development process to continue. We cannot assure that our engineering resources will be able to develop our technology and systems fast enough to meet market requirements. We can also not assure that our technology and systems will gain market acceptance and that we will be able to successfully commercialize the technologies. The failure to successfully develop and commercialize the technologies would result in continued losses and may require us to curtail or cease operations.

Our ability to produce and distribute commercially viable bio-fuel, clean-up frac flowback water and aqua-feed on a commercially viable basis is unproven, which could have a detrimental effect on our ability to generate or sustain revenues.

The technologies we will use to transform algae into a new form of oil, to clean up frac flowback water and produce acqua-feed have never been utilized on a full-scale commercial basis. Our technology and systems, while intended to create a new bio-fuel feedstock for many products such as diesel, gasoline, jet fuel, plastics and solvents, is in fact a new bio-fuel that may never achieve technical or commercial viability and our Electro Water Separation technology was only recently developed. All of the tests conducted to date by us with respect to the technology have been performed in a limited scale or small commercial scale environment and the same or similar results may not be obtainable at competitive costs on a large-scale commercial basis. We have never utilized technology under the conditions or in the volumes that will be required for us to be profitable and cannot predict all of the difficulties that may arise. Accordingly, our technology may not perform successfully on a commercial basis and may never generate any revenues or be profitable.

If a competitor were to achieve a technological breakthrough, our operations and business could be negatively impacted.

There currently exist a number of businesses that are pursuing the use of algae, bacteria and other micro-crops and other methods for creating biomass and other alternative fuels. Should a competitor achieve a research and development, technological or biological breakthrough where production costs are significantly reduced, or if the costs of similar competing products were to fall substantially, we may have difficulty attracting customer licensees. In addition, competition from other technologies considered “green technologies” could lessen the demand for the end-products produced by our technology. Furthermore, competitors may have access to larger resources (capital or otherwise) that provide them with an advantage in the marketplace, which could result in a negative impact on our business.

Any competing technology that produces biomass of similar quality, at a superior growth rate and more cost efficient than ours, could render our technology obsolete. In addition, because we do not have any issued patents for all but one of our patent applications, we may not be able to preclude development of even directly competing technologies using the same methods, materials and procedures as we use to achieve our results. Any of these competitive forces may inhibit or materially adversely affect our ability to attract customer licensees, or to obtain royalties or other fees from our customer licensees. This could have a material adverse effect on our business, prospects, results of operation and financial condition.

Our long-term success depends on future royalties paid to us by licensees, and we face the risks inherent in a royalty-based business model.

We intend to generate revenue through the licensing of our technology and systems, and our long-term success depends on future royalties paid to us by prospective customer licensees. The amount of royalty payments we may receive is expected to be based upon the revenues generated by our prospective customer licensees’ operations, and so we will be dependent on the successful operations of our prospective customer licensees for a significant portion of our revenues. We face risks inherent in a royalty-based business model, many of which are outside of our control, including those arising from our reliance on the management and operating capabilities of our customer licensees and the cyclicality of supply and demand for end-products produced using our technology. Should our prospective customer licensees fail to achieve sufficient profitability in their operations, our royalty payments would be diminished and our results of operations, cash flows and financial condition could be adversely affected, and any such effects could be material.

15

We rely on strategic partners.

We rely on strategic partners to aid in the development and marketing of our technology and processes. Should our strategic partners not regard us as significant to their own businesses, they could reduce their commitment to us or terminate their relationship with us, pursue competing relationships or attempt to develop or acquire products or services that compete with the end-products produced using our technology. Any such action could materially adversely affect our business.

A lack of government subsidies for the algae industry may hinder the usefulness of our technology.

Our business model is based on licensing our technology to distributors, manufacturers, engineering service firms, specialty operators, as well as, fuel refiners, chemical and oil companies, for building, installing and operating algae production systems in varied applications for bio-fuels, bio-chemicals, and animal feed and human nutritional feedstocks.  We are not in the business of producing and marketing oil or fuel, based on algae, as an end product, nor of building machinery for customers to build refining plants.  As a result, our business is not currently subject to government regulation for the production, distribution, and/or use of its technology.

We are however part of a new and emerging algae industry that may be subject to economic and other regulations that may have an adverse effect on the entire industry and subsequently our business. For example, the cost of biofuels has historically been higher than petroleum, therefore the lack of governmental subsidies for biofuels based on algae may limit the demand and marketability of our technology. There is no assurance that the biofuels industry, or any industry we market to, will have the need or the financial ability to use our technology. If government regulations on the electrical industry or fossil fuel industry were enacted, it may affect the outlook for oil from algae.

If we lose key employees and consultants or are unable to attract or retain qualified personnel, our business could suffer.

Our success is highly dependent on our ability to attract and retain qualified scientific, engineering and management personnel. We are highly dependent on our management, including T. Riggs Eckelberry, who has been critical to the development of our technology and business. The loss of the services of Mr. Eckelberry would have a material adverse effect on our operations. We do not have an employment agreement with Mr. Eckelberry. Accordingly, there can be no assurance that he will remain associated with us. His efforts will be critical to us as we continue to develop our technology and as we attempt to transition to a company with profitable company commercialized products and services. If we were to lose Mr. Eckelberry, or any other key employees or consultants, we may experience difficulties in competing effectively, developing our technology and implementing our business strategies.

Competition from other companies in our market and from producers of other alternative fuels may affect the market for our technology.

If prices of energy on the commodities markets, including oil and bio-diesel, rise, as they have in recent years, competition from other alternative fuels will likely increase. Additionally, new companies are constantly entering the market, thus increasing the competition. This could also have a negative impact on us or our customers’ ability to obtain additional capital from investors. Larger foreign owned and domestic companies which have been engaged in the alternative energy business for substantially longer periods of time may have access to greater financial and other resources. These companies may have greater success in the recruitment and retention of qualified employees, as well as in conducting their own fuel manufacturing and marketing operations, which may give them a competitive advantage. In addition, actual or potential competitors may be strengthened through the acquisition of additional assets and interests. If we or our customers are unable to compete effectively or adequately respond to competitive pressures, this may materially adversely affect our results of operation and financial condition.

Risks Related to Our Intellectual Property

If we fail to establish, maintain and enforce intellectual property rights with respect to our technology, our financial condition, results of operations and business could be negatively impacted.

Our ability to establish, maintain and enforce intellectual property rights with respect to the technology that we intend to license will be a significant factor in determining our future financial and operating performance. We seek to protect our intellectual property rights by relying on a combination of patent, trade secret and copyright laws. We also use confidentiality and other provisions in our agreements that restrict access to and disclosure of our confidential know-how and trade secrets.

We have filed patent applications with respect to many aspects of our technologies. However, we cannot provide any assurances that any of these applications will ultimately result in issued patents or, if patents are issued, that they will provide sufficient protections for our technology against competitors. Although we have filed various patent applications for some of our core technologies, we currently hold only two issued patents, one in Australia and one in Japan, and we may face delays and difficulties in obtaining our other filed patents, or we may not be able to obtain such patents at all. 

16

Outside of these patent applications, we seek to protect our technology as trade secrets and technical know-how. However, trade secrets and technical know-how are difficult to maintain and do not provide the same legal protections provided by patents. In particular, only patents will allow us to prohibit others from using independently developed technology that are similar. If competitors develop knowledge substantially equivalent or superior to our trade secrets and technical know-how, or gain access to our knowledge through other means such as observation of our technology that embodies trade secrets at customer sites which we do not control, the value of our trade secrets and technical know-how would be diminished.

While we strive to maintain systems and procedures to protect the confidentiality and security of our trade secrets and technical know-how, these systems and procedures may fail to provide an adequate degree of protection. For example, although we generally enter into agreements with our employees, consultants, advisors, and strategic partners restricting the disclosure and use of trade secrets, technical know-how and confidential information, we cannot provide any assurance that these agreements will be sufficient to prevent unauthorized use or disclosure. In addition, some of the technology deployed at customer sites in the future, which we do not control, may be readily observable by third parties who are not under contractual obligations of non-disclosure, which may limit or compromise our ability to continue to protect such technology as a trade secret.

In addition, on September 25, 2012, we filed a complaint in the US District Court Central District of California against MBD Energy Limited to protect our intellectual property. MBD was our first pilot customer who previously purchased from us test scale algae processing equipment as well as larger scale units. On December 20, 2012, we entered into a settlement agreement with MBD pursuant to which we agreed to a final settlement and release of claims in connection with the complaint.  On March 1, 2013, an order was entered dismissing the action without prejudice.

Monitoring and policing unauthorized use and disclosure of intellectual property is difficult. If we learned that a third party was in fact infringing or otherwise violating our intellectual property, we may need to enforce our intellectual property rights through litigation. Litigation relating to our intellectual property may not prove successful and might result in substantial costs and diversion of resources and management attention.

From our customer licensee’s standpoint, the strength of the intellectual property under which we intend to grant licenses can be a critical determinant of the value of these licenses. If we are unable to secure, protect and enforce our intellectual property, it may become more difficult for us to attract new customers.  Any such development could have a material adverse effect on our business, prospects, financial condition and results of operations.

Although we have filed various patent applications for some of our core technologies, we currently hold only two issued patents, one in Australia and one in Japan, and we may face delays and difficulties in obtaining other filed patents, or we may not be able to obtain such patents at all.

Patents are a key element of our intellectual property strategy. We have over forty currently pending patent applications in the United States and abroad but, to date, other than the two issued patents, no patents have been issued from these other applications. It may take a long time for any patents to issue from the applications, and we cannot provide any assurance that any patents will ultimately be issued or that any patents that do ultimately issue will issue in a form that will adequately protect our commercial advantage.

Our ability to obtain patent protection for our technologies is uncertain due to a number of factors, including that we may not have been the first to make the inventions covered by our pending patent applications or to file patent applications for these inventions.

Further, changes in U.S. and foreign patent law may also impact our ability to successfully prosecute our patent applications. For example, the United States Congress and other foreign legislative bodies may amend their respective patent laws in a manner that makes obtaining patents more difficult or costly. Courts may also render decisions that alter the application of patent laws and detrimentally affect our ability to obtain patent protection. 

Even if patents do ultimately issue from our patent applications, these patents may not provide meaningful protection or commercial advantage. In the US, patents only provide protection for a 20-year period starting from the filing date and the longer a patent application takes to issue the less time there is to enforce it. Further, the claims under any patents that issue from our applications may not be broad enough to prevent others from developing technologies that are similar or that achieve similar results. It is also possible that the intellectual property rights of others will bar us from licensing our technology and bar us or our future licensees from exploiting any patents that issue from our pending applications. Numerous U.S. and foreign issued patents and pending patent applications owned by others exist in the fields in which we have developed and are developing our technology. These patents and patent applications might have priority over our patent applications and could subject our patent applications to invalidation. Finally, in addition to those who may claim priority, any patents that issue from our applications may also be challenged by our competitors on the basis that they are otherwise invalid or unenforceable.

17

We may face claims that we are violating the intellectual property rights of others.

We may face claims, including from direct competitors, other energy companies, scientists or research universities, asserting that our technology or the commercial use of such technology infringes or otherwise violates the intellectual property rights of others. We have not conducted infringement, freedom to operate or landscape analyses, and as a result we cannot be certain that our technologies and processes do not violate the intellectual property rights of others. We expect that we may increasingly be subject to such claims as we begin to earn revenues and our market profile grows.

We may also face infringement claims from the employees, consultants, agents and outside organizations we have engaged to develop our technology. While we have sought to protect ourselves against such claims through contractual means, we cannot provide any assurance that such contractual provisions are adequate, and any of these parties might claim full or partial ownership of the intellectual property in the technology that they were engaged to develop.

If we were found to be infringing or otherwise violating the intellectual property rights of others, we could face significant costs to implement work-around methods, and we cannot provide any assurance that any such work-around would be available or technically equivalent to our current technology. In such cases, we might need to license a third party’s intellectual property, although any required license might not be available on acceptable terms, or at all. If we are unable to work around such infringement or obtain a license on acceptable terms, we might face substantial monetary judgments against us or an injunction against continuing to license our technology, which might cause us to cease operations.

In addition, even if we are not infringing or otherwise violating the intellectual property rights of others, we could nonetheless incur substantial costs in defending ourselves in suits brought against us for alleged infringement. Also, if any license agreements provide that we will defend and indemnify our customer licensees for claims against them relating to any alleged infringement of the intellectual property rights of third parties in connection with such customer licensees’ use of our technologies, we may incur substantial costs defending and indemnifying any customer licensees to the extent they are subject to these types of claims. Such suits, even if without merit, would likely require our management team to dedicate substantial time to addressing the issues presented. Any party bringing claims might have greater resources than we do, which could potentially lead to us settling claims against which we might otherwise prevail on the merits.

Any claims brought against us or any customer licensees alleging that we have violated the intellectual property of others could have negative consequences for our financial condition, results of operations and business, each of which could be materially adversely affected as a result.

Risks Related to Our Common Stock

Our common stock could be further diluted as the result of the issuance of additional shares of common stock, convertible securities, warrants or options.

In the past, we have issued common stock, convertible securities (such as convertible debentures and notes) and warrants in order to raise money, some of which have anti-dilution and other similar protections. We have also issued options and warrants as compensation for services and incentive compensation for our employees and directors. We have shares of common stock reserved for issuance upon the exercise of certain of these securities and may increase the shares reserved for these purposes in the future. Our issuance of additional common stock, convertible securities, options and warrants could affect the rights of our stockholders, result in a reduction in the overall percentage holdings of our stockholders, could put downward pressure on the market price of our common stock, could result in adjustments to conversion and exercise prices of outstanding notes and warrants, and could obligate us to issue additional shares of common stock to certain of our stockholders.

There may be a limited public market for our securities.

Trading in our common stock continues to be conducted on the electronic bulletin board in the over-the-counter market. As a result, an investor may find it difficult to dispose of or to obtain accurate quotations as to the market value of our common stock, and our common stock may be less attractive for margin loans, for investment by financial institutions, as consideration in future capital raising transactions or other purposes.

We may be unable to list our common stock on NASDAQ or on any securities exchange.

Our common stock currently does not meet all of the requirements for initial listing on a registered stock exchange. Although we may apply to list our common stock on NASDAQ or the NYSE MKT in the future, we cannot assure you that we will be able to meet the initial listing standards, including the minimum bid price per share and minimum capitalization requirements, or that we will be able to maintain a listing of our common stock on either of those or any other trading venue. Until such time as we qualify for listing on NASDAQ, the NYSE MKT or another trading venue, we expect our common stock will continue to trade on electronic bulletin board in the over-the-counter market.

18

The price of our common stock is volatile, which may cause investment losses for our stockholders.

The market for our common stock is highly volatile, having ranged in the last twelve months from a low of $0.16 to a high of $0.69 on the OTCBB. The trading price of our common stock on the OTCBB is subject to wide fluctuations in response to, among other things, quarterly variations in operating and financial results, and general economic and market conditions. In addition, statements or changes in opinions, ratings, or earnings estimates made by brokerage firms or industry analysts relating to our market or relating to us could result in an immediate and adverse effect on the market price of our common stock. The highly volatile nature of our stock price may cause investment losses for our shareholders. In the past, securities class action litigation has often been brought against companies following periods of volatility in the market price of their securities. If securities class action litigation is brought against us, such litigation could result in substantial costs while diverting management’s attention and resources.

Shares eligible for future sale may adversely affect the market.

From time to time, certain of our stockholders may be eligible to sell all or some of their shares of common stock by means of ordinary brokerage transactions in the open market pursuant to Rule 144 promulgated under the Securities Act, subject to certain limitations. In general, pursuant to Rule 144, non-affiliate stockholders may sell freely after six months subject only to the current public information requirement. Affiliates may sell after six months subject to the Rule 144 volume, manner of sale (for equity securities), current public information and notice requirements.  Mr. Eckelberry, our Chief Executive Officer and Chairman, previously sold an aggregate of 765,908 and beneficially owns 1,106,812 shares of our common stock as of March 31, 2014. Any substantial sales of our common stock pursuant to Rule 144 may have a material adverse effect on the market price of our common stock.

Our stock is subject to the penny stock rules, which impose significant restrictions on broker-dealers and may affect the resale of our stock.

Our common stock has been subject to the provisions of Section 15(g) and Rule 15g-9 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), commonly referred to as the “penny stock” rule. Section 15(g) sets forth certain requirements for transactions in penny stocks and Rule 15g-9(d)(1) incorporates the definition of penny stock as that used in Rule 3a51-1 of the Exchange Act. The SEC generally defines penny stock to be any equity security that has a market price less than US$5.00 per share, subject to certain exceptions. Rule 3a51-1 provides that any equity security is considered to be penny stock unless that security is: registered and traded on a national securities exchange meeting specified criteria set by the SEC; issued by a registered investment company; excluded from the definition on the basis of price (at least US$5.00 per share) or the registrant’s net tangible assets; or exempted from the definition by the Commission. Our common stock is considered to be a “penny stock.” The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in “penny stocks.” As our common stock is considered to be “penny stock,” trading in our common stock will be subject to additional sales practice requirements on broker-dealers who sell penny stock to persons other than established customers and accredited investors. This may reduce the liquidity and trading volume of our shares.

Financial Industry Regulatory Authority, Inc. (“FINRA”) sales practice requirements may limit a shareholder’s ability to buy and sell our common shares.

In addition to the “penny stock” rules described above, FINRA has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced securities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market for our shares.

If we fail to maintain effective internal controls over financial reporting, the price of our common stock may be adversely affected.

Our internal control over financial reporting may have weaknesses and conditions that could require correction or remediation, the disclosure of which may have an adverse impact on the price of our common stock.  We are required to establish and maintain appropriate internal controls over financial reporting.  Failure to establish those controls, or any failure of those controls once established, could adversely affect our public disclosures regarding our business, prospects, financial condition or results of operations.  In addition, management’s assessment of internal controls over financial reporting may identify weaknesses and conditions that need to be addressed in our internal controls over financial reporting or other matters that may raise concerns for investors.  Any actual or perceived weaknesses and conditions that need to be addressed in our internal control over financial reporting or disclosure of management’s assessment of our internal controls over financial reporting may have an adverse impact on the price of our common stock.

We are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002 and if we fail to comply in a timely manner, our business could be harmed and our stock price could decline.

Rules adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 require an annual assessment of internal controls over financial reporting, and for certain issuers an attestation of this assessment by the issuer’s independent registered public accounting firm.  The standards that must be met for management to assess the internal controls over financial reporting as effective are evolving and complex, and require significant documentation, testing, and possible remediation to meet the detailed standards.  We expect to incur significant expenses and to devote resources to Section 404 compliance on an ongoing basis.  It is difficult for us to predict how long it will take or costly it will be to complete the assessment of the effectiveness of our internal control over financial reporting for each year and to remediate any deficiencies in our internal control over financial reporting. As a result, we may not be able to complete the assessment and remediation process on a timely basis.  In addition, although attestation requirements by our independent registered public accounting firm are not presently applicable to us we could become subject to these requirements in the future and we may encounter problems or delays in completing the implementation of any resulting changes to internal controls over financial reporting.  In the event that our Chief Executive Officer or Chief Financial Officer determine that our internal control over financial reporting is not effective as defined under Section 404, we cannot predict how regulators will react or how the market prices of our shares will be affected; however, we believe that there is a risk that investor confidence and share value may be negatively affected.

19

We do not intend to pay dividends.

We do not anticipate paying cash dividends on our common stock in the foreseeable future. We may not have sufficient funds to legally pay dividends. Even if funds are legally available to pay dividends, we may nevertheless decide in our sole discretion not to pay dividends. The declaration, payment and amount of any future dividends will be made at the discretion of our board of directors, and will depend upon, among other things, the results of our operations, cash flows and financial condition, operating and capital requirements, and other factors our board of directors may consider relevant. There is no assurance that we will pay any dividends in the future, and, if dividends are paid, there is no assurance with respect to the amount of any such dividend.

ITEM 1B. UNRESOLVED STAFF COMMENTS

Not applicable.

ITEM 2. PROPERTIES.

Our principal offices are located at 5645 West Adams Blvd., Los Angeles, CA 90016. We rent 7,500 square feet of space in a corporate building at a current monthly rent of $10,950. Our lease expires August 31, 2016.

ITEM 3. LEGAL PROCEEDINGS.

From time to time we may be a defendant and plaintiff in various legal proceedings arising in the normal course of our business. We are currently not a party to any pending legal proceeding, nor is our property the subject of a pending legal proceeding, that is not in the ordinary course of business or otherwise material to the financial condition of our business. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS ISSUER PURCHASES OF EQUITY SECURITIES.

Our common stock is quoted on the OTC Bulletin Board under the symbol “OOIL”.

For the periods indicated, the following table sets forth the high and low bid prices per share of common stock. These prices represent inter-dealer quotations without retail markup, markdown, or commission and may not necessarily represent actual transactions. Where applicable, the prices set forth below give retroactive effect to our one-for-thirty reverse stock split which became effective on August 11, 2011.

	Fiscal Year 2012
	High		Low
First Quarter	$	1.95	$	1.50
Second Quarter	$	1.85	$	0.73
Third Quarter	$	1.28	$	0.82
Fourth Quarter	$	0.99	$	0.76

	Fiscal Year 2013
	High		Low
First Quarter	$	0.82	$	0.46
Second Quarter	$	0.69	$	0.30
Third Quarter	$	0.39	$	0.23
Fourth Quarter	$	0.36	$	0.16

20

The market price of our common stock, like that of other technology companies, is highly volatile and is subject to fluctuations in response to variations in operating results, announcements of technological innovations or new products, or other events or factors. Our stock price may also be affected by broader market trends unrelated to our performance.

Holders

As of March 31, 2014, we had approximately 420 holders of record of our common stock.  This number does not include beneficial owners whose shares are held in the names of various security brokers, dealers, and registered clearing agencies.

Dividend Policy

We have never paid any cash dividends on our common stock and do not anticipate paying any cash dividends on our common stock in the foreseeable future. We intend to retain future earnings to fund ongoing operations and future capital requirements of our business. Any future determination to pay cash dividends will be at the discretion of the board of directors and will be dependent upon our financial condition, results of operations, capital requirements and such other factors as the board of directors deems relevant.

Recent Sales of Unregistered Securities

There were no sales of unregistered securities during the fiscal year ended December 31, 2013 other than those transactions previously reported to the SEC on our quarterly reports on Form 10-Q and current reports on Form 8-K.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

ITEM 6. SELECTED FINANCIAL DATA

N/A

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION.

The following discussion and analysis should be read together with our financial statements and the related notes appearing elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. See “Forward-Looking Statements” for a discussion of the uncertainties, risks and assumptions associated with these statements. Actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under “Risk Factors” and elsewhere in this prospectus.

Overview of Business

We have developed a breakthrough water cleanup technology for the oil and gas, algae and other water-intensive industries.

Unlike other technologies, our patent-pending Electro Water Separation™ (EWS) process rapidly and efficiently removes organic material from large quantities of water without the need for chemicals.

EWS, our breakthrough water cleanup technology, is a high-speed, chemical-free process that efficiently extracts organic contaminants from very large quantities of water.  It is the core technology powering OriginOil’s innovative product line that spans multiple industries. These include:

Algae Harvesting

EWS is used cost-effectively to harvest algae, intact and bacteria-free, without chemicals, at a continuously high flow rate. Systems can be operated in parallel for increased throughput rates. Built-in intelligence ensures a minimum of operator intervention.

21

Oil and Gas Water Cleanup

When applied to the oil and gas industry, EWS technology is used in a continuous process to remove oils, suspended solids, insoluble organics and bacteria from produced and frac flowback water in well operations. This allows the water to be easily recycled for future fracking operations or disposed of safely.

Aquaculture Water Cleanup

EWS operates in a continuous, chemical-free loop to dramatically reduce ammonia levels, and kill up to 98% of bacteria and other invaders, potentially eliminating antibiotics usage. Optionally, it can produce nitrate-rich water to grow algae for highly nutritious and cost-effective fish feed.

Organic Waste Remediation (still in prototype phase)

In many applications, such as agriculture, fish farming and animal farming, EWS can efficiently remove organic contaminants and pathogens from incoming or outgoing water supplies.

Business Model for All Applications

At this early stage, to prove our systems for wide-scale distribution and licensing, we must build, sell and support our system to companies making use of such systems.

Our long-term business model is based on licensing this technology to distributors, manufacturers, engineering service firms, and specialty operators, as well as fuel refiners, chemical and oil companies. We are not in the business of producing and marketing oil or fuel as an end product, nor of engaging in volume manufacturing.

We have only been engaged in our current and proposed business operations since June 2007. While continuing to engage in research and development, we recently moved into the commercialization phase of our business plan.

Critical Accounting Policies

The Securities and Exchange Commission ("SEC") defines "critical accounting policies" as those that require application of management's most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Not all of the accounting policies require management to make difficult, subjective or complex judgments or estimates. However, the following policies could be deemed to be critical within the SEC definition. 

 Revenue Recognition

We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, and the fair value of stock options, warrants, convertible notes and common stock for services. Actual results could differ from those estimates.

Fair Value of Financial Instruments

Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2013, the amounts reported for cash, prepaid expenses, accounts payable and accrued expenses approximate the fair value because of their short maturities.

Recently Issued Accounting Pronouncements

Management reviewed accounting pronouncements issued during the year ended December 31, 2013, and the Company adopted certain pronouncements during the period.  (See Notes to Financial Statements, No. 2, Summary of Significant Accounting Policies, Recently Issued Accounting Pronouncements.)

22

OOIL

Results of Operations for the year ended December 31, 2013 compared to the year ended December 31, 2012.

	Year Ended
	December 31, 2013			December 31, 2012
Revenue	$	140,500		$	588,163
Cost Of Goods Sold		50,510			401,647
Operating Expenses, Depreciation and Amortization		6,634,802			5,936,090
Loss from Operations before Other Income/(Expense)		(6,544,812	)		5,749,574
Other Income/(Expense)		(2,218,179	)		(4,820,456	)
Net Loss	$	(8,762,991	)	$	(10,570,029	)

Revenue and Cost of Sales

Revenue for the year ended December 31, 2013 and 2012 was $140,500 and $588,163, respectively. Cost of sales for the year ended December 31, 2013 and 2012, was $50,510 and $401,647, respectively. To date we have had minimal revenues due to our focus on product development and testing.  In addition, our equipment sales are primarily for trial purposes, intended for licensing or private labeling type transactions, which we believe have the potential to yield stronger long term revenue.

Operating Expenses

Selling and General Administrative Expenses

Selling and general administrative (“SG&A”) expenses increased by $288,645 to $5,244,565 for the year ended December 31, 2013, compared to $4,955,920 for the year ended December 31, 2012. The majority of the increase in SG&A expenses was due primarily to the increase in marketing expense of $251,342, payroll expense of $69,346, with a net decrease in overall SG&A expenses of $32,043.

Research and Development Cost

Research and development (“R&D”) costs increased by $92,378 to $1,072,548 for the year ended December 31, 2013, compared to $980,170 for the year ended December 31, 2012.   The increase in overall R&D costs was primarily due to an increase in   the purchase of durable items for testing.

Impairment of Patents

As of December 31, 2012, we had unamortized capitalized patent costs of $317,689.  We initially determined that our patents have a finite useful life which were to be amortized over their useful life.  We performed our annual impairment test of our capitalized patents as of December 31, 2013, and determined that such costs were impaired and recorded an impairment loss of $317,689 at December 31, 2013.

Other Income and (Expense)

Other income and (expense) decreased by $2,602,277 to ($2,218,179) for the year ended December 31, 2013, compared to ($4,820,456) for the year ended December 31, 2012. The decrease was the result of a decrease in non-cash accounts associated with the fair value of the derivatives in the amount of $3,395,755 due to debt financing, with an increase in non-cash cost of modification of warrants in the amount of $645,398, foreign exchange loss of $3,096, and interest expense of $151,176.

Net Loss

Our net loss decreased by $1,807,038 to $8,762,991 for the year ended December 31, 2013, compared to a net loss of $10,570,029 for the year ended December 31, 2012. The majority of the decrease in net loss was due primarily to a decrease in other income and (expenses) of $2,602,277, and gross profit of $96,527, with an increase in SG&A expenses of $288,645, R&D in the amount of $92,378, and impairment of patents in the amount of $317,689.  Currently operating costs exceed revenue because sales are not yet sufficient to cover costs.  We cannot assure of when or if revenue will exceed operating costs.

23

 Liquidity and Capital Resources

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

During the year ended December 31, 2013, we did not generate significant revenue, incurred a net loss of $8,762,991 and cash used in operations of $4,488,315. As of December 31, 2013, we had a working capital deficit of $1,535,766 and a shareholders’ deficit of $1,513,199. These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2013 expressed substantial doubt about our ability to continue as a going concern. The ability of us to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. We have obtained funds from its shareholders in the year ended December 31, 2013, and have standing purchase orders and open invoices with customers. Management believes this funding will continue from its’ current investors and has also obtained funding from new investors. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet our obligations as they become due, and will allow the development of our core business operations.

At December 31, 2013 and December 31, 2012, we had cash of $821,448 and $507,355, respectively and working capital deficit of $1,535,766 and $961,099 respectively.  The increase in working capital deficit was primarily due to an increase in cash, derivative liabilities and convertible promissory notes, with a decrease in work-in-process, prepaid expenses, other receivables, accounts payable and accrued expenses.

During the year ended December 31, 2013, we raised an aggregate of $2,395,000 in an offering of unsecured convertible notes and $2,463,368 in an offering of shares of our common stock and warrants.  During the subsequent period, we raised an aggregate of $885,000 for unsecured convertible notes. Our ability to continue as a going concern is dependent upon raising capital from financing transactions and future revenue.

Net cash used in operating activities was $(4,488,315) for the year ended December 31, 2013, compared to $(3,102,421) for the year end December 31, 2012. The increase of $1,385,894 in cash used in operating activities was primarily due to an increase in non-cash fair value of stock and warrant compensation, with a net increase in fair value of derivatives. The net loss includes operating expenses and other income and (expenses).  Currently, operating costs exceed revenue because sales are not yet significant.

Net cash used in investing activities for the year ended December 31, 2013 and 2012 were $(45,960) and $(173,065) respectively.  The net decrease in cash used in investing activities was due to expensing the patents, rather than capitalizing compared to the previous year.

Net cash provided by financing activities was $4,848,368 for the year ended December 31, 2013, as compared to $3,584,973 for the year end December 31, 2012.  The increase in cash provided by financing activities was due to an increase in debt and equity financing.  To date we have principally financed our operations through the sale of our common stock and the issuance of debt.

We do not have any material commitments for capital expenditures during the next twelve months.  Although our proceeds from the issuance of convertible debt, our offering of shares of common stock and warrants together with revenue from operations are currently sufficient to fund our operating expenses, we will need to raise additional funds in the future so that we can expand our operations. Therefore, our future operations are dependent on our ability to secure additional financing.  Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms.  However, the trading price of our common stock and a downturn in the U.S. equity and debt markets could make it more difficult to obtain financing through the issuance of equity or debt securities. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Furthermore, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. The inability to obtain additional capital may restrict our ability to grow and may reduce our ability to continue to conduct business operations. If we are unable to obtain additional financing, we may have to curtail our marketing and development plans and possibly cease our operations.

We have estimated our current average burn, and believe that we have assets to ensure that we can function without liquidation over the next 9 months, due to our cash on hand, our ability to raise money from our investor base and future expected revenue.  Based on the aforesaid, we believe we have the ability to continue our operations for the foreseeable future and will be able to realize assets and discharge liabilities in the normal course of operations.

Off-Balance Sheet Arrangements

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, and results of operations, liquidity or capital expenditures.

24

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

All financial information required by this Item is attached hereto at the end of this report beginning on page F-1 and is hereby incorporated by reference.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

None

ITEM 9A. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures, as defined in Rules 13a-15(e) and 15(d)-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified by the rules promulgated by the SEC, and that such information is accumulated and communicated to management, including the chief executive officer and the chief financial officer, as appropriate, to allow timely decisions regarding required financial disclosure.

In connection with the preparation of this Annual Report on Form 10-K, we completed an evaluation, as of December 31, 2013, under the supervision of and with participation from this company’s management, including the current Chief Executive Officer and acting Chief Financial Officer, as to the effectiveness of the design and operation of our disclosure controls and procedures.  Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December 31, 2013, management, the Chief Executive Officer and the acting Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level at that date.

Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting for us, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external reporting purposes in accordance with GAAP. 

Our internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized use, acquisition, or disposition of this company’s assets that could have a material effect on the consolidated financial statements.

In making its assessment of the effectiveness of our internal control over financial reporting as of December 31, 2013, management used the criteria established in the Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).  A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Based on the criteria established by COSO, management determined that we did not have sufficient financial reporting personnel to adequately and timely record certain of our complex financial and financing transactions.  Accordingly, as a result of the foregoing weaknesses our Chief Executive Officer and acting Chief Financial Officer concluded that, as of December 31, 2013, we did not maintain effective internal control over financial reporting based on COSO.

To remedy the weaknesses, our Chief Executive Officer and acting Chief Financial Officer has asked an independent director to recommend additional entity level controls and additional procedures to bring our internal control procedures into compliance with the criteria established by COSO. We intend to implement these changes during 2014.  In addition, in order to remedy the identified weaknesses, we intend to engage an independent consultant to assist us with our complex financial and financing transactions.

In light of the material weaknesses described above, we  performed additional analyses and other procedures to ensure that our financial statements included in this Annual Report on Form 10-K were prepared in accordance with GAAP.  These measures included expanded year-end closing procedures, the dedication of significant internal resources and external consultant to scrutinize account analyses and reconciliations and management’s own internal reviews and efforts to remediate the material weaknesses in internal control over financial reporting described above.  As a result of these measures, management concluded that our consolidated financial statements included in this Annual Report on Form 10-K present fairly, in all material respects, our financial position, results of operations and cash flows as of the dates, and for the periods, presented in conformity with GAAP.

Pursuant to applicable SEC’s rules and regulations, we are not required to obtain an attestation report of our independent registered public accounting firm regarding internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls.

Internal control over financial reporting may not prevent or detect all errors and all fraud. Also, projections of any evaluation of effectiveness of internal control to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

25

Changes in internal controls

There were no changes (including corrective actions with regard to significant deficiencies or material weaknesses) in our internal controls over financial reporting that occurred during the quarter ended December 31, 2013 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION.

The following disclosure would have otherwise been filed on Form 8-K under the headings:

Cancellation of Series A Certificate of Designation

The following disclosure would have otherwise been filed on Form 8-K under the heading “Item 3.03 Material Modification to Rights of Security Holders” and “Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year”:

As previously disclosed, on December 31, 2013, we filed a Certificate of Designation for our Series A Preferred Stock with the Secretary of State of Nevada designating 1,000 shares of our authorized preferred stock as Series A Preferred Stock and subsequently issued to T. Riggs Eckelberry, our Chief Executive Officer, 1,000 shares of Series A Preferred Stock. The shares of Series A Preferred Stock had a par value of $0.0001 per share. The Series A Preferred Stock did not have a dividend rate or liquidation preference and were not convertible into shares of common stock. The Series A Preferred Stock had supermajority preferred voting rights effective from June 26, 2014.

Following our agreement with Mr. Eckelberry to cancel the 1,000 shares of Series A Preferred Stock issued to him, after which there were no shares of Series A Preferred Stock outstanding, on April 9, 2014, we filed with the Secretary of State of Nevada a Certificate of Withdrawal of Certificate of Designation for our Series A Preferred Stock which had the effect of cancelling the Certificate of Designation of our Series A Preferred Stock.

A copy of the Certificate of Withdrawal is attached to this Annual Report on Form 10-K as Exhibit 3.1.

Management Restricted Stock Grant Awards

The following disclosure would have otherwise been filed on Form 8-K under the heading “Item 3.02 Unregistered Sales of Equity Securities” and “Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers”:

As previously disclosed, on January 10, 2014, ourboard of directors authorized the entering into of restricted stock grant agreements providing for the grant of an aggregate of 45,000,000 shares of common stock including 30,000,000 shares to T. Riggs Eckelberry, our Chief Executive Officer and Chairman, 7,500,000 shares to Nicholas Eckelberry, a co-founder and brother of T. Riggs Eckelberry, 3,750,000 shares to William Charneski, our General Manager, Petro Division and 3,750,000 shares to Jean-Louis Kindler, our Chief Commercial Officer and director. The shares were eligible for issuance subject to the satisfaction of certain performance criteria and if such performance criteria were met, the shares then became eligible for vesting on a monthly basis. Prior to the issuance or vesting of any of the shares, each of the grantees mutually agreed with us to the termination of the restricted stock grant agreements.

Subsequently, on April 9, 2014, our board of directors authorized the entering into of new restricted stock grant agreements (the “RSGAs”) providing for the grant of an aggregate of 40,000,000 shares of common stock to certain officers and members of our management including 20,000,000 shares to T. Riggs Eckelberry, 7,500,000 shares to Nicholas Eckelberry, 4,200,000 shares to William Charneski and 5,000,000 shares to Jean-Louis Kindler. The purpose of the RSGAs is to create management incentives to improve our economic performance and to increase our value and stock price. All shares issuable under the RSGAs are performance shares and none have yet vested nor been issued.

The RSGAs provide that the shares shall be eligible for issuance in tranches subject to the satisfaction of certain performance goals. In the case of the grant to T. Riggs Eckelberry, (i) 40% shall be eligible for issuance if our market capitalization exceeds $15 million (market capitalization defined as our shares of common stock issued and outstanding multiplied by the average closing trade price of our common stock on the 10 trading days immediately prior to the date of determination), and (ii) 60% shall be eligible for issuance if our market capitalization exceeds $20 million. In the case of the grant to other members of our management, (i) 40% shall be eligible for issuance if our consolidated gross revenue, calculated in accordance with GAAP, equals or exceeds $2,500,000 for the trailing twelve month period; and (ii) 60% shall be eligible for issuance if our consolidated net profit, calculated in accordance with GAAP, equals or exceeds $500,000 for the trailing twelve month period.

26

The RSGAs further provide that if a performance goal has been met, the shares associated with that particular performance goal shall be issued on a monthly basis according to a vesting formula that is based in part on the overall trading volume of our common stock during the month immediately prior to the issuance. In addition, the RSGAs provide for a partial cash distribution in lieu of the issuance of the shares in order to cover taxes associated with the issuance of the shares.

If the grantee ceases to provide any services to us, then the shares associated with the unmet performance goals as of the date of such cessation shall immediately be forfeited as of the date of such cessation.  The shares associated with any performance goals met prior to the date the grantee ceases to provide any services to us shall continue to vest and be issued to the grantee in accordance with the terms of the RSGAs. Any shares that have not vested within 5 years of becoming eligible for vesting shall be forfeited.

After vesting and issuance the shares issued are subject to a lock-up for a period of one year in the case of the grant to T. Riggs Eckelberry and a period of three years for all other members of management.

The RSGAs also provide that if the fair market value of our common stock on the date of issuance is less than the fair market value (as defined in the RSGA) of our common stock on April 9, 2014 (the date of grant), then the number of shares shall be increased so that the aggregate fair value of shares issuable equals the aggregate fair value that such number of shares would have had on April 9, 2014.

The securities above were offered and sold pursuant to an exemption from the registration requirements under Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”) and Rule 506 of Regulation D promulgated thereunder since, among other things, the transactions did not involve a public offering and the securities were acquired for investment purposes only and not with a view to or for sale in connection with any distribution thereof.

The foregoing is a summary only and qualified in its entirety by reference to the terms of the RSGAs, copies of forms of which are attached hereto as Exhibits 10.1 and 10.2 and incorporated herein by reference.

Consultant Issuances

The following disclosure would have otherwise been filed on Form 8-K under the heading “Item 3.02 Unregistered Sales of Equity Securities”

On April 9, 2014, we agreed to issue 2,160,000 shares of our common stock to a consultant in lieu of cash consideration. In addition, on April 9, 2014, our board of directors authorized the issuance to consultants of an aggregate of 3,020,000 shares of our common stock in lieu of cash consideration including 1,000,000 shares of common stock to each of Robert Rashti and Eng Cheh Hong who own more than 5% of our shares of common stock.

The securities above were offered and sold pursuant to an exemption from the registration requirements under Section 4(2) of the Securities Act and Rule 506 of Regulation D promulgated thereunder since, among other things, the transactions did not involve a public offering and the securities were acquired for investment purposes only and not with a view to or for sale in connection with any distribution thereof.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

EXECUTIVE OFFICERS AND DIRECTORS

The following table sets forth the names and ages of the members of our board of directors and our executive officers and the positions held by each. There are no family relationships among any of our directors and executive officers.

Name	Age	Position
T. Riggs Eckelberry	62	Chief Executive Officer, Chairman of the Board of Directors, Secretary, Treasurer, President and acting Chief Financial Officer.
Anthony Fidaleo	54	Director
Jean-Louis Kindler	51	Chief Commercial Officer and Director
Byron Elton	59	Director

T. Riggs Eckelberry - Chief Executive Officer, Chairman of the Board of Directors, Secretary, Treasurer, President and acting Chief Financial Officer.

Mr. Eckelberry has served as our Chief Executive Officer, Chairman, Secretary, Treasurer, President and acting Chief Financial Officer since our inception in June 2007. Mr. Eckelberry, co-inventor of the Company’s technology, brings his veteran technology management skills to the alternative energy sector. In 2007, he developed and launched OriginOil. As President and COO of CyberDefender Corporation from 2005 to 2006, he was instrumental in building the company and its innovative product line, helping to achieve initial funding and a public company filing at the end of 2006. Previously, as founder and President of TechTransform, a technology consulting firm, he specialized in high tech launches and turnarounds, helping to turn around YellowPages.com in 2004, resulting in its sale for $100 million to SBC/BellSouth, and in 2003 helping to make Panda Software a key player in the US market as the General Manager of its US unit. During the high tech boom of the 1990s, he was responsible for the global brand success of the software product, CleanSweep; as Chief Operating Officer of MicroHouse Technologies, he drove record sales and a modernization of the company’s technology, helping to achieve a successful sale of the company to Earthweb; and as VP Marketing of venture-backed TriVida, he was a key member of the team that commercialized the company’s technology and achieved the sale of this technology company to BeFree, Inc. (now part of ValueClick: VCLK).  As one of the founders of the Company and a recognized expert in the algae oil area, Mr. Eckelberry’s experience and qualifications are essential to the board of directors.

27

Anthony Fidaleo – Director

Mr. Fidaleo has served as our director since June 2012. Mr. Fidaleo has run his own accounting and consulting practice since 1992, primarily as an acting Chief Financial Officer or Senior Consultant for publicly traded companies ranging from start-ups to Fortune 500’s.  From November 2005 to February 2009 Mr. Fidaleo was the Chief Financial Officer, Chief Operating Officer, Executive Vice President and Member of the Board of Directors and Operating Committee for iMedia International, Inc. an early stage publicly traded interactive content solutions company.  Mr. Fidaleo is a California CPA (inactive) and was in public accounting from 1982 through 1992, primarily with BDO Seidman, LLP where he attained the level of audit senior manager. Mr. Fidaleo holds a B.S. degree in Accounting from California State University at Long Beach.

Jean-Louis Kindler – Chief Commercial Officer and Director

Mr. Kindler has served as our Chief Commercial Officer since April 1, 2014 and director since January 2014. Mr. Kindler is a veteran of 25 years as both a top executive and engineer in environmental technologies. He joins the Company after three years as co-founder in 2010 of Ennesys, the company’s French joint venture, where he designed its acclaimed patent-pending waste-to-energy system. Prior to that from 2006 to 2009, he served as CEO of MHS Equipment, a French nanotechnologies equipment manufacturing firm, where he led the development of a revolutionary fuel cell process. Earlier in his career he spent twenty years in Japan which gave him a unique insight into the fast-growing Asian markets. There, as principal of incubator Pacific Junction Corporation, Mr. Kindler completed various assignments such as technology sourcing for the French industrial group Alstom, implementing a hydrogen production system using waste biomass as feedstock, and developing the market for a fluids mixing technology that helped inspire early the Company inventions. Mr. Kindler holds a Masters in Economics and Public Policies from the Institute of Political Sciences in Lyon, France, and an MBA in International Management.

Byron Elton – Director

Mr. Elton has served as our director since January 2014. Mr. Elton is an experienced media and marketing executive with a proven record in pioneering new business development strategies and building top-flight marketing organizations. Since June, 2013, Mr. Elton is a partner of Clear Search, an executive search firm. Prior to that, from January 2009 until May 2013, Mr. Elton served as President and Chief Executive Officer of Carbon Sciences, Inc. (OTCBB: CABN) and has served as Chairman of Carbon Sciences since March 2009. Carbon Sciences is an early stage company developing a technology to convert earth destroying carbon dioxide into a useful form that will not contribute to greenhouse gas. Mr. Elton previously served as Senior Vice President of Sales for Univision Online from 2007 to 2008. Mr. Elton also served for eight years as an executive at AOL Media Networks from 2000 to 2007, where his assignments included Regional Vice President of Sales for AOL and Senior Vice President of E-Commerce for AOL Canada. His broadcast media experience includes leading the ABC affiliate in Santa Barbara, California in 1995 to 2000 and the CBS affiliate in Monterrey, California, from 1998 to 1999, in addition to serving as President of the Alaskan Television Network from 1995 to 1999. Mr. Elton studied Advertising and Marketing Communications at Brigham Young University.

Election of Directors

Our directors are elected by the vote of a majority in interest of the holders of our voting stock and hold office until the expiration of the term for which he or she was elected and until a successor has been elected and qualified.

A majority of the authorized number of directors constitutes a quorum of the board of directors for the transaction of business.  The directors must be present at the meeting to constitute a quorum.  However, any action required or permitted to be taken by the board of directors may be taken without a meeting if all members of the board of directors individually or collectively consent in writing to the action.

Board Independence

We currently have four directors serving on our board of directors. We are not a listed issuer and, as such, are not subject to any director independence standards. Using the definition of “independent director,” as defined by Section 5605(a)(2) of the rules of the Nasdaq Stock Market, Anthony Fidaleo and Byron Elton would be considered an independent director.

Committees of the Board of Directors

We have established an audit committee and compensation committee however we have not yet nominated any members to such committees, which we intend to do in the near future. To date, our entire board has performed all of the duties and responsibilities which might be contemplated by a committee.

28

Audit Committee. The audit committee will be composed of three independent directors, one of whom that meets the requirements of an “Audit Committee Financial Expert.”  The audit committee's duties will be to recommend to the board of directors the engagement of independent auditors to audit our financial statements and to review our accounting and auditing principles.  The audit committee will review the scope and fees for the annual audit and the results of audit examinations performed by the internal auditors and independent public accountants, including their recommendations to improve the system of accounting and internal controls.  The audit committee will at all times to be composed exclusively of directors who are, in the opinion of the board of directors, free from any relationship which would interfere with the exercise of independent judgment as a committee member and who possess an understanding of financial statements and generally accepted accounting principles.

Compensation Committee. The compensation committee will be composed of at least two independent directors.  The compensation committee will review and approve our compensation policies, including compensation of executive officers.  The compensation committee will also review and administer our stock option plans, and recommend and approve grants of stock options under that plan.

We do not have a standing nominating committee nor are we required to have one. We do not currently have any established procedures by which security holders may recommend nominees to our Board of directors, however, any suggestions on directors, and discussions of board nominees in general, is handled by the entire board of directors.

Compensation Committee Interlocks and Insider Participation

None of our executive officers serves as a member of the board of directors or compensation committee of any other entity that has one or more of its executive officers serving as a member of our board of directors.

Code of Ethics

We have adopted a code of business conduct and ethics that applies to all our directors, officers (including our chief executive officer, chief financial officer and any person performing similar functions) and employees. We have made our Code of Ethics available on our website at www.originoil.com.

Board Leadership Structure and Role in Risk Oversight

Although we have not adopted a formal policy on whether the Chairman and Chief Executive Officer positions should be separate or combined, we have traditionally determined that it is in our best interests and our shareholders to combine these roles. Mr. Eckelberry has served as our Chairman since our inception in 2007. Due to the small size and early stage of the Company, we believe it is currently most effective to have the Chairman and Chief Executive Officer positions combined. Our board of directors receives and reviews periodic reports from management, auditors, legal counsel, and others, as considered appropriate regarding our company’s assessment of risks.

Our board of directors focuses on the most significant risks facing us and our general risk management strategy, and also ensures that risks undertaken by us are consistent with the Board’s appetite for risk. While the Board oversees our risk management, management is responsible for day-to-day risk management processes. We believe this division of responsibilities is the most effective approach for addressing the risks facing us.

ITEM 11. EXECUTIVE COMPENSATION.

The following table sets forth the cash compensation (including cash bonuses) paid or accrued by us to our Chief Executive Officer for the years ended 2013 and 2012:

Name and Principal Position	Year	Salary		Bonus		Stock Awards		Option Awards	Non-Equity Incentive Plan Compensation	Non-qualified Deferred Compensation Earnings		All Other Compensation	Total
		($)		($)		($)(1)		($)(1)	($)	($)		($)	($)
T. Riggs Eckelberry, Chairman of the Board, Acting	2013		260,000		120,000	-		182,315	-	-		-		562,315
CFO, President, Secretary & Treasurer and CEO	2012		260,000		130,000	-		-	-	-		-		390,000
Paul Reep,	2013		-		-		-	-	-	-		-		-
Former Senior VP of Technology (2)	2012		45,000		15,000		102,000	-	-		-	-		162,000

_________

(1)   Reflects the aggregate grant date fair value of stock and option awards granted during the relevant fiscal year calculated in accordance with ASC Topic 718.

(2) On May 15, 2012, we accepted Paul Reep’s resignation and appointed him an advisor to the Company. He received 60,000 shares of common stock in compensation for past contributions.

29

Outstanding Equity Awards at 2013 Fiscal Year-End

The following table sets forth certain information concerning option awards and stock awards held by our named executive officers as of December 31, 2013. Our named executive officers did not hold any stock awards as of December 31, 2013.

Option Awards

Stock Awards

Name

Number of Securities Underlying Unexercised Options (#) Exercisable

Number of Securities Underlying Unexercised Options (#) Unexercisable

Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)

Option Exercise Price ($)

Option Expiration Date

Number of Shares or Units of Stock that Have Not Vested (#)

Market Value of Shares or Units of Stock that Have Not Vested ($)

Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (#)

Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested ($)

T. Riggs Eckelberry

759,645

(1)

–

–

0.43

April 12, 2018

–

–

–

–

(1) On April 12, 2013, Mr. Eckelberry was granted options to purchase 759,645 shares of our common stock, fully vested, exercisable at $0.43 per share and expiring 5 years from the date of grant.

Employment Agreements

We currently do not have an employment agreement with our Chief Executive Officer, Mr. Eckelberry, who is paid an annual salary of $260,000. Bonus payments, if any, are determined by the Board of Directors. For the year ended 2013, our Chief Executive Officer had been awarded bonuses payments of $120,000.

In recognition of Mr. Eckelberry’s contributions in 2012 as our Chief Executive Officer, the Board of Directors issued to Mr. Eckelberry a fully vested, five-year option to purchase 759, 645 shares of our common stock exercisable at $0.43 per share.

Independent members of our Board of Directors, acting as a compensation committee, reviewed the compensation policies and practices relating to the compensation provided to our employees to determine whether such policies and practices are reasonably likely to have a material adverse effect on the Company.  Based on such review, we determined that any risks associated with our compensation policies and practices were not reasonably likely to have a material adverse effect on us.  In reaching that conclusion, the directors considered, among other factors, that salary and annual bonus programs, the two primary methods of compensation provided to our employees, were appropriately mitigated because salary levels and bonuses are generally discretionary in nature and considered on an annual basis.  In addition, we considered the overall level of our pay practices, including our incentive compensation awards and practices, in making this determination.

Management Restricted Stock Grant Awards

On January 10, 2014, ourboard of directors authorized the entering into of restricted stock grant agreements providing for the grant of an aggregate of 45,000,000 shares of common stock including 30,000,000 shares to T. Riggs Eckelberry, our Chief Executive Officer and Chairman, 7,500,000 shares to Nicholas Eckelberry, a co-founder and brother of T. Riggs Eckelberry, 3,750,000 shares to William Charneski, our General Manager, Petro Division and 3,750,000 shares to Jean-Louis Kindler, our Chief Commercial Officer and director. The shares were eligible for issuance subject to the satisfaction of certain performance criteria and if such performance criteria were met, the shares then became eligible for vesting on a monthly basis. Prior to the issuance or vesting of any of the shares, each of the grantees mutually agreed with us to the termination of the restricted stock grant agreements.

30

Subsequently, on April 9, 2014, our board of directors authorized the entering into of new restricted stock grant agreements (the “RSGAs”) providing for the grant of an aggregate of 40,000,000 shares of common stock to certain officers and members of our management including 20,000,000 shares to T. Riggs Eckelberry, 7,500,000 shares to Nicholas Eckelberry, 4,200,000 shares to William Charneski and 5,000,000 shares to Jean-Louis Kindler. The purpose of the RSGAs is to create management incentives to improve our economic performance and to increase our value and stock price. All shares issuable under the RSGAs are performance shares and none have yet vested nor been issued.

The RSGAs provide that the shares shall be eligible for issuance in tranches subject to the satisfaction of certain performance goals. In the case of the grant to T. Riggs Eckelberry, (i) 40% shall be eligible for issuance if our market capitalization exceeds $15 million (market capitalization defined as our shares of common stock issued and outstanding multiplied by the average closing trade price of our common stock on the 10 trading days immediately prior to the date of determination), and (ii) 60% shall be eligible for issuance if our market capitalization exceeds $20 million. In the case of the grant to other members of our management, (i) 40% shall be eligible for issuance if our consolidated gross revenue, calculated in accordance with GAAP, equals or exceeds $2,500,000 for the trailing twelve month period; and (ii) 60% shall be eligible for issuance if our consolidated net profit, calculated in accordance with GAAP, equals or exceeds $500,000 for the trailing twelve month period.

The RSGAs further provide that if a performance goal has been met, the shares associated with that particular performance goal shall be issued on a monthly basis according to a vesting formula that is based in part on the overall trading volume of our common stock during the month immediately prior to the issuance. In addition, the RSGAs provide for a partial cash distribution in lieu of the issuance of the shares in order to cover taxes associated with the issuance of the shares.

If the grantee ceases to provide any services to us, then the shares associated with the unmet performance goals as of the date of such cessation shall immediately be forfeited as of the date of such cessation.  The shares associated with any performance goals met prior to the date the grantee ceases to provide any services to us shall continue to vest and be issued to the grantee in accordance with the terms of the RSGAs. Any shares that have not vested within 5 years of becoming eligible for vesting shall be forfeited.

After vesting and issuance the shares issued are subject to a lock-up for a period of one year in the case of the grant to T. Riggs Eckelberry and a period of three years for all other members of management.

The RSGAs also provide that if the fair market value of our common stock on the date of issuance is less than the fair market value (as defined in the RSGA) of our common stock on April 9, 2014 (the date of grant), then the number of shares shall be increased so that the aggregate fair value of shares issuable equals the aggregate fair value that such number of shares would have had on April 9, 2014.

The foregoing is a summary only and qualified in its entirety by reference to the terms of the RSGAs, copies of forms of which are attached hereto as Exhibits 10.1 and 10.2 and incorporated herein by reference.

Employee Benefit Plans

Beginning June 1, 2008, we implemented a company health plan for our employees.

Compensation of Directors

Except as set forth below, our current directors presently do not receive monetary compensation for their service on the board of directors.  Directors may receive compensation for their services in the future and reimbursement for their expenses as shall be determined from time to time by resolution of the board of directors.

31

The following table reflects all compensation awarded to or earned by our directors for the fiscal year ended December 31, 2013.

Name	Fees Earned ($)		Stock Awards ($)			Options Awards ($)		Non-Equity Incentive Plan Compensation ($)		Nonqualified Deferred Compensation Earnings ($)		All Other Compensation ($)		Total ($)
T. Riggs Eckelberry
Ivan Ivankovich(1)		-		-			88,000		-		-		-	88,000
Steve Glovsky (2)							88,000							88,000
Anthony Fidaleo		-			-		88,000		-		-		-	88,000

_____________

(1) Mr. Ivankovich resigned as a director effective as of January 31, 2014.

(2) Mr. Glovsky resigned as a director effective as of October 11, 2013.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

The following table sets forth certain information regarding the beneficial ownership of our common stock as of April 14, 2014 by (i) each director, (ii) each executive officer, (iii) all directors and executive officers as a group, and (iv) each person who beneficially owns more than five percent of our common stock. Beneficial ownership is determined in accordance with the rules of the SEC. The percentage ownership of each beneficial owner is based on 73,365,231 outstanding shares of common stock. Except as indicated, each person listed below has sole voting and investment power with respect to the shares set forth opposite such person’s name.

Name and Address Beneficial Owner	Number of Shares		Percentage of Shares
	Beneficially Owned
Named Executive Officers and Directors (1)
T. Riggs Eckelberry,		1,106,812		1.5	%
Chief Executive Officer, Chairman, Secretary, Treasurer, President and acting Chief Financial Officer (2)
Anthony Fidaleo, Director		250,000		*	%
Jean-Louis Kindler, Director (3)		5,001		*	%
Byron Elton, Director		100,000		*	%
Directors and executive officers as a group (4 persons) (4)		1,461,813		2.0	%
5% or More Shareholders
Robert Rashti (5)		4,000,783		5.5	%
Eng Cheh Hong (6)		5,956,400		8.1	%

* Less than 1%

(1) The address of each director and named executive officer listed above is c/o OriginOil, Inc., 5645 W Adams Blvd, Los Angeles, CA 90016.

32

(2) Includes 759,645 shares of common stock issuable upon exercise of stock options at a price of $0.43 per shares. Does not include 20,000,000 shares of common stock subject to a restricted stock award grant made to Mr. Eckelberry on April 9, 2014.

(3) Does not include 5,000,000 shares of common stock subject to a restricted stock award grant made to Mr. Kindler on April 9, 2014.

(4) Includes 759,645 shares of common stock issuable upon exercise of stock options at a price of $0.43 per shares.

(5) Subject to certain exceptions, we are prohibited from effecting an exercise of the warrants beneficially owned by Mr. Rashti to the extent that, as a result of the exercise, the holder of the warrants beneficially owns more than 4.99% in the aggregate of the outstanding shares of our common stock calculated immediately after giving effect to the issuance of shares of common stock upon such exercise, which may be increased upon 61 days’ prior written notice to 9.99%.  The number of shares and the percentage, as the case may be, in this table is reflective of this ownership limitation and accordingly 8,923,082 shares of our common stock issuable upon exercise of warrants beneficially owned by Mr. Rashti have been excluded. In the event, this ownership limitation were not in effect, Mr. Hong would beneficially own 15.7% of the outstanding shares of our common stock calculated immediately after giving effect to the issuance of shares of common stock upon exercise of the warrants.

(6) Subject to certain exceptions, we are prohibited from effecting an exercise of the warrants beneficially owned by Mr. Hong to the extent that, as a result of the exercise, the holder of the warrants beneficially owns more than 4.99% in the aggregate of the outstanding shares of our common stock calculated immediately after giving effect to the issuance of shares of common stock upon such exercise, which may be increased upon 61 days’ prior written notice to 9.99%.  The number of shares and the percentage, as the case may be, in this table is reflective of this ownership limitation and accordingly 6,615,388 shares of our common stock issuable upon exercise of warrants beneficially owned by Mr. Hong have been excluded. In the event, this ownership limitation were not in effect, Mr. Hong would beneficially own 15.7% of the outstanding shares of our common stock calculated immediately after giving effect to the issuance of shares of common stock upon exercise of the warrants.

Equity Compensation Plan Information

On July 1, 2009, we instituted the OriginOil 2009 Incentive Stock Plan (the “2009 Plan”), after approval by the board of directors and a majority of our shareholders.  Under the 2009 Plan, 500,000 shares of our common stock were reserved for use.

 On May 25, 2012, we instituted the OriginOil 2012 Incentive Stock Plan (the “2012 Plan”), after approval by the board of directors and a majority of our shareholders.  Under the 2012 Plan, 1,000,000 shares of our common stock were reserved for use.  

On June 14, 2013, we instituted the OriginOil 2013 Incentive Stock Plan (the “2013 Plan”), after approval by the board of directors.  Under the 2013 Plan, 4,000,000 shares of our common stock were reserved for use.  

The purpose of the 2009 Plan, 2012 Plan and 2013 Plan is to retain executives and selected employees and consultants and reward them for making contributions to our success.  These objectives are accomplished by making long-term incentive awards under thereby providing participants with a proprietary interest in our growth and performance Each of the plans are administered by our board of directors.

The following table summarizes information as of the close of business on December 31, 2013 concerning the 2009 Plan, 2012 Plan, 2013 Plan and other options outstanding.

Plan category	Number of securities to be issued upon exercise of outstanding options (a)		Weighted-average exercise price of outstanding options  (b)		Securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c)
Equity compensation plans approved by security holders		1,218,480	$	0.85		815,357
Equity compensation plans not approved by security holders		3,466,163		0.41		0
Total		4,684,643	$	0.53		815,357

33

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Since January 1, 2013, there has not been, nor is there any proposed transaction where we were or will be a party in which the amount involved exceeded or will exceed $120,000 and in which any director, executive officer, holder of more than 5% of any class of our voting securities, or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest. 

Executive Officers and Directors

We have made equity awards and paid compensation to our executive officers and certain of our directors as more fully described in Item 11.

2013 Common Stock and Warrant Offering

During 2013, Eng Cheh Hong, a beneficial owner of more than 5% of our common stock, purchased, either directly or indirectly, an aggregate of 2,307,694 shares of common stock together with one-year warrants to purchase an aggregate of 2,000,000 of our common stock, three-year warrants to purchase an aggregate of 2,000,000 shares of our common stock and five-year warrants to purchase an aggregate of 4,000,000 shares of our common stock, for aggregate gross proceeds of $376,924. The warrants are exercisable at a price per share of $0.15, subject in each case to adjustment for stock splits, dividends, distributions, recapitalizations and the like.

During 2013, Mr. Hong exercised for cash warrants to purchase shares for common stock resulting in the issuance of 307,694 shares of common stock for gross proceeds to us of $76,924.

During 2013, Robert Rashti, a beneficial owner of more than 5% of our common stock, purchased, either directly or indirectly, an aggregate of 2,000,000 shares of common stock together with one-year warrants to purchase an aggregate of 2,000,000 of our common stock, three-year warrants to purchase an aggregate of 2,000,000 shares of our common stock and five-year warrants to purchase an aggregate of 4,000,000 shares of our common stock, for aggregate gross proceeds of $300,000. The warrants are exercisable at a price per share of $0.15, subject in each case to adjustment for stock splits, dividends, distributions, recapitalizations and the like.

Consultant Issuances

On April 29, 2013, we entered into an amendment to an advisory agreement previously entered into with Mr. Hong pursuant to which we extended the advisory term for a further 12 months, issued to Mr. Hong 150,000 shares of common stock and reduced the exercise price of a warrant to purchase 200,000 shares of common stock previously issued to Mr. Hong from $0.65 to $0.25 per share.

On April 9, 2014, our board of directors authorized the entering into of a further amendment to the advisory agreement with Mr. Hong pursuant to which the advisory term is extended for a further 12 months and Mr. Hong shall be issued 1,000,000 shares of our common stock.

On July 16, 2013, we entered into an amendment to an advisory agreement previously entered into with Mr. Rashti pursuant to which we extended the advisory term for a further 12 months, issued to Mr. Rashti a five-year warrant to purchase 250,000 shares of common stock at $0.25 per share.

 On April 9, 2014, our board of directors authorized the entering into of a further amendment to the advisory agreement with Mr. Rashti pursuant to which the advisory term is extended for a further 12 months and Mr. Rashti shall be issued 1,000,000 shares of our common stock.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

Audit Fees

The aggregate fees billed by our principal accountant for the audit of our annual financial statements, review of financial statements included in the quarterly reports and other fees that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for the fiscal years ended December 31, 2013 and 2012 were $84,201 and $74,012 respectively.

Tax Fees

There were no fees billed for professional services rendered by our principal accountant for tax compliance, tax advice and tax planning for the fiscal years ended December 31, 2013 and 2012.

All Other Fees

There were no other fees billed for products or services provided by our principal accountant for the fiscal years ended December 31, 2013 and 2012.

34

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

SEC Ref. No.
3.1.1	Articles of Incorporation of OriginOil, Inc. filed with the Secretary of State of Nevada on June 1, 2007 (1)
3.1.2	Certificate of Change of OriginOil, Inc. filed with the Secretary of State of Nevada on July 19, 2011 (2)
3.1.3	Certificate of Amendment of OriginOil, Inc. filed with the Secretary of State of Nevada on  June 14, 2012 (3)
3.1.4	Series A Certificate of Designation of OriginOil, Inc. filed with the Secretary of State of Nevada on December 31, 2013 (4)
3.1.5	Certificate of Withdrawal of Series A Certificate of Designation of OriginOil, Inc. filed with the Secretary of State of Nevada on April 9, 2014*
3.2	By-laws of OriginOil, Inc. (1)
10.1	Form of Restricted Stock Grant Agreement (CEO)*
10.2	Form of Restricted Stock Grant Agreement (Senior Management other than CEO)*
31	Certification of Chief Executive Officer pursuant to Sec. 302 of the Sarbanes-Oxley Act of 2002 (5)*
32	Certification of Chief Executive Officer pursuant to 18 U.S.C. SECTION 1350 (5)*
101	The following materials from OriginOil Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013 are formatted in XBRL (eXtensible Business Reporting Language):  (i) the Balance Sheets, (ii) the Statements of Operations, (iii) Statement of Shareholders' Deficit, (iv) the Statements of Cash Flow, and (iv) Notes to Financial Statements.

*Filed herewith

(1)	Incorporated by reference to the Company’s From SB-2 filed with the SEC on December 11, 2007.
(2)	Incorporated by reference to Company’s Current Report on Form 8-K filed with the SEC on July 20, 2011.
(3)	Incorporated by reference to Company’s Current Report on Form 8-K filed with the SEC on June 14, 2012.
(4)	Incorporated by reference to Company’s Current Report on Form 8-K filed with the SEC on December 31, 2013.
(5)	In accordance with Item 601of Regulation S-K, this Exhibit is hereby furnished to the SEC as an accompanying document and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933.

35

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Los Angeles, State of California, on April 15, 2014.

ORIGINOIL, INC.
By:	/s/ T Riggs Eckelberry
	T Riggs Eckelberry
	Chief Executive Officer (Principal Executive Officer)
	and Acting Chief Financial Officer
	(Principal Accounting and Financial Officer)

Pursuant to the requirements of the Securities Act of 1933, this registration statement or amendment has been signed below by the following persons in the capacities and on the dates indicated.

Date:  April 15, 2014	By:	/s/ T Riggs Eckelberry
		T Riggs Eckelberry
		Chief Executive Officer, Acting Chief Financial Officer and Director

Date:  April 15, 2014	By:	/s/ Anthony Fidaleo
		Anthony Fidaleo
		Director

Date:  April 15, 2014	By:	/s/ Jean-Louis Kindler
		Jean-Louis Kindler
		Director

Date:  April 15, 2014	By:	/s/ Byron Elton
		Byron Elton
		Director

36

ORIGINOIL, INC.

FINANCIAL STATEMENTS

As of December 31, 2013

TABLE OF CONTENTS

Reports of Independent Registered Public Accounting Firm	F2-3
Balance Sheets	F-4
Statements of Operations	F-5
Statements of Shareholders' Deficit	F-6
Statements of Cash Flows	F-7
Notes to Financial Statements	F-8

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of Originoil, Inc. Los Angeles, California

We have audited the accompanying balance sheet of Originoil, Inc. (the “Company”) as of December 31, 2013, and the related statements of operations, shareholders’ deficit and cash flows for the year then ended. The Company’s management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles  used  and  significant  estimates  made  by  management,  as  well  as evaluating the  overall  financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Originoil, Inc. as of December 31, 2013, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1, the Company has experienced recurring operating losses and negative cash flows from operating activities, which have resulted in a negative working capital and a stockholders’ deficit. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/WEINBERG & COMPANY, P.A.

Los Angeles, California

April 15, 2014

F-2

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders

OriginOil, Inc.

Los Angeles, California

We have audited the accompanying balance sheet of OriginOil, Inc. as of December 31, 2012, and the related statements of operations, shareholders' deficit, and cash flows for the year then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of OriginOil, Inc. as of December 31, 2012, and the results of its operations and its cash flows for the year then ended, in conformity with U.S. generally accepted accounting principles.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  As disclosed in Note 1 to the financial statements, the Company has deficit working capital, deficit shareholders’ equity, and has negative cash flows from operations.  This raises substantial doubt about the Company’s ability to continue as a going concern.  Management’s plans in regard to these matters are also described in Note 1.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ HJ Associates & Consultants, LLP

HJ Associates & Consultants, LLP

Salt Lake City, Utah

April 16, 2013

F-3

ORIGINOIL, INC.

BALANCE SHEETS

	December 31, 2013			December 31, 2012
ASSETS
CURRENT ASSETS
Cash	$	821,448		$	507,355
Work in process		21,049			35,666
Prepaid expenses		34,531			186,978
Other receivables		-			1,200
TOTAL CURRENT ASSETS		877,028			731,199
NET PROPERTY AND EQUIPMENT, NET		74,204			43,397
OTHER ASSETS
Other asset		40,000			45,000
Patents		-			317,689
Trademark		4,467			4,467
Security deposit		9,650			9,650
TOTAL OTHER ASSETS		54,117			376,806
TOTAL ASSETS	$	1,005,349		$	1,151,402
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current Liabilities
Accounts payable	$	114,803		$	353,200
Accrued expenses		262,518			376,846
Deferred income		50,000			-
Derivative liabilities		1,031,484			355,526
Convertible promissory notes, net of discount of $971,964 and 237,965, respectively		953,989			435,365
Unsecured notes payable, net of discount of $38,639		-			171,361
Total Current Liabilities		2,412,794			1,692,298
Long Term Liabilities
Obligation to issue common stock		105,754			-
Total Long Term Liabilities		105,754			-
TOTAL LIABILITIES		2,518,548			1,692,298
SHAREHOLDERS' DEFICIT
Preferred stock, $0.0001 par value;
25,000,000 authorized preferred shares		-			-
Common stock, $0.0001 par value, 250,000,000 shares authorized
53,664,506 and 17,967,544 shares issued and outstanding, respectively		5,366			1,797
Additional paid in capital		34,811,538			27,024,419
Accumulated deficit		(36,330,103	)		(27,567,112	)
TOTAL SHAREHOLDERS' DEFICIT		(1,513,199	)		(540,896	)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$	1,005,349		$	1,151,402

The accompanying notes are an integral part of these financial statements

F-4

ORIGINOIL, INC.

STATEMENTS OF OPERATIONS

	Years Ended
	December 31, 2013			December 31, 2012
Sales	$	140,500		$	588,163
Cost of Goods Sold		50,510			401,647
Gross Profit		89,990			186,516
Operating Expenses
Selling and general and administrative expenses		5,229,412			4,942,275
Research and development		1,072,548			980,170
Impairment of patents		317,689			-
Depreciation and amortization expense		15,153			13,645
Total Operating Expenses		6,634,802			5,936,090
Loss from Operations before Other Income/(Expenses)		(6,544,812	)		(5,749,574	)
OTHER INCOME/(EXPENSE)
Gain/(Loss) on extinguishment of derivative liability		3,407,340			(1,634,989	)
Change in valuation of derivative liability		(1,020,088	)		(737,185	)
Debt private placement cost		(956,337	)		-
Cost of modification of warrants		(645,398	)		-
Penalty, interest and default fees		(1,123,897	)		-
Foreign exchange loss		-			(3,096	)
Interest expense		(1,879,799	)		(2,445,185	)
TOTAL OTHER INCOME/(EXPENSE)		(2,218,179	)		(4,820,456	)
NET LOSS	$	(8,762,991	)	$	(10,570,029	)
BASIC LOSS PER SHARE	$	(0.32	)	$	(0.92	)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
BASIC AND DILUTED		27,742,399			11,474,316

The accompanying notes are an integral part of these financial statements

F-5

ORIGINOIL, INC.

STATEMENT OF SHAREHOLDERS' DEFICIT

Years Ended December 31, 2013 and 2012

									Additional
	Preferred stock				Common stock				Paid-in			Accumulated
	Shares		Amount		Shares		Amount		Capital			Deficit			Total
Balance at December 31, 2011		-	$	-		7,694,505	$	770	$	16,198,019		$	(16,997,083	)	$	(798,294	)
Common stock issued for cash and subscriptions payable		-		-		2,426,003		243		1,576,649			-			1,576,892
Common stock issued for conversion of debt		-		-		2,980,037		298		3,561,487			-			3,561,785
Common stock issued for conversion of interest payable on debt		-		-		96,791		10		88,843			-			88,853
Common stock issued for services at fair value		-		-		1,246,558		124		1,683,924			-			1,684,048
Common stock issued with unsecured subordinated debt at fair value		-		-		1,411,351		141		(141	)		-			-
Common stock issued for settlement of debt at fair value		-		-		1,850,019		185		1,605,457			-			1,605,642
Cashless exercise of  common stock purchase warrants		-		-		262,281		26		(26	)		-			-
Original issue discount for convertible debenture		-		-		-		-		92,662			-			92,662
Beneficial conversion feature on promissory notes		-		-		-		-		1,479,578			-			1,479,578
Options and warrant compensation expense		-		-		-		-		739,464			-			739,464
Stock issuance cost		-		-		-		-		(1,497	)		-			(1,497	)
Net loss for the year ended December 31, 2012		-		-		-		-		-			(10,570,029	)		(10,570,029	)
Balance at December 31, 2012		-		-		17,967,544		1,797		27,024,419			(27,567,112	)		(540,896	)
Common stock issued for cash		-		-		12,270,172		1,227		2,266,315			-			2,267,542
Common stock issued for services		-		-		2,448,976		245		901,868			-			902,113
Common stock issued for conversion of debt		-		-		19,861,112		1,986		2,973,240			-			2,975,226
Common stock issued upon exercise of warrants at fair value through a cashless exercise		-		-		332,960		33		(33	)		-			-
Common stock issued upon exercise of warrants		-		-		779,298		78		194,748			-			194,826
Issuance of shares of common stock		-		-		4,444		-		1,000			-			1,000
Fair value of warrants issued with notes		-		-		-		-		88,370			-			88,370
Cost of modification of warrants		-		-		-		-		645,398			-			645,398
Beneficial conversion feature on note		-		-		-		-		161,422			-			161,422
Fair value of options issued in current year previously reflected in accrued expenses		-		-		-		-		209,000			-			209,000
Stock and warrant compensation cost		-		-		-		-		345,791			-			345,791
Net loss for the year ended December 31, 2013		-		-		-		-		-			(8,762,991	)		(8,762,991	)
Balance at December 31, 2013		-	$	-		53,664,506	$	5,366	$	34,811,538		$	(36,330,103	)	$	(1,513,199	)

The accompanying notes are an integral part of these financial statements

F-6

ORIGINOIL, INC.

STATEMENTS OF CASH FLOWS

	Years Ended
	December 31, 2013			December 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(8,762,991	)	$	(10,570,029	)
Adjustment to reconcile net loss to net cash
used in operating activities
Depreciation & amortization		15,153			13,645
Common stock and warrants issued for services		902,113			1,617,538
Stock and warrant compensation expense		345,791			739,464
Change in valuation of derivative liability		1,020,088			737,185
Debt discount and beneficial conversion feature recognized as interest expense		1,879,697			2,174,910
Gain/(Loss) on extinguishment of derivative liability		(3,407,340	)		1,634,989
Penalty, interest and default fees		1,123,897			92,662
Common stock issued for interest on debt		-			88,852
Debt private placement cost		956,337			-
Impairment loss on patents		317,689			34,078
Cost of modification of warrants		645,398			-
Obligation to issue common stock		105,754			-
Changes in Assets and Liabilities
(Increase) Decrease in:
Prepaid expenses		152,447			179,635
Work in progress		14,617			212,777
Other receivables		1,200			16,777
Other asset		5,000			(25,000	)
Increase (Decrease) in:
Accounts payable		52,163			10,830
Accrued expenses		94,672			252,429
Deferred income		50,000			(313,163	)
NET CASH USED IN OPERATING ACTIVITIES		(4,488,315	)		(3,102,421	)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets		(45,960	)		(1,678	)
Patent expenditures		-			(171,387	)
CASH USED IN INVESTING ACTIVITIES		(45,960	)		(173,065	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from unsecured subordinated debt		-			1,479,578
Payments on unsecured debt		(10,000	)		-
Proceeds from convertible promissory notes		2,395,000			530,000
Proceeds from issuance of common stock		2,463,368			1,575,395
NET CASH PROVIDED BY FINANCING ACTIVITIES		4,848,368			3,584,973
NET INCREASE/(DECREASE) IN CASH		314,093			309,487
CASH BEGINNING OF PERIOD		507,355			197,868
CASH END OF PERIOD	$	821,448		$	507,355
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	-		$	5,262
Taxes paid	$	-		$	-
SUPPLEMENTAL DISCLOSURES OF NON CASH INVESTING AND FINANCING TRANSACTIONS
Fair value of derivative issued	$	3,063,210		$	1,199,762
Reclass of value of options issued in current year previously reflected in accrued expenses	$	209,000		$	0
Common stock issued for conversion of debt	$	2,975,226		$	2,362,023
Common stock issued for settlement of debt	$	-		$	1,605,642

The accompanying notes are an integral part of these financial statements

F-7

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

1.      ORGANIZATION AND LINE OF BUSINESS

Organization

OriginOil, Inc. (the "Company") was incorporated in the state of Nevada on June 1, 2007.  The Company, based in Los Angeles, California, began operations on June 1, 2007 to develop and market a renewable oil technology. The Company began its planned principal operations in December, 2010, at which time it exited the development stage.

Line of Business

OriginOil is a pure technology company that has developed a water cleanup technology for the oil and gas, algae and other water-intensive industries.  The Company’s technology integrates easily with other industry processes and can be embedded into larger systems through licensing and joint ventures.

Going Concern

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business.  The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. During the year ended December 31, 2013, the Company did not generate significant revenue, incurred a net loss of $8,762,991 and used cash used in operations of $4,488,315.  As of December 31, 2013, the Company had a working capital deficiency of $1,535,766 and a shareholders’ deficit of $1,513,199.   These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern.  Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2013, expressed substantial doubt about our ability to continue as a going concern.

The ability of the Company to continue as a going concern and the appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash infusions. During the year ended December 31, 2013, the Company obtained funds from the issuance of convertible note agreements and from sales of its common stock and warrants. The Company also has standing purchase orders and open invoices with customers which will provide funds for operations. Management believes this funding will continue from its current investors and from new investors. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stock holders, in case of equity financing.

2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICES

Revenue Recognition

We recognize revenue upon delivery of equipment, provided that evidence of an arrangement exists, title, and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.  Title to the equipment is transferred to the customer once the last payment is received. We record revenue as goods are shipped, and the equipment has been fully accepted by the customer. Generally, we extend credit to our customers and do not require collateral.  We do not ship a product until we have a purchase agreement signed by the customer with a payment arrangement.  

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

Loss per Share Calculations

Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the years ended December 31, 2013 and 2012, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss.

For the years ended December 31, 2013 and 2012, the dilutive impact of outstanding stock options of 4,684,643  and 465,294, and  outstanding warrants of 42,033,596 and 7,554,616 and notes convertible into 12,037,206 and 841,663 shares of our common stock, respectively, have been excluded because their impact on the loss per share is anti-dilutive.

Research and Development

Research and development costs are expensed as incurred.  Total research and development costs were $1,072,548 and $980,170 for the years ended December 31, 2013 and 2012, respectively.

Advertising Costs

The Company expenses the cost of advertising and promotional materials when incurred.  The advertising costs were $220,535 and $209,761 for the years ended December 31, 2013 and 2012, respectively, which are included in selling and general and administrative expenses in the statement of operations.

F-8

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

2.     SUMMARY OF SIGNIFICANT ACCOUNTING POLICES (Continued)

Use of Estimates

The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in valuing our stock options, warrants, convertible notes, and common stock issued for services, among other items. Actual results could differ from these estimates.

Work-in-Process

The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.

Capitalized Patents

As of December 31, 2012, the Company had unamortized capitalized patent costs of $317,689.  In prior years and during the year ended December 31, 2013, the Company capitalized various legal fees incurred in the patent application process related to the Company's Electro Water Separation (EWS) Technology. The Company accounted for these capitalized patents pursuant to ASC 350-30, General Intangibles Other Than Goodwill.  The Company initially determined that its patents have a finite useful life, which were to be amortized over its useful life. The Company performed its annual impairment test of its capitalized intangible assets as of December 31, 2013, and based upon its analysis, determined that such costs were impaired and recorded an impairment loss of $317,689 at December 31, 2013.

Impairment of Long-lived Assets  

Management regularly reviews property, equipment and other long-lived assets for possible impairment. This review occurs annually or more frequently if events or changes in circumstances indicate the carrying amount of the asset may not be recoverable.  The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.  Based on upon management’s annual assessment, there were no indicators of impairment of the Company’s property and equipment and other long-lived assets during the year ended December 31, 2013.

Concentration of Credit Risk

As of December 31, 2013 and 2012, the Company had bank deposits in excess of Federally insured limits of $571,448 and $252,270, respectively.

Stock-Based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

Property and Equipment

Property and equipment are stated at cost, and are depreciated using the straight line method over their estimated useful lives:

Leasehold improvements	lease term or 2 years
Computer equipment	5 Years
Furniture & fixtures	7 Years
Machinery & equipment	10 Years

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statement of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Black-Scholes-Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Reclassification

During 2013, the Company reclassified $20,000 of current assets to long term assets based on a reassessment of the time to be realized. The prior year amount of $25,000 was also reclassified for comparability.

F-9

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

2.     SUMMARY OF SIGNIFICANT ACCOUNTING POLICES (Continued)

Fair Value of Financial Instruments

Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2013, the balances reported for cash, prepaid expenses, accounts payable, and accrued expenses approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

· Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

· Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

· Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s  balance sheets on a recurring basis and their level within the fair value hierarchy as of December 31, 2013 and 2012.

	(Level 1)		(Level 2)		(Level 3)
Derivative Liability, December 31, 2013	$	-	$	-	$	1,031,484
Derivative Liability, December 31, 2012	$	-	$	-	$	355,526

Recently Issued Accounting Pronouncements

On March 4, 2013, the FASB issued ASU 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (“ASU 2013-05”). ASU 2013-05 updates accounting guidance related to the application of guidance and foreign currency matters. This guidance resolves the diversity in practice about what guidance applies to the release of the cumulative translation adjustment into net income. This guidance is effective for interim and annual periods beginning after December 15, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Loss, or a Tax Credit Carryforward Exists. Topic 740, Income Taxes, does not include explicit guidance on the financial statement presented of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. There is diversity in practice in the presentation of unrecognized tax benefits in those instances and the amendments in this update are intended to eliminate that diversity in practice. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Early adoption is permitted.  We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future financial statements.

F-10

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

3.     PROPERTY & EQUIPMENT

Property and Equipment consists of the following as of December 31, 2013 and 2012:

	2013			2012
Machinery & equipment	$	77,665		$	32,670
Furniture & fixtures		27,056			27,056
Computer equipment		29,789			28,824
Leasehold improvements		94,914			94,914
		229,424			183,464
Less accumulated depreciation and amortization		(155,220	)		(140,067	)
	$	74,204		$	43,397

Depreciation expense for the years ended December 31, 2013 and 2012 was $15,153 and $13,645, respectively.

4.    CONVERTIBLE PROMISSORY NOTES PAYABLE

Convertible promissory notes payable consist of the following as of December 31, 2013 and 2012:

	2013			2012
Convertible Promisory Notes (a)	$	1,530,000		$	-
OID Notes (b)		273,125			573,330
Security Purchase Agreement (c)		122,828			100,000
Total Notes		1,925,953			673,330
Debt Discount		(971,964	)		(237,965	)
	$	953,989		$	435,365

(a)   Convertible Promissory Notes

During 2013, the Company issued $1,910,000 of unsecured convertible promissory notes to investors (the “Convertible Promissory Notes” or “Notes”). The Convertible Promissory Notes mature on various dates ranging from six to nine months from the date of issuance and bear interest at 10% per annum. The Notes may be converted into shares of the Company’s common stock at a conversion price range of the lesser of $0.21 to $0.50 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Notes.  The Notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In the event of default, the Notes shall become immediately due and payable at the mandatory default amount. The mandatory default amount is 150% of the Notes amount and such mandatory default amount shall bear interest at 10% per annum.  In addition, for as long as the Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the Notes or such other convertible notes or a term was not similarly provided to the purchaser of the Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the Notes and such other convertible notes. The conversion feature of the Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes (see below).

During the year ended December 31, 2013, the Company converted $380,000 of the Notes principal due plus accrued interest of $19,923 into 3,909,121 shares of common stock. As of December 31, 2013, the remaining Notes of $1,530,000 are due at various times through August 26, 2014.

(b)   OID Notes

In prior years and during the year ended December 31, 2013, the Company issued unsecured convertible promissory notes (the “OID Notes”) to various investors (holders). Each OID Note bears an original issue discount and one time interest which are being amortized over the term of the OID Notes. The OID Notes were originally convertible into the common stock of the Company at conversion prices ranging from $0.4375 to $0.65. The original maturity date of the OID Notes is ninety (90) days from their effective date.  If the OID Notes are not repaid on maturity, then the maturity date is automatically extended for up to three further 30 day periods and an extension fee of 25% of the then outstanding principal is applied. Every extension period, interest and other fees are also added to the principal amount of the OID Notes at the end of each 30 day period that the OID Notes are still outstanding. In the event of default, such as failure to pay any principal and interest when due and payable (or payable upon conversion), the OID Notes immediately become due and payable at the mandatory default amount which is 150% or 200% of the OID Note amounts. The OID Notes’ mandatory default amount bear interest at 10% per annum.

F-11

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

4.    CONVERTIBLE PROMISSORY NOTES PAYABLE (Continued)

OID Notes

The OID Notes are convertible into shares of the Company’s common stock at a conversion price range from the lesser of $0.4375 to $0.65 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 70% to 50% of the average of the three lowest closing prices in the 25 trading days previous to a conversion.  In addition, so long as the OID Notes or other convertible note transactions currently in effect between the Company and the holders are outstanding, upon any issuance by the Company of any security with any term more favorable to the holder of such security or with a term in favor of the holder of such security that was not similarly provided to the holders in these OID Notes, then such additional or more favorable term shall at the OID Notes holders’ option become a part of any or all of the outstanding OID Notes with the holders. The conversion feature of the OID Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the OID Notes (see below).

At December 31, 2012, the balance of the OID Notes amounted to $573,330 of which $237,234 represented Original Issue Discount (OID). During the year ended December 31, 2013, the Company issued new OID Notes to various investors in an aggregate principal amount of $235,000, with an OID of $78,333 ($313,333 total). The maturity dates of the new OID Notes are ninety (90) days from their effective issuance date. The new OID Notes have similar terms and conditions as the old OID Notes mentioned in the preceding paragraph.

During the year ended December 31, 2013, the majority of the OID Notes’ due dates were extended numerous times and extension fees, additional one time interest and defaults fees were charged by the OID Note holders totaling $1,073,974. During the year ended December 31, 2013, OID Notes that totaled $1,687,512 (composed of principal, interest and default fees) were converted into 12,480,520 shares of the Company’s common stock.  The balance of the OID Notes outstanding as of December 31, 2013 was $273,125, which is due in various amounts through July 14, 2014.

(c)    Securities Purchase Agreement

On June 20, 2012, the Company received an initial advance of $100,000, and subsequently issued warrants to purchase an aggregate of up to 153,846 shares of our common stock. The funds were received in consideration of the sale of a 10% unsecured convertible promissory note (the “Note”), with an aggregate sum of $400,000, plus warrants to purchase an aggregate of up to 615,385 shares of the Company’s common stock at a purchase price of $0.65 per share. The Note originally matured six months from the date of each purchase made under the Note, and bore interest at a rate of 10% per annum, which increased to 15% when the Note was not repaid by September 18, 2012. The Note was originally convertible into shares of the Company’s common stock at a conversion price of $0.65. The warrants may be exercised at any time for a period of four years from the date of issuance at an exercise price of $0.65.  The balance outstanding under the Note at December 31, 2012 was $100,000.

The Note was issued with a discount, which is amortized over the life of the note. The Company recorded amortization of the debt discount of $76,122 in interest expense for the year ended December 31, 2012.

On February 15, 2013, the Company and the lender entered into an amendment to the Note providing for, among other things, an extension of the maturity date of the Note until July 21, 2013 and the amendment of the conversion price of the Note to the lesser of $0.65 or 70% of the average of the three lowest closing prices in the 25 trading days previous to a conversion. During the months of June and December, 2013, the lender advanced another $250,000 under the securities purchase agreement and was issued 307,692 warrants to acquire shares of our common stock, bringing the total principal received under the Note to $350,000. The warrants were valued at $88,370 and accounted for as a discount that is being amortized over the life of the Note. During the year ended December 31, 2013, the lender converted $227,172 of the Note, plus accrued interest of $30,000, into 1,189,417 shares of the Company’s common stock leaving a remaining principal balance of $122,828, which is due in August 2014. During the year ended December 31, 2013, the Company recognized interest expense of $37,500 relating to the Note.

 (d)   Other Convertible Note

On May 21, 2013, the Company entered into a convertible promissory note for the conversion of an accounts payable in the amount of $290,560. The note was non-interest bearing and was to mature on December 31, 2015. The Company had the ability to pay the note in full on or before the maturity date without penalty. The note may be converted into shares of the Company’s common stock at a conversion price of 75% of the average of the three (3) lowest sale prices during the 25 trading days immediately preceding the date of delivery. As the conversion price of the note was less than the market price of the Company’s common stock at the date of its issuance, the Company determined that the note contained a beneficial conversion feature of $161,422. The note’s beneficial conversion feature was considered as debt discount and was being amortized over the life of the note. As of the December 31, 2013, the note was converted into 1,788,034 shares of common stock of the Company and all remaining unamortized note discount was recorded as interest expense.

F-12

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

4.    CONVERTIBLE NOTES PAYABLE (Continued)

Conversion feature of the notes

The agreements governing the convertible notes (a), (b) and (c) discussed above include an anti-dilution provision that allows for the automatic reset of the conversion price upon any future sale of the Company’s common stock, warrants, options, convertible debt or any other equity-linked securities at an issuance, exercise or conversion price below the current conversion price of the Notes or exercise price of the warrants issued with the Convertible Notes. The Company considered the current FASB guidance of “Determining Whether an Instrument Indexed to an Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability or whether or not within the issuers’ control, means the instrument is not indexed to the issuers own stock. Accordingly, the Company determined that the conversion prices of the Convertible Notes are not a fixed amount because they are subject to fluctuations based on the occurrence of future offerings or events. As a result, the Company determined that the conversion features are not considered indexed to the Company’s own stock and characterized the initial fair value of these warrants as derivative liabilities upon issuance. The Company determined the aggregate initial fair value of the embedded beneficial conversion feature of the Conversion Notes issued during the year ended December 31, 2013 to be $3,063,210. These amounts were determined by management with the use of a probability weighted average Black-Scholes Merton option pricing model. As the aggregate fair value of these liabilities of $3,063,210 exceeded the aggregate Note value of $2,106,873, the excess of the liability over the Note value of $956,337 was considered as a cost of the private placement and is reported in the accompanying statement of operations. As such, the Company recorded a $2,106,873 valuation discount upon issuance of the notes. The Company is amortizing this valuation discount to interest expense over the life of the notes. During the year ended December 31, 2013, the Company included $1,591,266 of interest relating to the amortization of these discounts, and as of December 31, 2013 and December 31, 2012, the unamortized balance of the note discount was $971,964 and $237,965, respectively.

5. UNSECURED NOTES PAYABLE

The January 2012 Notes had an aggregate principal amount of $1,669,828 with a one-year term and were convertible into shares of common stock of the Company at a conversion price of $1.75 per share. In addition, the Company issued upfront shares of common stock in the amount of 1,411,351, which included the amount from the December exchange during the period. In the event the note was converted in full prior to maturity, the holder was entitled to one additional share of common stock for each share converted. The January 2012 Notes accrued interest at 8% per annum and were payable on the conversion date and/or at maturity. The January 2012 Notes were also redeemable by the Company, at the holder’s option, at maturity at a redemption price of 112% of the outstanding principal plus accrued and unpaid interest. During the year ended December 31, 2012, note holders converted $1,269,578 of principal into shares of common stock.  The aggregate principal amount outstanding at December 31, 2012 was $210,000.

The Company evaluated the three notes for a beneficial conversion feature and accounted for the notes under ASC 815 (Statement 133, EITF Issue 07-5, and EITF Issue 00-19). The instrument was not stated at fair value, and could not be settled partially or wholly in cash. The beneficial conversion feature is equal to the difference between the Company’s market price of its common stock on the measurement date and the effective conversion price multiplied by the number of shares the holder is entitled to upon conversion

The notes were issued with a discount, which is amortized over the life of the note. The Company recorded amortization of the debt discount of $1,629,016 in interest expense for the year ended December 31, 2012.

During the year ended December 31, 2013, the Company settled payment of principal in the amount of $200,000 plus accrued interest of $16,113 through the issuance of 494,020 shares of its common stock valued at $340,059.  As a result, the Company recognized an additional cost of $123,964 upon conversion of this note payable which has been included in penalties, interest and default fees on the accompanying 2013 statement of operations. The remaining $10,000 was paid in cash to a holder.  The aggregate principal amount outstanding of the January 2012 Notes at December 31, 2013 was $0.

6.     CAPITAL STOCK

Sale of common stock and warrants

During the year ended December 31, 2013, the Company offered up to $2,000,000 in shares of the Company’s common stock, par value $0.0001 per share, which in the sole discretion of the Company, without further notice, could be increased to $3,000,000 in shares of common stock at a price per share of $0.25 per share. For subscribers who subscribed for $300,000 or more of shares in this offering, the common stock price was $0.15 per share. The Company raised aggregate proceeds of $2,267,542 from the sale of these shares. Based upon the offering, the Company issued (i) 4,274,616 shares to investors at $0.25 per share for cash of $1,068,543 and, (ii) issued 8,000,000 shares to investors at $0.15 per share for cash of $1,200,000.  Included in the sale of shares of common stock were warrants to purchase 36,995,692 shares of common stock.  The warrants are exercisable from 1 up to 5 years upon grant with an exercise price of $0.15 per share up to $0.25 per share.

Subsequent to sale of the common stock units discussed above, the Company entered into a supplemental agreement with the subscribers of the original subscription agreement. Under the terms of the supplemental agreement, if at any time within eighteen (18) months following the issuance of shares to the subscriber  (the  "Adjustment  Period"), the  market  price  (as  defined  below)  of the Company's common stock is less than the price per share,  then the price per  share shall be reduced one time to the market price (the "Adjusted Price") such that the Company shall promptly issue additional shares of the Company's common stock to the Subscriber for no additional  consideration, in an amount sufficient that the aggregate purchase price, when divided by the total number of shares purchased thereunder plus those shares of common stock issued as a result of the dilutive Issuance will equal the adjusted price.  For the purposes hereof: the ''Market Price" shall mean the average closing price of the Company's common stock for any ten (10) consecutive trading days during the Adjustment Period.

F-13

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

6.     CAPITAL STOCK (Continued)

Sale of common stock and warrants (Continued)

The company considered the effects of the above and determined that it should record a provision to reflect its potential obligation to issue such shares.  The Company intends to account for this liability as of each reporting period until the defined adjustment period has terminated.  Based upon its calculation, the company believes that as of December 31, 2013, it may have the obligation to issue shares with a fair value of $105,754. This amount has been reflected as an obligation to issue common stock in the accompanying December 31, 2013 balance sheet.

Other issuances of Common Shares

During the year ended December 31, 2013, the Company issued 2,448,972 shares of common stock for services with prices ranging from $0.25 up to $0.63 with a total fair value of $902,113.  The shares issued were valued at the trading price at the date of the agreement or issuance date. The Company also granted, but did not issue, 400,000 shares of common stock to certain directors of the Company.  The fair value of the shares was $64,000 at the date of the agreement which has been included in accrued expenses on the accompanying December 31, 2013 balance sheet.

During the year ended December 31, 2013, the Company issued 19,861,012 shares of common stock for the settlement of convertible promissory notes in an aggregate principal amount of $2,975,226 based upon a conversion price of $0.11 up to $0.875.

Designation and Withdrawal of Series A Preferred Stock

On December 26, 2013, the Company authorized the designation of 1,000 shares of Series A Preferred Stock and subsequently, the Company issued 1,000 shares of Series A Preferred Stock to the Company’s Chief Executive Officer and Director, T. Riggs Eckelberry. The shares of Series A Preferred Stock had a par value of $0.0001 per share, did not have a dividend rate or liquidation preference and were not convertible into shares of common stock. The shares of Series A Preferred Stock had supermajority preferred voting rights effective from June 26, 2014. However, on April 7, 2014, the Company and Mr. Eckelberry mutually agreed to the cancellation of the shares and on April 9, 2014, the Company withdrew its Certificate of Designation for its Series A Preferred Stock.

7.     OPTIONS AND WARRANTS

Options

The Board of Directors adopted the OriginOil, Inc., 2009 Incentive Stock Option Plan (the “2009 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for Five Hundred Thousand (500,000) shares of Common Stock.  

On May 25, 2012, the Board of Directors adopted a new OriginOil, Inc., 2012 Incentive Stock Option Plan (the “2012 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for One Million (1,000,000) shares of Common Stock.  Options granted under these Plans may be either incentive options or nonqualified options and shall be administered by the Company's Board.  Each Option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the Plan or of any option agreement, each Option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the effective date of grant.

On June 14, 2013, the Board of Directors adopted a new OriginOil, Inc., 2013 Incentive Stock Option Plan (the “2013 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for Four Million (4,000,000) shares of Common Stock.  Options granted under the Plan may be either incentive options or nonqualified options and shall be administered by the Company's Board.  Each Option shall state the number of shares to which it pertains. The exercise price will be determined by the holders percentage owned as follows: If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant. Notwithstanding any other provision of the 2013 Plan or of any option agreement, each Option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the date of grant. If the status of an employee terminates for any reason other than disability or death, then the Optionee or their representative shall have the right to exercise the portion of any Options which were exercisable as of the date of such termination, in whole or in part, not less than 30 days nor more than three (3) months after such termination.

F-14

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

7.    OPTIONS AND WARRANTS (Continued)

With respect to Non-statutory Options granted to employees, directors or consultants, the Board or Committee may specify such period for exercise that the Option shall automatically terminate following the termination of employment or services as to shares covered by the Option as the Board or Committee deems reasonable and appropriate.

During the year ended December 31, 2013, the Company granted 533,498 incentive stock options to employees with an estimated fair value of approximately $122,705 using the Black-Scholes-Merton calculation. The options are exercisable at $0.44/share, vest monthly after 90 days from grant date over a period of five (5) years and expire in ten (10) years from the date of grant. As of December 31, 2013, 483,498 incentive stock options were outstanding, due to forfeiture of 50,000 options. During the year ended December 31, 2013, the Company recognized compensation costs of $9,815 based on the fair value of options that vested.

During the year ended December 31, 2013, the Company granted 2,532,665 Non-statutory stock options under the 2013 Stock Option Plan to employees and members of the Board of Directors with an estimated fair value of approximately $597,974 using the Black-Scholes-Merton calculation. The options are exercisable at $0.38/share up to $0.44/share, vest over a period of five (5) years and expire in ten (10) years from the date of grant. As of December 31, 2013, 2,482,665 incentive stock options were outstanding, due to forfeiture of 50,000 options. During the year ended December 31, 2013, the Company recognized compensation costs of $71,772 based on the fair value of options that vested.

During the year ended December 31, 2013, the Company granted 500,000 options under the 2013 Stock Option Plan to an employee with an estimated fair value of approximately $70,000 using the Black-Scholes-Merton calculation. The options are exercisable at $0.43/share, vest immediately and expire in five (5) years from the date of grant. During the year ended December 31, 2013, the Company recognized compensation costs of $70,000 based on the fair value of options that vested.

During the year ended December 31, 2013, the Company recorded $95,890 of compensation cost based on the vesting of the options granted to employees, directors and consultants in prior periods. Future unamortized compensation expense on the unvested outstanding options at December 31, 2013 was approximately $855,243.

In fiscal 2012, the Board of Directors agreed to grant an officer of the Company options to purchase 759,645 shares of common stock at $0.43 per share.  Upon grant, the options vested immediately and will expire in 5 years.  Total fair value of the options granted amounted to $209,000 determined by using the Black-Scholes Option Pricing Model and was recorded in 2012 and was reflected as compensation cost and as due to officer which is included as part of accrued expenses in the accompanying 2012 balance sheet.  In April 2013, the Board formally approved the issuance of the 759,645 options and the amount was reclassified from due to officer to additional paid in capital.

	2013			2012
Risk free interest rate		0.28% - 0.49	%		0.87 - 1.58	%
Stock volatility factor		88.00% - 91.00	%		69.93 - 70.25	%
Weighted average expected option life	4 - 10 years			4 - 10 years
Expected dividend yield	None			None

A summary of the Company’s stock option activity and related information follows:

	December 31, 2013					December 31, 2012
				Weighted					Weighted
	Number			average		Number			average
	of			exercise		of			exercise
	Options			price		Options			price
Outstanding, beginning of year		465,294		$	1.67		351,130		$	6.14
Granted		4,325,808			0.41		384,000			0.90
Exercised		-			-		-			-
Forfeited/Expired		(106,459	)		0.39		(269,836	)		(6.40	)
Outstanding, end of year		4,684,643		$	0.53		465,294		$	1.67
Exercisable at the end of year		1,792,083		$	0.45		75,732		$	3.08
Weighted average fair value of
options granted during the year				$	0.41				$	0.68

As of December 31, 2013, the outstanding options had no intrinsic value.

F-15

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

7.    OPTIONS AND WARRANTS (Continued)

The weighted average remaining contractual life of options outstanding issued under the 2009 Plan, 2012 Plan, and 2013 Plan as of  December 31, 2013 was as follows:

						Weighted
						Average
		Stock		Stock		Remaining
Exercise		Options		Options		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	0.43 - 7.20		1,701,978		981,750		1.98 - 9.71
$	0.29 - 0.44		2,982,665		810,333		9.71
			4,684,643		1,792,083

Stock-based compensation expense recognized during the year is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the year ended December 31, 2013, included compensation expense for the stock-based payment awards granted prior to, but not yet vested, as of December 31, 2013 based on the grant date fair value estimated.

Warrants

During the year ended December 31, 2013, in conjunction with the Company’s issuance of shares of common stock for cash, the Company granted warrants to purchase a total of 37,427,384 shares of our common stock.  Each warrant is exercisable at a price per share between $0.15  to $0.25 subject to adjustment for stock splits, dividends, distributions, recapitalizations and the like and will expire in one up to five years from date of grant (see Note 6).

During the year ended December 31, 2013, the Company issued 332,960 shares of common stock in exchange for a cashless exercise of 454,911 purchase warrants. During the year ended December 31, 2013, the Company issued 779,298 shares of common stock upon exercise of the purchase warrants of 779,298 for cash in the amount of $194,826.

During the year ended December 31, 2013, the Company amended the exercise price of approximately 4,308,000 warrants issued in 2012, from $0.65 per share to $0.25 per share. The Company calculated the change in fair value of the warrants before and after the modification using the Black Scholes Pricing Option Model and recorded an expense in the statement of operations during the year ended December 31, 2013 amounting to $645,398.

		2013				2012
Risk free interest rate			0.17% - 0.44	%			.62% - .86	%
Stock volatility factor			83.00% - 88.00	%			68.56% - 70.61	%
Weighted average expected option life	5 years				5 years
Expected dividend yield	None				None

F-16

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

7. OPTIONS AND WARRANTS (Continued)

A summary of the Company’s warrant activity and related information follows:

	December 31, 2013					December 31, 2012
				Weighted					Weighted
				average					average
				exercise					exercise
	Options			price		Options			price
Outstanding -beginning of year		7,554,616		$	0.79		836,188		$	4.20
Granted		37,427,384			0.20		6,818,430			0.66
Exercised		(1,234,210	)		0.30		-			-
Forfeited		(1,714,194	)		1.26		(100,002	)		(4.10	)
Outstanding - end of year		42,033,596		$	0.31		7,554,616		$	0.79
Exercisable - end of year		41,782,058					7,098,104

 At December 31, 2013, the weighted average remaining contractual life of warrants outstanding:

						Weighted
						Average
						Remaining
Exercise		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	0.15 - 0.65		40,355,718		40,355,718		0.14 - 4.45
$	0.90 - 10.20		811,516		811,516		0.50 - 4.72
$	0.26 - 5.70		866,362		614,824		1.59 - 4.72
			42,033,596		41,782,058

At December 31, 2013 the aggregate intrinsic value of the warrants outstanding was $320,000.

8.    DERIVATIVE LIABILITIES

In June 2008, the FASB issued authoritative guidance on determining whether an instrument (or embedded feature) is indexed to an entity’s own stock. Under the authoritative guidance, effective January 1, 2009, instruments which did not have fixed settlement provisions were deemed to be derivative instruments. As a result, certain convertible notes issued related to the private placements described in Note 4 do not have fixed settlement provisions because their conversion prices may be lowered if the Company issues securities at lower prices in the future. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.  At December, 31, 2012, the outstanding fair value of the convertible notes accounted as derivative liabilities amounted to $355,526.

F-17

ORIGINOIL, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2013 AND 2012

8.    DERIVATIVE LIABILITIES (Continued)

During the year ended December 31, 2013, we determined that the fair value of the conversion feature of the convertible notes issued during the year at issuance was $3,063,210, based upon the weighted average Black-Sholes-Merton pricing model calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes. As the aggregate fair value of these liabilities of $3,063,210 exceeded the aggregate Note value of $2,106,873, the excess of the liabilities over the Note value of $956,337 was considered as a cost of the private placement and reported in the accompanying statement of operations.

During the year ended December 31, 2013, $1,172,172 of convertible notes were converted.  As a result of the conversion of these notes, the Company recorded a gain of $3,407,340 due to the extinguishment of the corresponding derivative liability.  Furthermore, during the year ended December 31, 2013, the Company recognized a change in fair value of $1,020,088 to account for the change in fair value of the derivative liabilities.  At December 31, 2013, the fair value of the derivative liability was $1,031,484.

For purpose of determining the fair market value of the derivative liability for the embedded conversion features, the Company used the Black Scholes option valuation model. The significant assumptions used in the valuation of the derivatives are as follows:

Risk free interest rate	.05% - .72%
Stock volatility factor	86.88% - 101.0%
Weighted average expected life	6 months - 4 years
Expected dividend yield	None

9. INCOME TAXES

The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2011.

Deferred income taxes have been provided by temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. To the extent allowed by GAAP, we provide valuation allowances against the deferred tax assets for amounts when the realization is uncertain.Included in the balance at December 31, 2013 and 2012, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility.  Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period.

The Company prescribes a recognition threshold and a measurement attributable for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized.

The Company's policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periods ended December 31, 2013 and 2012, the Company did not recognize interest and penalties.

At December 31, 2013, the Company had net operating loss carry-forwards of approximately $21,059,100, which expire at various through dates that have not been determined. No tax benefit has been reported in the December 31, 2013 financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.

The income tax provision differs from the amount of income tax determined by applying the U.S. federal and state income tax rate to pretax income from continuing operations for the years ended December 31, 2013 and 2012 due to the following:

	2013			2012
Book income	$	(3,505,200	)	$	(4,228,000	)
Tax to book differences for deductible expenses		(17,600	)		106,200
Tax non deductible expenses		1,403,200			2,834,200
Valuation Allowance		2,119,600			1,287,600
Income tax expense	$	-		$	-

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

F-18

9. INCOME TAXES (Continued)

The net deferred tax assets and liabilities consist of the following components as of December 31,

	2013			2012
Deferred tax assets:
NOL carryover	$	8,423,640		$	6,051,100
Other carryovers		449,650			436,700
Deferred tax liabilites:
Depreciation		(49,600	)		(25,200	)
Less Valuation Allowance		(8,823,690	)		(6,462,600	)
Net deferred tax asset	$	-		$	-

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years.

10.   SUBSEQUENT EVENTS

On January 1, 2014, the Company issued an aggregate of 400,000 shares of its common stock previously granted to Ivan Ivankovich and Anthony Fidaleo, both of whom received 200,000 shares of common stock each, for serving on the Company’s Board of Directors at time of issuance.  The fair value of these shares has been included in accrued expenses as of December 31, 2013.

Between January 6, 2014 and February 19, 2014, a Lender converted an aggregate principal and interest amount of $87,828 into 676,032 shares of common stock under the prior securities purchase agreement.

On January 10, 2014, the Company’s Board of Directors authorized the entering into of restricted stock grant agreements providing for the grant of an aggregate of 45,000,000 shares of common stock to certain officers and members of the Company’s management. The shares were eligible for issuance subject to the satisfaction of certain performance criteria and if such performance criteria were met, the shares then become eligible for vesting on a monthly basis. On April 5, 2014, and prior to the issuance or vesting of any of the shares, each of the grantees mutually agreed with the Company to the termination of the restricted stock grant agreements. Subsequently, on April 9, 2014, the Company’s Board of Directors authorized the entering into of restricted stock grant agreements providing for the grant of an aggregate of 40,000,000 shares of common stock to certain officers and members of the Company’s management. The shares are eligible for issuance subject to the satisfaction of certain performance criteria and if such performance criteria are met, the shares then become eligible for vesting on a monthly basis.

Between January 16, 2014 and March 31, 2014, holders of convertible notes, known in our filings as “Convertible Promissory Notes” converted an aggregate outstanding principal amount of $665,000, plus unpaid interest of $34,074 into an aggregate of 8,877,130 shares of the Company’s common stock.

On January 31, 2014, the Company’s Board of Directors appointed Mr. Byron Elton as director.  On February 10, 2014, in connection with Mr. Elton’s appointment, the Company issued to Mr. Elton 100,000 shares of its common stock and was recorded as compensation expense.

Between January 31, 2014 through March 31, 2014, the Company sold convertible promissory notes ("Notes") in the aggregate principal amount of $885,000. The Notes mature on various dates, nine months from the date of issuance and bear interest at 10% per annum. The Notes may be converted into shares of the Company’s common stock at a conversion price range of the lesser of $0.20 to $0.22 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Notes.  The Notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In the event of default, the Notes shall become immediately due and payable at the mandatory default amount. The mandatory default amount is 150% of the Notes amount and such mandatory default amount shall bear interest at 10% per annum.  In addition, for as long as the Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the Notes or such other convertible notes or a term was not similarly provided to the purchaser of the Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the Notes and such other convertible notes.

In March 2014, holders of warrants to purchase up to an aggregate of 3,000,000 shares of the Company’s common stock at an exercise price of $0.15 per share delivered notices of election to exercise the warrants in full on a cash basis resulting in the issuance of 3,000,000 shares of the Company’s common stock for an aggregate purchase price of $450,000.

During the subsequent period through April 7, 2014, in connection with certain one-time make good agreements, the Company issued an aggregate of 434,223 shares of its common stock at a fair value of $96,254 to certain holders of its common stock.

During the subsequent period through April 15, 2014, the Company issued 6,213,340 shares of common stock for services at a fair value of $1,300,920. Included in the issuance of those shares, on April 9, 2014, we agreed to issue 2,160,000 shares of our common stock to a consultant in lieu of cash consideration.  In addition, on April 9, 2014, our board of directors authorized the issuance to consultants of an aggregate of 3,020,000 shares of our common stock in lieu of cash consideration including 1,000,000 shares of common stock to each of Robert Rashti and Eng Cheh Hong who beneficially own more than 5% of the outstanding shares of our common stock.

F-19

EX-3.1.5

Exhibit 3.1.5

EX-10.1

Exhibit 10.1

ORIGINOIL, INC.

RESTRICTED STOCK GRANT AGREEMENT

This Restricted Stock Grant Agreement (the “Agreement”) is made and entered into as of   DATE                                        , (the “Effective Date”) by and between OriginOil, Inc., a Nevada corporation (the “Company”), and the person named below (the “Grantee”).

Grantee:
Address:
Total Number of Shares to Be Granted:	(the “Restricted Shares”)

1.           Grant of Restricted Shares.  In consideration for the performance of services by the Grantee for the Company, whether as a director, officer, employee or consultant, the Company hereby grants the Restricted Shares to the Grantee, subject to the conditions of this Agreement. As used in this Agreement, the term “Shares” shall mean shares of the Company’s common stock, par value $0.001 per share, which includes the Restricted Shares granted under this Agreement, and all securities received (i) in replacement of the Shares, (ii) as a result of stock dividends or stock splits with respect to the Shares, (iii) in replacement of the Shares in a merger, recapitalization, reorganization or similar corporate transaction; and (iv) pursuant to an adjustment to the number of Shares issuable on any vesting date by virtue of Section 2.7 of this Agreement.

2.           Issuance andVesting. The Restricted Shares shall vest and be issued to the Grantee upon the satisfaction of the conditions set forth in Section 2.1 and 2.2 of this Agreement. The Restricted Shares are forfeitable as set forth in Section 2.4 and Section 2.5 of this Agreement.

2.1           Schedule of Company Performance Goals.  Grantee shall be eligible for the issuance of Restricted Shares for each Company Performance Goal attained as follows:

Restricted Shares	Company Performance Goals
[40%]	The Company's Market Capitalization exceeds $15,000,000.  Market Capitalization shall mean the total number of shares of issued and outstanding common stock, multiplied by the average closing trade price of the Company's common stock on the 10 trading days immediately  prior to the date of determination.
[60%]	The Company's Market Capitalization exceeds $20,000,000.  Market Capitalization shall mean the total number of shares of issued and outstanding common stock, multiplied by the average closing trade price of the Company's common stock on the 10 trading days immediately  prior to the date of determination.

1

2.2           Vesting and Issuance of Eligible Restricted Shares and Cash Distribution. After a particular Company Performance Goal has been met, the Restricted Shares associated with that particular Company Performance Goal shall be eligible for vesting (the “Eligible Restricted Shares”).  The Eligible Restricted Shares shall vest on a monthly basis, based on the following formula:

Vesting Percentage      x	Prior Monthly Trade Value
Monthly Vested Shares =	Fair Market Value of the Company’s Shares

For the purposes of this Agreement,

(i)            the “Prior Monthly Trade Value” of the Company’s Shares shall mean the aggregate sum of the Daily Trade Value in the calendar month immediately before the date of determination.

(ii)           the “Daily Trade Value” is defined as the closing trade price of the Company’s Shares multiplied by the daily trade volume.  For example, if the closing trade price was $1.00 and the daily trade volume on that day was 500,000 shares, then the Daily Trade Value for that day would be $500,000.

(iii)           the “Vesting Percentage” shall mean the product (expressed as a percentage) of (a) 10%, multiplied by (b) a fraction, (1) the numerator of which is [__________] [insert number of Restricted Shares on first page],and (2) the denominator of which shall be such number of shares of common stock as determined by the Company from time to time in its sole discretion, and which shall initially be 40,000,000. For example, if the numerator is 10,000,000 and the denominator is 40,000,000, then the Vesting Percentage shall be 2.5%.

(iv)           the “Fair Market Value” shall equal the average of the trailing ten (10) closing trade prices of the Company’s common stock on the last ten (10) trading days of the month immediately prior to the date of determination as quoted on the public securities trading market on which the Company’s common stock is then traded; provided, that if the Company’s common stock is not then publicly trading or quoted, “Fair Market Value” shall be determined by the Company’s Board of Directors in good faith.

If the Company’s common stock is no longer publicly traded, then the Board of Directors in good faith shall determine the Monthly Vested Shares.

If the Prior Monthly Trade Value is less than $50,000, then zero Eligible Restricted Shares shall vest for that month.

By way of example only, if the Vesting Percentage is 2.5%, the Prior Monthly Trade Value is $10,000,000 and the Fair Market Value is $1.00, then the number of Monthly Vested Shares shall be 250,000.

2

The Monthly Vested Shares, if any, shall be computed on the first day of every month for the prior month (the “Monthly Vesting Date”).  Subject to reduction as set forth in this paragraph below, fifty percent (50%) of the Shares of the Monthly Vested Shares shall be issued to the Grantee within ten (10) business days.  The Fair Market Value (as described in Section 2.8 below) of the remaining amount of Monthly Vested Shares shall be paid by the Company to the Grantee in cash, in lieu of Shares (the “Cash Distribution”).  If the Grantee is an employee of the Company as of the Monthly Vesting Date, then the Company shall withhold the Grantee’s share of the Required Payroll Taxes (as defined below) on the full Fair Market Value of all one hundred percent (100%) of the Monthly Vested Shares from the Cash Distribution and pay the balance, if any, to the Grantee within thirty (30) business days.  If the Cash Distribution is not sufficient to pay the Required Payroll Taxes, then the amount of the Cash Distribution shall be increased to equal the amount of the Required Payroll Taxes and the number of Shares issued from the Monthly Vested Shares shall be decreased accordingly.  If the Grantee is not an employee of the Company as of the Monthly Vesting Date, then the Cash Distribution shall equal fifty percent (50%) of the total Fair Market Value of all one hundred percent (100%) of the Monthly Vested Shares, and the Grantee shall assume full responsibility for all taxes associated with the Shares issued from the Monthly Vested Shares and the Cash Distribution.  For the purposes of this Agreement, the term “Required Payroll Taxes” means the amount of payroll taxes mandated by federal, state, and local law to be withheld by an employer from an employee’s compensation for ultimate payment to the appropriate government agency, plus additional withholding mutually and voluntarily agreed to in writing by the Grantee and the Company.

2.3           Lock-Up Agreement. For a period of one (1) year  after vesting and issuance, Grantee hereby agrees that Grantee shall not without the prior written consent of the Company, offer, pledge, sell, contract to sell, grant any option for the sale of, or otherwise dispose of, directly or indirectly, the Shares issued from the Monthly Vested Shares, otherwise permitted by Rule 144 promulgated under the Securities Act and consents to the placement of a legend with respect to the foregoing on each certificate representing the Shares issued from the Monthly Vested Shares.

2.4           Forfeiture. Grantee shall forfeit all vesting rights for any Eligible Restricted Shares that have not vested within five (5) years of the date that the Eligible Restricted Shares were eligible for vesting.

2.5           Termination. If the Grantee ceases to provide any services to the Company as officer, director, employee or consultant, for any reason before the date that the Company Performance Goals have been met (it being understood that if the Grantee continues without interruption to serve thereafter in one or more capacities as officer, director, employee or consultant of the Company this shall not be considered a cessation of service), then the Restricted Shares associated with the unmet Company Performance Goals as of the date of such cessation of services shall immediately be forfeited as of the date of such cessation of services.  The Eligible Restricted Shares associated with any Company Performance Goals met prior to the date the Grantee ceases to provide any services to the Company shall continue to vest and be issued to the Grantee in accordance with Sections 2.2 and 2.3 of this Agreement.

2.6           Title to Shares. The exact spelling of the name(s) under which Grantee shall take title to the Shares is:

Grantee desires to take title to the Shares as follows:

[  ]      Individual, as separate property

[  ]      Husband and wife, as community property

[  ]      Joint Tenants

2.7           Adjustment to Number of Shares.  The Company agrees that if the Fair Market Value of the Company’s common stock on the Monthly Vesting Date is less than the Fair Market Value of the Company’s common stock on the Effective Date, then the number of Monthly Vested Shares issuable (assuming all conditions are satisfied) within ten business days of the Monthly Vesting Date shall be increased so that the aggregate Fair Market Value of Monthly Vested Shares issuable equals the aggregate Fair Market Value that such number of Shares would have had on the Effective Date.

3

3.           Representations and Warranties of Grantee.  Grantee represents and warrants to the Company that:

3.1           Agrees to Terms of this Agreement.  Grantee has received a copy of this Agreement, has read and understands the terms of this Agreement, and agrees to be bound by its terms and conditions.

3.2           Acceptance of Shares for Own Account for Investment.  Grantee is acquiring the Shares for Grantee's own account for investment purposes only and not with a view to, or for sale in connection with, a distribution of the Shares within the meaning of the Securities Act of 1933, as amended (the “Securities Act”).  Grantee has no present intention of selling or otherwise disposing of all or any portion of the Shares.

3.3           Access to Information.  Grantee has had access to all information regarding the Company and its present and prospective business, assets, liabilities and financial condition that Grantee reasonably considers important in making the decision to acquire the Shares, and Grantee has had ample opportunity to ask questions of the Company's representatives concerning such matters and this investment.

3.4           Understanding of Risks.  Grantee is fully aware of:  (i) the highly speculative nature of the investment in the Shares; (ii) the financial hazards involved; (iii) the lack of liquidity of the Shares and the restrictions on transferability of the Shares (e.g., that Grantee may not be able to sell or dispose of the Shares or use them as collateral for loans); (iv) the qualifications and backgrounds of the management of the Company; and (v) the tax consequences of investment in the Shares.  Grantee is capable of evaluating the merits and risks of this investment, has the ability to protect Grantee's own interests in this transaction and is financially capable of bearing a total loss of this investment.

3.5           No General Solicitation.  At no time was Grantee presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of general advertising or solicitation in connection with the offer, sale and issue of the Shares.

4.           Compliance with Securities Laws.  Grantee understands and acknowledges that the Shares have not been registered with the Securities and Exchange Commission (the “SEC”) under the Securities Act and that, notwithstanding any other provision of this Agreement to the contrary, the issuance of any Shares is expressly conditioned upon compliance with the Securities Act and all applicable state securities laws.  Grantee agrees to cooperate with the Company to ensure compliance with such laws.

5.           Restricted Securities.

5.1           No Transfers Unless Registered or Exempt.  In addition to the lock-up agreement in Section 2.3 above, Grantee understands that Grantee may not transfer any Shares unless such Shares are registered under the Securities Act and qualified under applicable state securities laws or unless, in the opinion of counsel to the Company, exemptions from such registration and qualification requirements are available.  Grantee understands that only the Company may file a registration statement with the SEC and that the Company is under no obligation to do so with respect to the Shares.  Grantee has also been advised that exemptions from registration and qualification may not be available or may not permit Grantee to transfer all or any of the Shares in the amounts or at the times proposed by Grantee.

5.2           SEC Rule 144.  In addition, Grantee has been advised that SEC Rule 144 promulgated under the Securities Act, which permits certain limited sales of unregistered securities, is not presently available with respect to the Shares and, in any event, requires that the Shares be held for a minimum of six months, and in certain cases one (1) year, after they have been acquired, before they may be resold under Rule 144.  Grantee understands that Rule 144 may indefinitely restrict transfer of the Shares so long as Grantee remains an "affiliate" of the Company.

6.           Market Standoff Agreement.  Grantee agrees in connection with any registration of the Company's securities that, upon the request of the Company or the underwriters managing any public offering of the Company's securities, Grantee shall not sell or otherwise dispose of any Shares without the prior written consent of the Company or such underwriters, as the case may be, for such period of time (not to exceed one hundred eighty (180) days) after the effective date of such registration requested by such underwriters and subject to all restrictions as the Company or the underwriters may specify.  Grantee further agrees to enter into any agreement reasonably required by the underwriters to implement the foregoing.

4

7.           Company Take-Along Right.

7.1           Approved Sale.  If the Board of Directors of the Company (the “Board”) shall deliver a notice to Grantee (a “Sale Event Notice”) stating that the Board has approved a sale of all or a portion of the Company (an “Approved Sale”) and specifying the name and address of the proposed parties to such transaction and the consideration payable in connection therewith, Grantee shall (i) consent to and raise no objections against the Approved Sale or the process pursuant to which the Approved Sale was arranged, (ii) waive any dissenter’s rights and other similar rights, and (iii) if the Approved Sale is structured as a sale of securities, agree to sell Grantee’s Shares on the terms and conditions of the Approved Sale which terms and conditions shall treat all stockholders of the Company equally (on a pro rata basis), except that shares having a liquidation preference may, if so provided in the documents governing such shares, receive an amount of consideration equal to such liquidation preference in addition to the consideration being paid to the holders of Shares not having a liquidation preference.

Grantee shall take all necessary and desirable lawful actions as directed by the Board and the stockholders of the Company approving the Approved Sale in connection with the consummation of any Approved Sale, including without limitation, the execution of such agreements and such instruments and other actions reasonably necessary to (A) provide the representations, warranties, indemnities, covenants, conditions, non-compete agreements, escrow agreements and other provisions and agreements relating to such Approved Sale and, (B) effectuate the allocation and distribution of the aggregate consideration upon the Approved Sale, provided, that this Section 8 shall not require Grantee to indemnify the purchaser in any Approved Sale for breaches of the representations, warranties or covenants of the Company or any other stockholder, except to the extent (x) Grantee is not required to incur more than its pro rata share of such indemnity obligation (based on the total consideration to be received by all stockholders that are similarly situated and hold the same class or series of capital stock) and (y) such indemnity obligation is provided for and limited to a post-closing escrow or holdback arrangement of cash or stock paid in connection with the Approved Sale.

7.2           Costs.  Grantee shall bear Grantee’s pro rata share (based upon the amount of consideration to be received) of the reasonable costs of any sale of Shares pursuant to an Approved Sale to the extent such costs are incurred for the benefit of all selling stockholders of the Company and are not otherwise paid by the Company or the acquiring party.  Costs incurred by Grantee on Grantee’s own behalf shall not be considered costs of the transaction hereunder.

7.3           Share Delivery.  At the consummation of the Approved Sale, Grantee shall, if applicable, deliver certificates representing the Shares to be transferred, duly endorsed for transfer and accompanied by all requisite stock transfer taxes, if any, and the Shares to be transferred shall be free and clear of any liens, claims or encumbrances (other than restrictions imposed by this Section 7) and Grantee shall so represent and warrant.

7.4           Termination of Company Take-Along Right.  The Take-Along Right shall terminate as to the Shares upon the Public Trading Date of the Shares.  For the purposes of this Agreement, the “Public Trading Date” of the Shares is the date on which the Shares first become freely tradable, without volume or manner-of-sale restrictions or current public information requirements, under the Securities Act, either pursuant to Rule 144 or another provision of the Securities Act, and are no longer subject to lock-up under Section 2.3 of this Agreement.  The holder of the Shares may apply to have all restrictive transfer legends removed from the certificates evidencing the Shares, provided that the request for legend removal is made at such times and in such manner that removal is accomplished in compliance with the Securities Act and the rules and regulations promulgated under the Securities Act, and Section 2.3 of this Agreement; and provided further, that any proposed sale of Shares must comply with all Company policies and procedures, and with applicable federal, state and local laws.

8.              Rights as a Stockholder.  Subject to the terms and conditions of this Agreement, Grantee shall have all of the rights of a stockholder of the Company with respect to the Shares after the Restricted Shares vest until such time as Grantee disposes of the Shares.

9.              Restrictive Legends and Stop-Transfer Orders.

9.1           Legends.  Grantee understands and agrees that the Company shall place the legends set forth below or similar legends on any stock certificate(s) evidencing the Shares, together with any other legends that may be required by state or federal securities laws, the Company's Articles of Incorporation or Bylaws, any other agreement between Grantee and the Company or any agreement between Grantee and any third party:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES.  THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.  INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.  THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

5

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A THREE (3) YEAR LOCK-UP RESTRICTION FROM DATE OF ISSUANCE AND A 180 DAY MARKET STANDOFF RESTRICTION AS SET FORTH IN A CERTAIN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER.  AS A RESULT OF SUCH AGREEMENT, THESE SHARES MAY NOT BE TRADED PRIOR TO THE EXPIRATION OF THE THREE (3) YEAR LOCK-UP PERIOD AND 180 DAYS AFTER THE EFFECTIVE DATE OF A PUBLIC OFFERING OF THE COMMON STOCK OF THE ISSUER HEREOF.  SUCH RESTRICTION IS BINDING ON TRANSFEREES OF THESE SHARES.

9.2           Stop-Transfer Instructions.  Grantee agrees that, to ensure compliance with the restrictions imposed by this Agreement, the Company may issue appropriate "stop-transfer" instructions to its transfer agent, if any, and if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records.

9.3           Refusal to Transfer.  The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares, or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares have been so transferred.

10.           Tax Consequences.  GRANTEE UNDERSTANDS THAT GRANTEE MAY SUFFER ADVERSE TAX CONSEQUENCES AS A RESULT OF GRANTEE'S ACQUISITION OR DISPOSITION OF THE SHARES.  GRANTEE REPRESENTS (i) THAT GRANTEE HAS CONSULTED WITH A TAX ADVISER THAT GRANTEE DEEMS ADVISABLE IN CONNECTION WITH THE ACQUISITION OR DISPOSITION OF THE SHARES AND (ii) THAT GRANTEE IS NOT RELYING ON THE COMPANY FOR ANY TAX ADVICE.

11.           Compliance with Laws and Regulations.  The issuance and transfer of the Shares shall be subject to and conditioned upon compliance by the Company and Grantee with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company's common stock may be listed or quoted at the time of such issuance or transfer.

12.           Successors and Assigns.  The Company may assign any of its rights under this Agreement.This Agreement shall be binding upon and inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer herein set forth, this Agreement shall be binding upon Grantee and Grantee's heirs, executors, administrators, legal representatives, successors and assigns.

13.           Governing Law; Severability.  This Agreement shall be governed by and construed in accordance with the internal laws of the State of Nevada as such laws are applied to agreements betweenNevada residents entered into and to be performed entirely within Nevada, excluding that body of laws pertaining to conflict of laws.  If any provision of this Agreement is determined by a court of law to be illegal or unenforceable, then such provision shall be enforced to the maximum extent possible and the other provisions shall remain fully effective and enforceable.

14.           Notices.  Any notice required to be given or delivered to the Company shall be in writing and addressed to the Corporate Secretary of the Company at its principal corporate offices.  Any notice required to be given or delivered to Grantee shall be in writing and addressed to Grantee at the address indicated above or to such other address as Grantee may designate in writing from time to time to the Company.  All notices shall be deemed effectively given upon personal delivery, (i) three (3) days after deposit in the United States mail by certified or registered mail (return receipt requested), (ii) one (1) business day after its deposit with any return receipt express courier (prepaid), or (iii) one (1) business day after transmission by facsimile or email.

15.           Further Instruments.  The parties agree to execute such further instruments and to take such further action as may be reasonably necessary to carry out the purposes and intent of this Agreement.

16.           Headings; Counterparts.  The captions and headings of this Agreement are included for ease of reference only and shall be disregarded in interpreting or construing this Agreement.  All references herein to Sections shall refer to Sections of this Agreement.  This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, and all of which together shall constitute one and the same agreement.

6

17.           Entire Agreement.  This Agreement constitutes the entire agreement and understanding of the parties with respect to the subject matter of this Agreement, and supersedes all prior understandings and agreements, whether oral or written, between the parties hereto with respect to the specific subject matter of this Agreement.

18.           Equitable Adjustments. The number of Restricted Shares, Monthly Vested Shares, Eligible Restricted Shares and Shares, the Company’s Market Capitalization and similar figures set forth herein shall be equitably adjusted in the sole discretion of the Company to offset the effect of stock splits or similar events.

WHEREOF, the Company has caused this Agreement to be executed by its duly authorized representative and Grantee has executed this Agreement as of the Effective Date.

OriginOil, Inc.	Grantee
By:	(Signature)
(Please print name)	(Please print name)
Chief Executive Officer
(Please print title)

7

Spouse Consent

The undersigned spouse of _______________________ (the “Grantee”) has read, understands, and hereby approves the Restricted Stock Grant Agreement between OriginOil, Inc., a Nevada corporation (the “Company”) and Grantee (the “Agreement”). In consideration of the Company's granting my spouse the right to purchase the Shares as set forth in the Agreement, the undersigned hereby agrees to be irrevocably bound by the Agreement and further agrees that any community property interest shall similarly be bound by the Agreement. The undersigned hereby appoints Grantee as my attorney-in-fact with respect to any amendment or exercise of any rights under the Agreement.

Date:
Print Name of Grantee's Spouse	Signature of Grantee's Spouse
(Please print title)	Address:

o Check this box if you do not have a spouse.

8

EX-10.2

Exhibit 10.2

ORIGINOIL, INC.

RESTRICTED STOCK GRANT AGREEMENT

This Restricted Stock Grant Agreement (the “Agreement”) is made and entered into as of   DATE                                        , (the “Effective Date”) by and between OriginOil, Inc., a Nevada corporation (the “Company”), and the person named below (the “Grantee”).

Grantee:
Address:
Total Number of Shares to Be Granted:	(the “Restricted Shares”)

1.           Grant of Restricted Shares.  In consideration for the performance of services by the Grantee for the Company, whether as a director, officer, employee or consultant, the Company hereby grants the Restricted Shares to the Grantee, subject to the conditions of this Agreement. As used in this Agreement, the term “Shares” shall mean shares of the Company’s common stock, par value $0.001 per share, which includes the Restricted Shares granted under this Agreement, and all securities received (i) in replacement of the Shares, (ii) as a result of stock dividends or stock splits with respect to the Shares, (iii) in replacement of the Shares in a merger, recapitalization, reorganization or similar corporate transaction; and (iv) pursuant to an adjustment to the number of Shares issuable on any vesting date by virtue of Section 2.7 of this Agreement.

2.           Issuance andVesting. The Restricted Shares shall vest and be issued to the Grantee upon the satisfaction of the conditions set forth in Section 2.1 and 2.2 of this Agreement. The Restricted Shares are forfeitable as set forth in Section 2.4 and Section 2.5 of this Agreement.

2.1           Schedule of Company Performance Goals.  Grantee shall be eligible for the issuance of Restricted Shares for each Company Performance Goal attained as follows:

Restricted Shares	Company Performance Goals
[40%]	The Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $2,500,000 for the trailing twelve-month period as reported in the Company’s quarterly or annual financial statements
[60%]	The Company’s consolidated net profit, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $500,000 for the trailing twelve-month period as reported in the Company’s quarterly or annual financial statements.

1

2.2           Vesting and Issuance of Eligible Restricted Shares and Cash Distribution. After a particular Company Performance Goal has been met, the Restricted Shares associated with that particular Company Performance Goal shall be eligible for vesting (the “Eligible Restricted Shares”).  The Eligible Restricted Shares shall vest on a monthly basis, based on the following formula:

Vesting Percentage     x   Prior Monthly Trade Value

Monthly Vested Shares =                   ---------------------------------------------------------------

                    Fair Market Value of the Company’s Shares

For the purposes of this Agreement,

(i)            the “Prior Monthly Trade Value” of the Company’s Shares shall mean the aggregate sum of the Daily Trade Value in the calendar month immediately before the date of determination.

(ii)           the “Daily Trade Value” is defined as the closing trade price of the Company’s Shares multiplied by the daily trade volume.  For example, if the closing trade price was $1.00 and the daily trade volume on that day was 500,000 shares, then the Daily Trade Value for that day would be $500,000.

(iii)           the “Vesting Percentage” shall mean the product (expressed as a percentage) of (a) 10%, multiplied by (b) a fraction, (1) the numerator of which is [__________] [insert number of Restricted Shares on first page],and (2) the denominator of which shall be such number of shares of common stock as determined by the Company from time to time in its sole discretion, and which shall initially be 40,000,000. For example, if the numerator is 10,000,000 and the denominator is 40,000,000, then the Vesting Percentage shall be 2.5%.

(iv)           the “Fair Market Value” shall equal the average of the trailing ten (10) closing trade prices of the Company’s common stock on the last ten (10) trading days of the month immediately prior to the date of determination as quoted on the public securities trading market on which the Company’s common stock is then traded; provided, that if the Company’s common stock is not then publicly trading or quoted, “Fair Market Value” shall be determined by the Company’s Board of Directors in good faith.

If the Company’s common stock is no longer publicly traded, then the Board of Directors in good faith shall determine the Monthly Vested Shares.

If the Prior Monthly Trade Value is less than $50,000, then zero Eligible Restricted Shares shall vest for that month.

By way of example only, if the Vesting Percentage is 2.5%, the Prior Monthly Trade Value is $10,000,000 and the Fair Market Value is $1.00, then the number of Monthly Vested Shares shall be 250,000.

2

The Monthly Vested Shares, if any, shall be computed on the first day of every month for the prior month (the “Monthly Vesting Date”).  Subject to reduction as set forth in this paragraph below, fifty percent (50%) of the Shares of the Monthly Vested Shares shall be issued to the Grantee within ten (10) business days.  The Fair Market Value (as described in Section 2.8 below) of the remaining amount of Monthly Vested Shares shall be paid by the Company to the Grantee in cash, in lieu of Shares (the “Cash Distribution”).  If the Grantee is an employee of the Company as of the Monthly Vesting Date, then the Company shall withhold the Grantee’s share of the Required Payroll Taxes (as defined below) on the full Fair Market Value of all one hundred percent (100%) of the Monthly Vested Shares from the Cash Distribution and pay the balance, if any, to the Grantee within thirty (30) business days.  If the Cash Distribution is not sufficient to pay the Required Payroll Taxes, then the amount of the Cash Distribution shall be increased to equal the amount of the Required Payroll Taxes and the number of Shares issued from the Monthly Vested Shares shall be decreased accordingly.  If the Grantee is not an employee of the Company as of the Monthly Vesting Date, then the Cash Distribution shall equal fifty percent (50%) of the total Fair Market Value of all one hundred percent (100%) of the Monthly Vested Shares, and the Grantee shall assume full responsibility for all taxes associated with the Shares issued from the Monthly Vested Shares and the Cash Distribution.  For the purposes of this Agreement, the term “Required Payroll Taxes” means the amount of payroll taxes mandated by federal, state, and local law to be withheld by an employer from an employee’s compensation for ultimate payment to the appropriate government agency, plus additional withholding mutually and voluntarily agreed to in writing by the Grantee and the Company.

2.3           Lock-Up Agreement. For a period three (3) years after vesting and issuance, Grantee hereby agrees that Grantee shall not without the prior written consent of the Company, offer, pledge, sell, contract to sell, grant any option for the sale of, or otherwise dispose of, directly or indirectly, the Shares issued from the Monthly Vested Shares, otherwise permitted by Rule 144 promulgated under the Securities Act and consents to the placement of a legend with respect to the foregoing on each certificate representing the Shares issued from the Monthly Vested Shares.

2.4           Forfeiture. Grantee shall forfeit all vesting rights for any Eligible Restricted Shares that have not vested within five (5) years of the date that the Eligible Restricted Shares were eligible for vesting.

2.5           Termination. If the Grantee ceases to provide any services to the Company as officer, director, employee or consultant, for any reason before the date that the Company Performance Goals have been met (it being understood that if the Grantee continues without interruption to serve thereafter in one or more capacities as officer, director, employee or consultant of the Company this shall not be considered a cessation of service), then the Restricted Shares associated with the unmet Company Performance Goals as of the date of such cessation of services shall immediately be forfeited as of the date of such cessation of services.  The Eligible Restricted Shares associated with any Company Performance Goals met prior to the date the Grantee ceases to provide any services to the Company shall continue to vest and be issued to the Grantee in accordance with Sections 2.2 and 2.3 of this Agreement.

2.6           Title to Shares. The exact spelling of the name(s) under which Grantee shall take title to the Shares is:

Grantee desires to take title to the Shares as follows:

[  ]      Individual, as separate property

[  ]      Husband and wife, as community property

[  ]      Joint Tenants

2.7           Adjustment to Number of Shares.  The Company agrees that if the Fair Market Value of the Company’s common stock on the Monthly Vesting Date is less than the Fair Market Value of the Company’s common stock on the Effective Date, then the number of Monthly Vested Shares issuable (assuming all conditions are satisfied) within ten business days of the Monthly Vesting Date shall be increased so that the aggregate Fair Market Value of Monthly Vested Shares issuable equals the aggregate Fair Market Value that such number of Shares would have had on the Effective Date.

3.           Representations and Warranties of Grantee.  Grantee represents and warrants to the Company that:

3.1           Agrees to Terms of this Agreement.  Grantee has received a copy of this Agreement, has read and understands the terms of this Agreement, and agrees to be bound by its terms and conditions.

3

3.2           Acceptance of Shares for Own Account for Investment.  Grantee is acquiring the Shares for Grantee's own account for investment purposes only and not with a view to, or for sale in connection with, a distribution of the Shares within the meaning of the Securities Act of 1933, as amended (the “Securities Act”).  Grantee has no present intention of selling or otherwise disposing of all or any portion of the Shares.

3.3           Access to Information.  Grantee has had access to all information regarding the Company and its present and prospective business, assets, liabilities and financial condition that Grantee reasonably considers important in making the decision to acquire the Shares, and Grantee has had ample opportunity to ask questions of the Company's representatives concerning such matters and this investment.

3.4           Understanding of Risks.  Grantee is fully aware of:  (i) the highly speculative nature of the investment in the Shares; (ii) the financial hazards involved; (iii) the lack of liquidity of the Shares and the restrictions on transferability of the Shares (e.g., that Grantee may not be able to sell or dispose of the Shares or use them as collateral for loans); (iv) the qualifications and backgrounds of the management of the Company; and (v) the tax consequences of investment in the Shares.  Grantee is capable of evaluating the merits and risks of this investment, has the ability to protect Grantee's own interests in this transaction and is financially capable of bearing a total loss of this investment.

3.5           No General Solicitation.  At no time was Grantee presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of general advertising or solicitation in connection with the offer, sale and issue of the Shares.

4.           Compliance with Securities Laws.  Grantee understands and acknowledges that the Shares have not been registered with the Securities and Exchange Commission (the “SEC”) under the Securities Act and that, notwithstanding any other provision of this Agreement to the contrary, the issuance of any Shares is expressly conditioned upon compliance with the Securities Act and all applicable state securities laws.  Grantee agrees to cooperate with the Company to ensure compliance with such laws.

5.           Restricted Securities.

5.1           No Transfers Unless Registered or Exempt.  In addition to the lock-up agreement in Section 2.3 above, Grantee understands that Grantee may not transfer any Shares unless such Shares are registered under the Securities Act and qualified under applicable state securities laws or unless, in the opinion of counsel to the Company, exemptions from such registration and qualification requirements are available.  Grantee understands that only the Company may file a registration statement with the SEC and that the Company is under no obligation to do so with respect to the Shares.  Grantee has also been advised that exemptions from registration and qualification may not be available or may not permit Grantee to transfer all or any of the Shares in the amounts or at the times proposed by Grantee.

5.2           SEC Rule 144.  In addition, Grantee has been advised that SEC Rule 144 promulgated under the Securities Act, which permits certain limited sales of unregistered securities, is not presently available with respect to the Shares and, in any event, requires that the Shares be held for a minimum of six months, and in certain cases one (1) year, after they have been acquired, before they may be resold under Rule 144.  Grantee understands that Rule 144 may indefinitely restrict transfer of the Shares so long as Grantee remains an "affiliate" of the Company.

6.           Market Standoff Agreement.  Grantee agrees in connection with any registration of the Company's securities that, upon the request of the Company or the underwriters managing any public offering of the Company's securities, Grantee shall not sell or otherwise dispose of any Shares without the prior written consent of the Company or such underwriters, as the case may be, for such period of time (not to exceed one hundred eighty (180) days) after the effective date of such registration requested by such underwriters and subject to all restrictions as the Company or the underwriters may specify.  Grantee further agrees to enter into any agreement reasonably required by the underwriters to implement the foregoing.

7.           Company Take-Along Right.

7.1           Approved Sale.  If the Board of Directors of the Company (the “Board”) shall deliver a notice to Grantee (a “Sale Event Notice”) stating that the Board has approved a sale of all or a portion of the Company (an “Approved Sale”) and specifying the name and address of the proposed parties to such transaction and the consideration payable in connection therewith, Grantee shall (i) consent to and raise no objections against the Approved Sale or the process pursuant to which the Approved Sale was arranged, (ii) waive any dissenter’s rights and other similar rights, and (iii) if the Approved Sale is structured as a sale of securities, agree to sell Grantee’s Shares on the terms and conditions of the Approved Sale which terms and conditions shall treat all stockholders of the Company equally (on a pro rata basis), except that shares having a liquidation preference may, if so provided in the documents governing such shares, receive an amount of consideration equal to such liquidation preference in addition to the consideration being paid to the holders of Shares not having a liquidation preference.

Grantee shall take all necessary and desirable lawful actions as directed by the Board and the stockholders of the Company approving the Approved Sale in connection with the consummation of any Approved Sale, including without limitation, the execution of such agreements and such instruments and other actions reasonably necessary to (A) provide the representations, warranties, indemnities, covenants, conditions, non-compete agreements, escrow agreements and other provisions and agreements relating to such Approved Sale and, (B) effectuate the allocation and distribution of the aggregate consideration upon the Approved Sale, provided, that this Section 8 shall not require Grantee to indemnify the purchaser in any Approved Sale for breaches of the representations, warranties or covenants of the Company or any other stockholder, except to the extent (x) Grantee is not required to incur more than its pro rata share of such indemnity obligation (based on the total consideration to be received by all stockholders that are similarly situated and hold the same class or series of capital stock) and (y) such indemnity obligation is provided for and limited to a post-closing escrow or holdback arrangement of cash or stock paid in connection with the Approved Sale.

7.2           Costs.  Grantee shall bear Grantee’s pro rata share (based upon the amount of consideration to be received) of the reasonable costs of any sale of Shares pursuant to an Approved Sale to the extent such costs are incurred for the benefit of all selling stockholders of the Company and are not otherwise paid by the Company or the acquiring party.  Costs incurred by Grantee on Grantee’s own behalf shall not be considered costs of the transaction hereunder.

7.3           Share Delivery.  At the consummation of the Approved Sale, Grantee shall, if applicable, deliver certificates representing the Shares to be transferred, duly endorsed for transfer and accompanied by all requisite stock transfer taxes, if any, and the Shares to be transferred shall be free and clear of any liens, claims or encumbrances (other than restrictions imposed by this Section 7) and Grantee shall so represent and warrant.

4

7.4           Termination of Company Take-Along Right.  The Take-Along Right shall terminate as to the Shares upon the Public Trading Date of the Shares.  For the purposes of this Agreement, the “Public Trading Date” of the Shares is the date on which the Shares first become freely tradable, without volume or manner-of-sale restrictions or current public information requirements, under the Securities Act, either pursuant to Rule 144 or another provision of the Securities Act, and are no longer subject to lock-up under Section 2.3 of this Agreement.  The holder of the Shares may apply to have all restrictive transfer legends removed from the certificates evidencing the Shares, provided that the request for legend removal is made at such times and in such manner that removal is accomplished in compliance with the Securities Act and the rules and regulations promulgated under the Securities Act, and Section 2.3 of this Agreement; and provided further, that any proposed sale of Shares must comply with all Company policies and procedures, and with applicable federal, state and local laws.

8.              Rights as a Stockholder.  Subject to the terms and conditions of this Agreement, Grantee shall have all of the rights of a stockholder of the Company with respect to the Shares after the Restricted Shares vest until such time as Grantee disposes of the Shares.

9.              Restrictive Legends and Stop-Transfer Orders.

9.1           Legends.  Grantee understands and agrees that the Company shall place the legends set forth below or similar legends on any stock certificate(s) evidencing the Shares, together with any other legends that may be required by state or federal securities laws, the Company's Articles of Incorporation or Bylaws, any other agreement between Grantee and the Company or any agreement between Grantee and any third party:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES.  THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.  INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.  THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A THREE (3) YEAR LOCK-UP RESTRICTION FROM DATE OF ISSUANCE AND A 180 DAY MARKET STANDOFF RESTRICTION AS SET FORTH IN A CERTAIN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER.  AS A RESULT OF SUCH AGREEMENT, THESE SHARES MAY NOT BE TRADED PRIOR TO THE EXPIRATION OF THE THREE (3) YEAR LOCK-UP PERIOD AND 180 DAYS AFTER THE EFFECTIVE DATE OF A PUBLIC OFFERING OF THE COMMON STOCK OF THE ISSUER HEREOF.  SUCH RESTRICTION IS BINDING ON TRANSFEREES OF THESE SHARES.

9.2           Stop-Transfer Instructions.  Grantee agrees that, to ensure compliance with the restrictions imposed by this Agreement, the Company may issue appropriate "stop-transfer" instructions to its transfer agent, if any, and if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records.

9.3           Refusal to Transfer.  The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares, or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares have been so transferred.

10.           Tax Consequences.  GRANTEE UNDERSTANDS THAT GRANTEE MAY SUFFER ADVERSE TAX CONSEQUENCES AS A RESULT OF GRANTEE'S ACQUISITION OR DISPOSITION OF THE SHARES.  GRANTEE REPRESENTS (i) THAT GRANTEE HAS CONSULTED WITH A TAX ADVISER THAT GRANTEE DEEMS ADVISABLE IN CONNECTION WITH THE ACQUISITION OR DISPOSITION OF THE SHARES AND (ii) THAT GRANTEE IS NOT RELYING ON THE COMPANY FOR ANY TAX ADVICE.

11.           Compliance with Laws and Regulations.  The issuance and transfer of the Shares shall be subject to and conditioned upon compliance by the Company and Grantee with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company's common stock may be listed or quoted at the time of such issuance or transfer.

12.           Successors and Assigns.  The Company may assign any of its rights under this Agreement.This Agreement shall be binding upon and inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer herein set forth, this Agreement shall be binding upon Grantee and Grantee's heirs, executors, administrators, legal representatives, successors and assigns.

13.           Governing Law; Severability.  This Agreement shall be governed by and construed in accordance with the internal laws of the State of Nevada as such laws are applied to agreements betweenNevada residents entered into and to be performed entirely within Nevada, excluding that body of laws pertaining to conflict of laws.  If any provision of this Agreement is determined by a court of law to be illegal or unenforceable, then such provision shall be enforced to the maximum extent possible and the other provisions shall remain fully effective and enforceable.

14.           Notices.  Any notice required to be given or delivered to the Company shall be in writing and addressed to the Corporate Secretary of the Company at its principal corporate offices.  Any notice required to be given or delivered to Grantee shall be in writing and addressed to Grantee at the address indicated above or to such other address as Grantee may designate in writing from time to time to the Company.  All notices shall be deemed effectively given upon personal delivery, (i) three (3) days after deposit in the United States mail by certified or registered mail (return receipt requested), (ii) one (1) business day after its deposit with any return receipt express courier (prepaid), or (iii) one (1) business day after transmission by facsimile or email.

5

15.           Further Instruments.  The parties agree to execute such further instruments and to take such further action as may be reasonably necessary to carry out the purposes and intent of this Agreement.

16.           Headings; Counterparts.  The captions and headings of this Agreement are included for ease of reference only and shall be disregarded in interpreting or construing this Agreement.  All references herein to Sections shall refer to Sections of this Agreement.  This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, and all of which together shall constitute one and the same agreement.

17.           Entire Agreement.  This Agreement constitutes the entire agreement and understanding of the parties with respect to the subject matter of this Agreement, and supersedes all prior understandings and agreements, whether oral or written, between the parties hereto with respect to the specific subject matter of this Agreement.

18.           Equitable Adjustments. The number of Restricted Shares, Monthly Vested Shares, Eligible Restricted Shares and Shares, the Company’s Market Capitalization and similar figures set forth herein shall be equitably adjusted in the sole discretion of the Company to offset the effect of stock splits or similar events.

WHEREOF, the Company has caused this Agreement to be executed by its duly authorized representative and Grantee has executed this Agreement as of the Effective Date.

OriginOil, Inc.	Grantee
By:	(Signature)
(Please print name)	(Please print name)
Chief Executive Officer
(Please print title)

6

Spouse Consent

The undersigned spouse of _______________________ (the “Grantee”) has read, understands, and hereby approves the Restricted Stock Grant Agreement between OriginOil, Inc., a Nevada corporation (the “Company”) and Grantee (the “Agreement”). In consideration of the Company's granting my spouse the right to purchase the Shares as set forth in the Agreement, the undersigned hereby agrees to be irrevocably bound by the Agreement and further agrees that any community property interest shall similarly be bound by the Agreement. The undersigned hereby appoints Grantee as my attorney-in-fact with respect to any amendment or exercise of any rights under the Agreement.

Date:
Print Name of Grantee's Spouse	Signature of Grantee's Spouse
(Please print title)	Address:

o Check this box if you do not have a spouse.

7

EX-31

EXHIBIT 31

Certifications

I, T Riggs Eckelberry, certify that:

1.       I have reviewed this Annual Report on Form 10-K of OriginOil, Inc.;

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.       I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)         Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)         Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)         Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.       I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 15, 2014

/s/ T Riggs Eckelberry

T Riggs Eckelberry

Chief Executive Officer (Principal Executive Officer Acting Chief Financial Officer

(Principal Accounting and Financial Officer)

EX-32

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Annual Report of OriginOil, Inc. (the “Company”) on Form 10-K filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, T Riggs Eckelberry, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/  T Riggs Eckelberry

T Riggs Eckelberry

Chief Executive Officer (Principal Executive Officer

Acting Chief Financial Officer

(Principal Accounting and Financial Officer)

Date: April 15, 2014

XML

Options and Warrants (Details 5) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2013
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Warrants Outstanding	42,033,596
Warrants Exercisable	41,782,058
Range One [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices Lower limit	$ 0.15
Exercisable Prices Upper limit	$ 0.65
Warrants Outstanding	40,355,718
Warrants Exercisable	40,355,718
Range One [Member] | Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractua Life (years)	1 month 21 days
Range One [Member] | Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractua Life (years)	4 years 5 months 12 days
Range Two [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices Lower limit	$ 0.90
Exercisable Prices Upper limit	$ 10.20
Warrants Outstanding	811,516
Warrants Exercisable	811,516
Range Two [Member] | Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractua Life (years)	6 months
Range Two [Member] | Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractua Life (years)	4 years 8 months 19 days
Range Three [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices Lower limit	$ 0.26
Exercisable Prices Upper limit	$ 5.70
Warrants Outstanding	866,362
Warrants Exercisable	614,824
Range Three [Member] | Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractua Life (years)	1 year 7 months 2 days
Range Three [Member] | Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractua Life (years)	4 years 8 months 19 days

XML

Subsequent Events (Details) (USD $)	12 Months Ended		0 Months Ended						1 Months Ended		3 Months Ended		1 Months Ended	2 Months Ended	3 Months Ended	2 Months Ended			0 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Apr. 09, 2014 Robert Rashti [Member]	Apr. 09, 2014 Eng Cheh Hong [Member]	Apr. 09, 2014 Subsequent Event [Member]	Apr. 15, 2014 Subsequent Event [Member]	Apr. 10, 2014 Subsequent Event [Member]	Jan. 01, 2014 Subsequent Event [Member]	Mar. 31, 2014 Subsequent Event [Member]	Feb. 19, 2014 Subsequent Event [Member]	Apr. 01, 2014 Subsequent Event [Member]	Apr. 02, 2014 Subsequent Event [Member]	Oct. 23, 2013 Subsequent Event [Member] Convertible Notes Payable [Member]	Mar. 31, 2014 Subsequent Event [Member] Convertible Notes Payable [Member]	Mar. 31, 2014 Subsequent Event [Member] Convertible Notes Payable [Member]	Mar. 31, 2014 Subsequent Event [Member] Convertible Notes Payable [Member] Common Stock [Member] Conversion of debt, Option 2 [Member]	Mar. 31, 2014 Subsequent Event [Member] Convertible Notes Payable [Member] Common Stock [Member] Maximum [Member] Conversion of debt, Option 1 [Member]	Mar. 31, 2014 Subsequent Event [Member] Convertible Notes Payable [Member] Common Stock [Member] Minimum [Member] Conversion of debt, Option 1 [Member]	Jan. 01, 2014 Subsequent Event [Member] Ivan Ivankovich [Member]	Jan. 01, 2014 Subsequent Event [Member] Anthony Fidaleo [Member]	Feb. 10, 2014 Subsequent Event [Member] Byron Elton [Member]
Subsequent Event [Line Items]
Stock issued for share based compensation, shares	400,000							400,000											200,000	200,000	100,000
Stock issued for share based compensation	$ 64,000
Sales of convertible promissory note														885,000	885,000
Debt conversion converted amount	2,975,226	3,561,785								87,828
Common stock issued for conversion of debt (in shares)										676,032			2,931,214		8,877,130
Convertible note outstanding principal amount														665,000	665,000
Unpaid interest														34,074	34,074
Common stock issued during period	1,000								450,000
Common stock shares issued									3,000,000			434,223
Shares issued, price per share		$ 0.43							$ 0.15
Common stock issued for services	$ 902,113	$ 1,684,048				$ 1,300,920	$ 1,300,920				$ 227,004
Common stock issued for services (in shares)			1,000,000	1,000,000	2,160,000	6,213,340					1,103,340
Interest rate on notes														10.00%
Conversion price of debt																	$ 0.22	$ 0.20
Conversion of debt																50% of the lowest trade price on any trade day following issuance of the Notes
Mandatory default condition														The mandatory default amount is 150% of the Notes amount and such mandatory default amount shall bear interest at 10% per annum.
Additional issuance of common stock to consultants					3,020,000
Oustanding share of comon stock percentage					In addition, on April 9, 2014, our board of directors authorized the issuance to consultants of an aggregate of 3,020,000 shares of our common stock in lieu of cash consideration including 1,000,000 shares of common stock to each of Robert Rashti and Eng Cheh Hong who beneficially own more than 5% of the outstanding shares of our common stock.

XML

Capital Stock (Details) (USD $)	12 Months Ended			12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 26, 2013 Series A Preferred Stock [Member]	Dec. 31, 2013 Investor One [Member]	Dec. 31, 2013 Investor Two [Member]	Dec. 31, 2013 Common Stock [Member]	Dec. 31, 2012 Common Stock [Member]	Dec. 31, 2013 Common Stock [Member] Minimum [Member]	Dec. 31, 2013 Common Stock [Member] Maximum [Member]	Dec. 31, 2013 Warrant [Member] Minimum [Member]	Dec. 31, 2013 Warrant [Member] Maximum [Member]
Capital Stock [Line Items]
Sale of common stock	$ 2,267,542			$ 1,068,543	$ 1,200,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Sale of common stock price per share				$ 0.25	$ 0.15
Sale of common stock, shares				4,274,616	8,000,000
Sale of common stock description	For subscribers who subscribed for $300,000 or more of shares in this offering, the common stock price was $0.15 per share.
Common stock issued for purchase warrants at fair value through a cash exercise	36,995,692
Exercise price of warrants (in dollars per share)										0.15	0.25
Warrants exercisable grant period										1 year	5 years
Stock issued for share based compensation, shares	400,000
Stock issued for share based compensation	64,000
Common stock fair value in obligation	105,754
Common stock issued for services (in shares)						2,448,976	1,246,558
Issue price of common stock issued for services at fair value (in dollars per share)								$ 0.63	$ 0.63
Common stock issued for services	902,113	1,684,048				245	124
Debt conversion converted amount	$ 2,975,226	$ 3,561,785				$ 1,986	$ 298
Common stock issued for conversion of debt (in shares)						19,861,112	2,980,037
Conversion price								$ 0.11	$ 0.875
Preferred stock, shares authorized	25,000,000	25,000,000	1,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001

XML

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2013
Leasehold improvements
Property, Plant and Equipment [Line Items]
Estimated useful lives	P2Y
Computer equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives	P5Y
Furniture & fixtures
Property, Plant and Equipment [Line Items]
Estimated useful lives	P7Y
Machinery & equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives	P10Y

XML

Derivative Liabilities (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Derivative Liabilities (Textual)
Fair value of derivative liabilities	$ 1,031,484	$ 355,526
Debt conversion converted amount	2,975,226	3,561,785
Gain on extinguishment of debt	3,407,340	(1,634,989)
Change in valuation of derivative liability	(1,020,088)	(737,185)
Convertible notes issuance	2,106,873
Derivative liabilities [Member]
Derivative Liabilities (Textual)
Fair value of derivative liabilities	1,031,484
Aggregate amount of fair value liabilities	3,063,210
Notes payable derivative liabilities	2,106,873
Changes in derivative liability	956,337
Debt conversion converted amount	1,172,172
Gain on extinguishment of debt	3,407,340
Change in valuation of derivative liability	1,020,088
Convertible notes issuance	$ 3,063,210

XML

Options and Warrants (Details 3)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk free interest rate	0.05%
Stock volatility factor	86.88%
Weighted average expected option life	6 months
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk free interest rate	0.72%
Stock volatility factor	101.00%
Weighted average expected option life	4 years
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average expected option life	5 years	5 years
Expected dividend yield
Warrant [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk free interest rate	0.17%	0.62%
Stock volatility factor	83.00%	68.56%
Warrant [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk free interest rate	0.44%	0.86%
Stock volatility factor	88.00%	70.61%

XML

Property & Equipment

12 Months Ended

Dec. 31, 2013

Property & Equipment [Abstract]

PROPERTY & EQUIPMENT

3.     PROPERTY & EQUIPMENT

Property and Equipment consist of the following as of December 31, 2013 and 2012:

	2013			2012
Machinery & equipment	$	77,665		$	32,670
Furniture & fixtures		27,056			27,056
Computer equipment		29,789			28,824
Leasehold improvements		94,914			94,914
		229,424			183,464
Less accumulated depreciation and amortization		(155,220	)		(140,067	)
	$	74,204		$	43,397

Depreciation expense for the years ended December 31, 2013 and 2012 was $15,153 and $13,645, respectively.

XML

Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Taxes [Abstract]
Book income	$ (3,505,200)	$ (4,228,000)
Tax to book differences for deductible expenses	(17,600)	106,200
Tax non deductible expenses	1,403,200	2,834,200
Valuation Allowance	2,119,600	1,287,600
Income tax expense

XML

Property & Equipment (Detail Textuals) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Property And Equipment (Textual)
Depreciation expense	$ 15,153	$ 13,645

XML

Property & Equipment (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, gross	$ 229,424	$ 183,464
Less accumulated depreciation and amortization	(155,220)	(140,067)
NET PROPERTY AND EQUIPMENT	74,204	43,397
Machinery & equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, gross	77,665	32,670
Furniture & fixtures
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, gross	27,056	27,056
Computer equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, gross	29,789	28,824
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, gross	$ 94,914	$ 94,914

XML

Income Taxes (Details 1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:
NOL carryover	$ 8,423,640	$ 6,051,100
Other carryovers	449,650	436,700
Deferred tax liabilities:
Depreciation	(49,600)	(25,200)
Less Valuation Allowance	(8,823,690)	(6,462,600)
Net deferred tax asset

XML

Convertible Promissory Notes Payable (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Convertible Promissory Notes Payable [Abstract]
Convertible Promisory Notes (a)	$ 1,530,000
OID Notes (b)	273,125	573,330
Security Purchase Agreement (c)	122,828	100,000
Total Notes	1,925,953	673,330
Debt Discount	(971,964)	(237,965)
Convertible notes payable, Current	$ 953,989	$ 435,365

XML

Convertible Promissory Notes Payable (Detail Textuals) (USD $)	12 Months Ended		1 Months Ended			12 Months Ended				0 Months Ended	1 Months Ended		12 Months Ended					12 Months Ended			12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Jun. 20, 2012 Securities Purchase Agreement [Member]	Dec. 31, 2013 Warrant [Member] Minimum	Dec. 31, 2013 Warrant [Member] Maximum	Dec. 31, 2013 Common Stock [Member]	Dec. 31, 2012 Common Stock [Member]	Dec. 31, 2013 Common Stock [Member] Minimum	Dec. 31, 2013 Common Stock [Member] Maximum	May 21, 2013 Convertible Promissory Notes [Member]	Dec. 31, 2013 Convertible Promissory Notes [Member]	Jun. 30, 2013 Convertible Promissory Notes [Member]	Dec. 31, 2013 Convertible Promissory Notes [Member]	Dec. 31, 2012 Convertible Promissory Notes [Member]	Dec. 31, 2013 Convertible Promissory Notes [Member] Securities Purchase Agreement [Member]	Dec. 31, 2013 Convertible Promissory Notes [Member] Minimum	Dec. 31, 2013 Convertible Promissory Notes [Member] Maximum	Dec. 31, 2013 OID Notes [Member]	Dec. 31, 2013 OID Notes [Member] Minimum	Dec. 31, 2013 OID Notes [Member] Maximum	Dec. 31, 2013 OID Notes One [Member]	Dec. 31, 2013 Other Convertible Note [Member]
Short-term Debt [Line Items]
Aggregate principal amount debt	$ 2,106,873		$ 400,000							$ 290,560	$ 1,910,000	$ 350,000	$ 1,910,000								$ 235,000
Debt instrument maturity description													Convertible Promissory Notes mature on various dates ranging from six to nine months from the date of issuance.					The original maturity date of the OID Notes is ninety (90) days from their effective date. If the OID Notes are not repaid on maturity, then the maturity date is automatically extended for up to three further 30 day periods and an extension fee of 25% of the then outstanding principal is applied.			The maturity dates of the new OID Notes are ninety (90) days from their effective issuance date.
Debt instrument interest rate			10.00%								10.00%		10.00%
Conversion price of debt								$ 0.11	$ 0.875							$ 0.21	$ 0.50		$ 0.4375	$ 0.65
Conversion price per share of debt, Description													50% of the lowest trade price on any trade day following issuance of the Notes.					70% to 50% of the average of the three lowest closing prices in the 25 trading days previous to a conversion.
Debt instrument debt default													The mandatory default amount is 150% of the Notes amount and such mandatory default amount shall bear interest at 10% per annum.					In the event of default, such as failure to pay any principal and interest when due and payable (or payable upon conversion), the OID Notes immediately become due and payable at the mandatory default amount which is 150% or 200% of the OID Note amounts. The OID Notes' mandatory default amount bear interest at 10% per annum.
Debt conversion converted amount	2,975,226	3,561,785				1,986	298						380,000		227,172						1,687,512
Common stock issued for conversion of debt (in shares)						19,861,112	2,980,037						3,909,121		1,189,417						12,480,520	1,788,034
Debt instrument outstanding amount											1,530,000		1,530,000		122,828						273,125
Debt issuance cost		237,234													37,500
Extension period of maturity on repayment of notes																		30 days
Original issue discount on promissory notes	273,125	573,330																			78,333
Interest and extension fee amount													19,923		30,000						1,073,974
Debt instrument maturity date										Dec. 31, 2015											Jul. 14, 2014
Security purchase agreement	122,828	100,000
Number of common stock called by warrants (in shares)			615,385
Number of common stock called by warrants at first closing (in shares)			153,846								307,692	307,692	307,692
Exercise price of warrants (in dollars per share)			0.65	0.15	0.25
Increased interest rate			15.00%
Amortization of debt discount in interest expense	1,591,266	76,122											237,965	971,964
Percentage of average of lowest closing prices										75.00%			70.00%
Number of trading days previous to conversion										25 days			25 days
Unsecured convertible promissory issued											250,000	250,000
Fair Value Adjustment of Warrants	88,370
Beneficial conversion feature on promissory notes	161,422	1,479,578
Fair Value of Assets Acquired	3,063,210	1,199,762
Debt private placement cost	$ 956,337

XML

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2013

Summary of Significant Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICES

Revenue Recognition

We recognize revenue upon delivery of equipment, provided that evidence of an arrangement exists, title, and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.  Title to the equipment is transferred to the customer once the last payment is received. We record revenue as goods are shipped, and the equipment has been fully accepted by the customer. Generally, we extend credit to our customers and do not require collateral.  We do not ship a product until we have a purchase agreement signed by the customer with a payment arrangement.  

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

Loss per Share Calculations

Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the years ended December 31, 2013 and 2012, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss.

For the years ended December 31, 2013 and 2012, the dilutive impact of outstanding stock options of 4,684,643  and 465,294, and  outstanding warrants of 42,033,596 and 7,554,616 and notes convertible into 12,037,206 and 841,663 shares of our common stock, respectively, have been excluded because their impact on the loss per share is anti-dilutive.

Research and Development

Research and development costs are expensed as incurred.  Total research and development costs were $1,072,548 and $980,170 for the years ended December 31, 2013 and 2012, respectively.

Advertising Costs

The Company expenses the cost of advertising and promotional materials when incurred.  The advertising costs were $220,535 and $209,761 for the years ended December 31, 2013 and 2012, respectively, which are included in selling and general and administrative expenses in the statement of operations.

Use of Estimates

The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in valuing our stock options, warrants, convertible notes, and common stock issued for services, among other items. Actual results could differ from these estimates.

Work-in-Process

The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.

Capitalized Patents

As of December 31, 2012, the Company had unamortized capitalized patent costs of $317,689.  In prior years and during the year ended December 31, 2013, the Company capitalized various legal fees incurred in the patent application process related to the Company's Electro Water Separation (EWS) Technology. The Company accounted for these capitalized patents pursuant to ASC 350-30, General Intangibles Other Than Goodwill.  The Company initially determined that its patents have a finite useful life, which were to be amortized over its useful life. The Company performed its annual impairment test of its capitalized intangible assets as of December 31, 2013, and based upon its analysis, determined that such costs were impaired and recorded an impairment loss of $317,689 at December 31, 2013.

Impairment of Long-lived Assets  

Management regularly reviews property, equipment and other long-lived assets for possible impairment. This review occurs annually or more frequently if events or changes in circumstances indicate the carrying amount of the asset may not be recoverable.  The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.  Based on upon management’s annual assessment, there were no indicators of impairment of the Company’s property and equipment and other long-lived assets during the year ended December 31, 2013.

Concentration of Credit Risk

As of December 31, 2013 and 2012, the Company had bank deposits in excess of Federally insured limits of $571,448 and $252,270, respectively.

Stock-Based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

Property and Equipment

Property and equipment are stated at cost, and are depreciated using the straight line method over their estimated useful lives:

Leasehold improvements	lease term or 2 years
Computer equipment	5 Years
Furniture & fixtures	7 Years
Machinery & equipment	10 Years

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statement of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Black-Scholes-Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Reclassification

During 2013, the Company reclassified $20,000 of current assets to long term assets based on a reassessment of the time to be realized. The prior year amount of $25,000 was also reclassified for comparability.

Fair Value of Financial Instruments

Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2013, the balances reported for cash, prepaid expenses, accounts payable, and accrued expenses approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

· Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

· Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

· Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s  balance sheets on a recurring basis and their level within the fair value hierarchy as of December 31, 2013 and 2012.

	(Level 1)		(Level 2)		(Level 3)
Derivative Liability, December 31, 2013	$	-	$	-	$	1,031,484
Derivative Liability, December 31, 2012	$	-	$	-	$	355,526

Recently Issued Accounting Pronouncements

On March 4, 2013, the FASB issued ASU 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (“ASU 2013-05”). ASU 2013-05 updates accounting guidance related to the application of guidance and foreign currency matters. This guidance resolves the diversity in practice about what guidance applies to the release of the cumulative translation adjustment into net income. This guidance is effective for interim and annual periods beginning after December 15, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Loss, or a Tax Credit Carryforward Exists. Topic 740, Income Taxes, does not include explicit guidance on the financial statement presented of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. There is diversity in practice in the presentation of unrecognized tax benefits in those instances and the amendments in this update are intended to eliminate that diversity in practice. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Early adoption is permitted.  We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future financial statements.

XML

Unsecured Notes Payable (Detail Textuals) (USD $)	1 Months Ended	12 Months Ended
	Jan. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Short-term Debt [Line Items]
Gross proceeds from unsecured debt			$ 171,361
Issuance of shares of common stock		1,000
January 2012 Unsecured Convertible Promissory Note
Short-term Debt [Line Items]
Gross proceeds from unsecured debt	1,669,828
Debt instrument interest rate	8.00%
Unsecured promissory note payment term	The January 2012 Notes were also redeemable by the Company, at the holder's option, at maturity at a redemption price of 112% of the outstanding principal plus accrued and unpaid interest.
Aggregate principal amount outstanding			210,000
Common stock shares issued		494,020
Issuance of shares of common stock		340,059
Converted aggregate principal amount of promissory note		200,000
Balance paid in cash		10,000
Options grant date	The notes matured in one year
Gain loss on settlement of debt		123,964
Accrued interest		$ 16,113

XML

Options and Warrants (Detail Textuals) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Common Stock [Member]

Dec. 31, 2012

Common Stock [Member]

Dec. 31, 2013

Stock Options

Dec. 31, 2012

Stock Options

Dec. 31, 2011

Stock Options

Dec. 31, 2013

Warrant

Dec. 31, 2013

Maximum

Stock Options

Dec. 31, 2012

Maximum

Stock Options

Dec. 31, 2013

Maximum

Warrant

Dec. 31, 2013

Minimum

Stock Options

Dec. 31, 2012

Minimum

Stock Options

Dec. 31, 2013

Minimum

Warrant

Dec. 31, 2013

2009 Incentive Stock Option Plan

Dec. 31, 2013

Stock option plan

May 31, 2012

Stock option plan

Dec. 31, 2013

2013 Incentive Stock Option Plan

Dec. 31, 2013

2013 Plan

Dec. 31, 2013

2013 Plan

Maximum

Dec. 31, 2013

2013 Plan

Minimum

Dec. 31, 2013

Exchange plan one [Member]

Common Stock [Member]

Dec. 31, 2013

Exchange plan two [Member]

Common Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock shares reserves and sets aside for the granting of options (in shares)

500,000

1,000,000

4,000,000

Exercise period of stock option exercisable

10 years

10 years

4 years

4 years

10 years

10 years

Determination of exercise price by holders percentage description

If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant.

Vest monthly after 90 days from grant ate over a period of five (5) years

Employee Termination

not less than 30 days nor more than three (3) months after such termination

Non-Statutory stock options

2,532,665

Vested Term

5 years

5 years

5 years

Granted options

533,498

500,000

Options exercisable price, per share

$ 0.44

$ 0.43

$ 0.44

$ 0.38

Estimated fair value of option

$ 122,705

$ 700,000

$ 597,974

Share based compensation expense

95,890

645,398

9,815

70,000

71,772

Future unamortized compensation expense

855,243

Common stock issued upon exercise of warrants at fair value through a cashless exercise (in shares)

332,960

262,281

Option to purchase shares to officer

759,645

Shares issued, price per share

$ 0.43

Stock options forfeited

483,498

2,482,665

Stock Options Outstanding

4,684,643

465,294

4,684,643

465,294

351,130

50,000

50,000

Fair value of options issued in current year previously reflected in accrued expenses

209,000

Warrants, granted

37,427,384

Weighted average exercise price, granted

$ 0.25

$ 0.15

Conversion of Stock, Shares Issued

12,037,206

841,663

332,960

779,298

Warrants outstanding, intrinsic value

$ 320,000

XML

Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS
Cash	$ 821,448	$ 507,355
Work in process	21,049	35,666
Prepaid expenses	34,531	186,978
Other receivables		1,200
TOTAL CURRENT ASSETS	877,028	731,199
NET PROPERTY AND EQUIPMENT, NET	74,204	43,397
OTHER ASSETS
Other asset	40,000	45,000
Patents		317,689
Trademark	4,467	4,467
Security deposit	9,650	9,650
TOTAL OTHER ASSETS	54,117	376,806
TOTAL ASSETS	1,005,349	1,151,402
Current Liabilities
Accounts payable	114,803	353,200
Accrued expenses	262,518	376,846
Deferred income	50,000
Derivative liabilities	1,031,484	355,526
Convertible promissory notes, net of discount of $971,964 and 237,965, respectively	953,989	435,365
Unsecured notes payable, net of discount of $38,639		171,361
Total Current Liabilities	2,412,794	1,692,298
Long Term Liabilities
Obligation to issue common stock	105,754
Total Long Term Liabilities	105,754
TOTAL LIABILITIES	2,518,548	1,692,298
SHAREHOLDERS' DEFICIT
Preferred stock, $0.0001 par value; 25,000,000 authorized preferred shares
Common stock, $0.0001 par value, 250,000,000 shares authorized 53,664,506 and 17,967,544 shares issued and outstanding, respectively	5,366	1,797
Additional paid in capital	34,811,538	27,024,419
Accumulated deficit	(36,330,103)	(27,567,112)
TOTAL SHAREHOLDERS' DEFICIT	(1,513,199)	(540,896)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 1,005,349	$ 1,151,402

XML

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013
Deferred Tax Benefit [Abstract]
Operating Loss Carryforwards	$ 21,059,100
Income Tax Expense Benefit Description	The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized.

XML

Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (8,762,991)	$ (10,570,029)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation & amortization	15,153	13,645
Common stock and warrants issued for services	902,113	1,617,538
Stock compensation expense	345,791	739,464
Change in valuation of derivative liability	1,020,088	737,185
Debt discount and beneficial conversion feature recognized as interest expense	1,879,697	2,174,910
Gain/(Loss) on extinguishment of derivative liability	(3,407,340)	1,634,989
Penalty, interest and default fees	1,123,897
Common stock issued for interest on debt		88,852
Debt private placement cost	956,337
Impairment loss on patents	317,689
Cost of modification of warrants	645,398
Obligation to issue common stock	105,754
(Increase) Decrease in:
Prepaid expenses	152,447	179,635
Work in progress	14,617	212,777
Other receivables	1,200	16,777
Other asset	5,000	(25,000)
Increase (Decrease) in:
Accounts payable	52,163	10,830
Accrued expenses	94,672	252,429
Deferred income	50,000	(313,163)
NET CASH USED IN OPERATING ACTIVITIES	(4,488,315)	(3,102,421)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(45,960)	(1,678)
Patent expenditures		(171,387)
CASH USED IN INVESTING ACTIVITIES	(45,960)	(173,065)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from unsecured subordinated debt		1,479,578
Payments for unsecured debt	(10,000)
Proceeds from convertible promissory notes	2,395,000	530,000
Proceeds for issuance of common stock	2,463,368	1,575,395
NET CASH PROVIDED BY FINANCING ACTIVITIES	4,848,368	3,584,973
NET INCREASE/(DECREASE) IN CASH	314,093	309,487
CASH BEGINNING OF PERIOD	507,355	197,868
CASH END OF PERIOD	821,448	507,355
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid		5,262
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Fair value of derivative issued	3,063,210	1,199,762
Reclass of value of options issued in current year previously reflected in accrued expenses	209,000	0
Common stock issued for conversion of debt	2,975,226	3,561,785
Common stock issued for settlement of debt		$ 1,605,642

XML

Options and Warrants (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options, outstanding, end of year	4,684,643	465,294
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options, outstanding, beginning of year	465,294	351,130
Number of Options, granted	4,325,808	384,000
Number of Options, exercised
Number of Options, forfeited/expired	(106,459)	(269,836)
Number of Options, outstanding, end of year	4,684,643	465,294
Number of Options, exercisable at the end of year	1,792,083	75,732
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted average exercise price, outstanding, beginning of year	$ 1.67	$ 6.14
Weighted average exercise price, granted	$ 0.41	$ 0.90
Weighted average exercise price, exercised
Weighted average exercise price, forfeited/expired	$ 0.39	$ (6.40)
Weighted average exercise price, outstanding, end of year	$ 0.53	$ 1.67
Weighted average exercise price, exercisable at the end of year	$ 0.45	$ 3.08
Weighted average fair value of options granted during the year	$ 0.41	$ 0.68

XML

Derivative Liabilities (Tables)

12 Months Ended

Dec. 31, 2013

Derivative Liabilities [Abstract]

Schedule of Derivative Liabilities at Fair Value

Risk free interest rate	.05% - .72%
Stock volatility factor	86.88% - 101.0%
Weighted average expected option life	6 months - 4 years
Expected dividend yield	None

XML

Options and Warrants (Details 2) (Stock Options, 2009 Plan, 2012 Plan, and 2013 Plan, USD $)	12 Months Ended
	Dec. 31, 2013
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options Outstanding	4,684,643
Stock Options Exercisable	1,792,083
Range One [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices Lower limit	$ 0.43
Exercisable Prices Upper limit	$ 7.20
Stock Options Outstanding	1,701,978
Stock Options Exercisable	981,750
Range One [Member] | Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractua Life (years)	1 year 11 months 23 days
Range One [Member] | Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractua Life (years)	9 years 8 months 16 days
Range Two [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices Lower limit	$ 0.29
Exercisable Prices Upper limit	$ 0.44
Stock Options Outstanding	2,982,665
Stock Options Exercisable	810,333
Weighted Average Remaining Contractua Life (years)	9 years 8 months 16 days

XML

Organization and Line of Business (Detail Textuals) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Organization and Line of Business [Abstract]
Net cash used in operating activities	$ (4,488,315)	$ (3,102,421)
Shareholders' deficit	(1,513,199)	(540,896)	(798,294)
Working Capital Deficiency	1,535,766
Net loss	$ (8,762,991)	$ (10,570,029)

XML

Organization and Line of Business

12 Months Ended

Dec. 31, 2013

Organization and Line of Business [Abstract]

ORGANIZATION AND LINE OF BUSINESS

1.      ORGANIZATION AND LINE OF BUSINESS

Organization

OriginOil, Inc. (the "Company") was incorporated in the state of Nevada on June 1, 2007.  The Company, based in Los Angeles, California, began operations on June 1, 2007 to develop and market a renewable oil technology. The Company began its planned principal operations in December, 2010, at which time it exited the development stage.

Line of Business

OriginOil is a pure technology company that has developed a water cleanup technology for the oil and gas, algae and other water-intensive industries.  The Company’s technology integrates easily with other industry processes and can be embedded into larger systems through licensing and joint ventures.

Going Concern

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business.  The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. During the year ended December 31, 2013, the Company did not generate significant revenue, incurred a net loss of $8,762,991 and used cash used in operations of $4,488,315.  As of December 31, 2013, the Company had a working capital deficiency of $1,535,766 and a shareholders’ deficit of $1,513,199.   These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern.  Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2013, expressed substantial doubt about our ability to continue as a going concern.

The ability of the Company to continue as a going concern and the appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash infusions. During the year ended December 31, 2013, the Company obtained funds from the issuance of convertible note agreements and from sales of its common stock and warrants. The Company also has standing purchase orders and open invoices with customers which will provide funds for operations. Management believes this funding will continue from its current investors and from new investors. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stock holders, in case of equity financing.

XML

Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	25,000,000	25,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	53,664,506	17,967,544
Common stock, shares outstanding	53,664,506	17,967,544
Unsecured notes payable
Discount on debt (in dollars)		$ 38,639
Convertible Promissory Note
Discount on debt (in dollars)	$ 971,964	$ 237,965

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2013

Summary of Significant Accounting Policies [Abstract]

Revenue Recognition

Revenue Recognition

We recognize revenue upon delivery of equipment, provided that evidence of an arrangement exists, title, and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.  Title to the equipment is transferred to the customer once the last payment is received. We record revenue as goods are shipped, and the equipment has been fully accepted by the customer. Generally, we extend credit to our customers and do not require collateral.  We do not ship a product until we have a purchase agreement signed by the customer with a payment arrangement.

Cash and Cash Equivalent

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

Loss per Share Calculations

Loss per Share Calculations

Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the years ended December 31, 2013 and 2012, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss.

For the years ended December 31, 2013 and 2012, the dilutive impact of outstanding stock options of 4,684,643  and 465,294, and  outstanding warrants of 42,033,596 and 7,554,616 and notes convertible into 12,037,206 and 841,663 shares of our common stock, respectively, have been excluded because their impact on the loss per share is anti-dilutive.

Research and Development

Research and Development

Research and development costs are expensed as incurred.  Total research and development costs were $1,072,548 and $980,170 for the years ended December 31, 2013 and 2012, respectively.

Advertising Costs

Advertising Costs

The Company expenses the cost of advertising and promotional materials when incurred.  The advertising costs were $220,535 and $209,761 for the years ended December 31, 2013 and 2012, respectively, which are included in selling and general and administrative expenses in the statement of operations.

Use of Estimates

Use of Estimates

The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in valuing our stock options, warrants, convertible notes, and common stock issued for services, among other items. Actual results could differ from these estimates.

Work-in-Process

Work-in-Process

The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.

Capitalized Patents

Capitalized Patents

As of December 31, 2012, the Company had unamortized capitalized patent costs of $317,689.  In prior years and during the year ended December 31, 2013, the Company capitalized various legal fees incurred in the patent application process related to the Company's Electro Water Separation (EWS) Technology. The Company accounted for these capitalized patents pursuant to ASC 350-30, General Intangibles Other Than Goodwill.  The Company initially determined that its patents have a finite useful life, which were to be amortized over its useful life. The Company performed its annual impairment test of its capitalized intangible assets as of December 31, 2013, and based upon its analysis, determined that such costs were impaired and recorded an impairment loss of $317,689 at December 31, 2013.

Impairment of Long-lived Assets

Impairment of Long-lived Assets  

Management regularly reviews property, equipment and other long-lived assets for possible impairment. This review occurs annually or more frequently if events or changes in circumstances indicate the carrying amount of the asset may not be recoverable.  The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.  Based on upon management’s annual assessment, there were no indicators of impairment of the Company’s property and equipment and other long-lived assets during the year ended December 31, 2013.

Concentration of Credit Risk

Concentration of Credit Risk

As of December 31, 2013 and 2012, the Company had bank deposits in excess of Federally insured limits of $571,448 and $252,270, respectively.

Stock-Based Compensation

Stock-Based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

Property and Equipment

Property and Equipment

Property and equipment are stated at cost, and are depreciated using the straight line method over their estimated useful lives:

Leasehold improvements	lease term or 2 years
Computer equipment	5 Years
Furniture & fixtures	7 Years
Machinery & equipment	10 Years

Accounting for Derivatives

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statement of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Black-Scholes-Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Reclassification

Reclassification

During 2013, the Company reclassified $20,000 of current assets to long term assets based on a reassessment of the time to be realized. The prior year amount of $25,000 was also reclassified for comparability.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2013, the balances reported for cash, prepaid expenses, accounts payable, and accrued expenses approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

· Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

· Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

· Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s  balance sheets on a recurring basis and their level within the fair value hierarchy as of December 31, 2013 and 2012.

	(Level 1)		(Level 2)		(Level 3)
Derivative Liability, December 31, 2013	$	-	$	-	$	1,031,484
Derivative Liability, December 31, 2012	$	-	$	-	$	355,526

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

On March 4, 2013, the FASB issued ASU 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (“ASU 2013-05”). ASU 2013-05 updates accounting guidance related to the application of guidance and foreign currency matters. This guidance resolves the diversity in practice about what guidance applies to the release of the cumulative translation adjustment into net income. This guidance is effective for interim and annual periods beginning after December 15, 2013. We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Loss, or a Tax Credit Carryforward Exists. Topic 740, Income Taxes, does not include explicit guidance on the financial statement presented of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. There is diversity in practice in the presentation of unrecognized tax benefits in those instances and the amendments in this update are intended to eliminate that diversity in practice. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Early adoption is permitted.  We do not believe the adoption of this update will have a material effect on our financial position and results of operations.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future financial statements.

XML

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Apr. 14, 2014	Jun. 28, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	ORIGINOIL INC
Entity Central Index Key	0001419793
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2013
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2013
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		73,365,231
Entity Public Float			$ 11,707,942

XML

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2013

Summary of Significant Accounting Policies [Abstract]

Schedule of Property and Equipment

	2013			2012
Machinery & equipment	$	77,665		$	32,670
Furniture & fixtures		27,056			27,056
Computer equipment		29,789			28,824
Leasehold improvements		94,914			94,914
		229,424			183,464
Less accumulated depreciation and amortization		(155,220	)		(140,067	)
	$	74,204		$	43,397

Schedule of fair value of financial instruments

	(Level 1)		(Level 2)		(Level 3)
Derivative Liability, December 31, 2013	$	-	$	-	$	1,031,484
Derivative Liability, December 31, 2012	$	-	$	-	$	355,526

XML

Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Sales	$ 140,500	$ 588,163
Cost of Goods Sold	50,510	401,647
Gross Profit	89,990	186,516
Operating Expenses
Selling and general and administrative expenses	5,229,412	4,942,275
Research and development	1,072,548	980,170
Impairment of patents	317,689
Depreciation and amortization expense	15,153	13,645
Total Operating Expenses	6,634,802	5,936,090
Loss from Operations before Other Income/(Expenses)	(6,544,812)	(5,749,574)
OTHER INCOME/(EXPENSE)
Gain/(Loss) on extinguishment of derivative liability	3,407,340	(1,634,989)
Change in valuation of derivative liability	(1,020,088)	(737,185)
Debt private placement cost	(956,337)
Cost of modification of warrants	(645,398)
Penalty, interest and default fees	(1,123,897)
Foreign exchange loss		(3,096)
Interest expense	(1,879,799)	(2,445,185)
TOTAL OTHER INCOME/(EXPENSE)	(2,218,179)	(4,820,456)
NET LOSS	$ (8,762,991)	$ (10,570,029)
BASIC LOSS PER SHARE	$ (0.32)	$ (0.92)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED	27,742,399	11,474,316

XML

Capital Stock

12 Months Ended

Dec. 31, 2013

Capital Stock [Abstract]

CAPITAL STOCK

6.     CAPITAL STOCK

Sale of common stock and warrants

During the year ended December 31, 2013, the Company offered up to $2,000,000 in shares of the Company’s common stock, par value $0.0001 per share, which in the sole discretion of the Company, without further notice, could be increased to $3,000,000 in shares of common stock at a price per share of $0.25 per share. For subscribers who subscribed for $300,000 or more of shares in this offering, the common stock price was $0.15 per share. The Company raised aggregate proceeds of $2,267,542 from the sale of these shares. Based upon the offering, the Company issued (i) 4,274,616 shares to investors at $0.25 per share for cash of $1,068,543 and, (ii) issued 8,000,000 shares to investors at $0.15 per share for cash of $1,200,000.  Included in the sale of shares of common stock were warrants to purchase 36,995,692 shares of common stock.  The warrants are exercisable from 1 up to 5 years upon grant with an exercise price of $0.15 per share up to $0.25 per share.

Subsequent to sale of the common stock units discussed above, the Company entered into a supplemental agreement with the subscribers of the original subscription agreement. Under the terms of the supplemental agreement, if at any time within eighteen (18) months following the issuance of shares to the subscriber  (the  "Adjustment  Period"), the  market  price  (as  defined  below)  of the Company's common stock is less than the price per share  then the price per  share shall be reduced one time to the market price (the "Adjusted Price") such that the Company shall promptly issue additional shares of the Company's common stock to the Subscriber for no additional  consideration, in an amount sufficient that the aggregate purchase price, when divided by the total number of shares purchased thereunder plus those shares of common stock issued as a result of the dilutive Issuance will equal the adjusted price.  For the purposes hereof: the ''Market Price" shall mean the average closing price of the Company's common stock for any ten (10) consecutive trading days during the Adjustment Period.

Sale of common stock and warrants (Continued)

The company considered the effects of the above and determined that it should record a provision to reflect its potential obligation to issue such shares.  The Company intends to account for this liability as of each reporting period until the defined adjustment period has terminated.  Based upon its calculation, the company believes that as of December 31, 2013, it may have the obligation to issue shares with a fair value of $105,754. This amount has been reflected as an obligation to issue common stock in the accompanying December 31, 2013 balance sheet.

Other issuances of Common Shares

During the year ended December 31, 2013, the Company issued 2,448,972 shares of common stock for services with prices ranging from $0.25 up to $0.63 with a total fair value of $902,113.  The shares issued were valued at the trading price at the date of the agreement or issuance date. The Company also granted, but did not issue, 400,000 shares of common stock to certain directors of the Company.  The fair value of the shares was $64,000 at the date of the agreement which has been included in accrued expenses on the accompanying December 31, 2013 balance sheet.

During the year ended December 31, 2013, the Company issued 19,861,012 shares of common stock for the settlement of convertible promissory notes in an aggregate principal amount of $2,975,226 based upon a conversion price of $0.11 up to $0.875.

Designation of Series A Preferred Stock

On December 26, 2013, the Company authorized the designation of 1,000 shares of Series A Preferred Stock and subsequently on the same day, the Company authorized the issuance of 1,000 shares of Series A Preferred Stock to the Company’s Chief Executive Officer and Director, T. Riggs Eckelberry. The shares of Series A Preferred Stock had a par value of $0.0001 per share, did not have a dividend rate or liquidation preference and were not convertible into shares of common stock. The share provisions did not become effective until June 16, 2014. However, on April 7, 2014, the Board of Directors rescinded the issuance of these shares.

XML

Unsecured Notes Payable

12 Months Ended

Dec. 31, 2013

Unsecured Notes Payable [Abstract]

UNSECURED NOTES PAYABLE

5.     UNSECURED NOTES PAYABLE

In January 2012, the Company issued its “January 2012 Notes” for gross proceeds of $1,669,828.  The notes matured in one year upon issuance, accrued interest at 8% per annum and were payable on the conversion date and/or at maturity. The January 2012 Notes were also redeemable by the Company, at the holder’s option, at maturity for a redemption price of 112% of the outstanding principal, plus accrued and unpaid interest. At December 31, 2012, the January 2012 Notes had an aggregate remaining principal amount of $210,000.

During the year ended December 31, 2013, the Company settled payment of principal in the amount of $200,000 plus accrued interest of $16,113 through the issuance of 494,020 shares of its common stock valued at $340,059.  As a result, the Company recognized an additional cost of $123,964 upon conversion of this note payable which has been included in penalties, interest and default fees on the accompanying 2013 statement of operations. The remaining $10,000 was paid in cash to a holder.  The aggregate principal amount outstanding of the January 2012 Notes at December 31, 2013 was $0.

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2013

Income Taxes [Abstract]

Schedule of components of income tax expense (benefit)

	2013			2012
Book income	$	(3,505,200	)	$	(4,228,000	)
Tax to book differences for deductible expenses		(17,600	)		106,200
Tax non deductible expenses		1,403,200			2,834,200
Valuation Allowance		2,119,600			1,287,600
Income tax expense	$	-		$	-

Summary of deferred tax assets and liabilities

	2013			2012
Deferred tax assets:
NOL carryover	$	8,423,640		$	6,051,100
Other carryovers		449,650			436,700
Deferred tax liabilites:
Depreciation		(49,600	)		(25,200	)
Less Valuation Allowance		(8,823,690	)		(6,462,600	)
Net deferred tax asset	$	-		$	-

XML

Property & Equipment (Tables)

12 Months Ended

Dec. 31, 2013

Property & Equipment [Abstract]

Schedule of Property and Equipment

	2013			2012
Machinery & equipment	$	77,665		$	32,670
Furniture & fixtures		27,056			27,056
Computer equipment		29,789			28,824
Leasehold improvements		94,914			94,914
		229,424			183,464
Less accumulated depreciation and amortization		(155,220	)		(140,067	)
	$	74,204		$	43,397

XML

Income Taxes

12 Months Ended

Dec. 31, 2013

Income Taxes [Abstract]

INCOME TAXES

9. INCOME TAXES

The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2011.

Deferred income taxes have been provided by temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. To the extent allowed by GAAP, we provide valuation allowances against the deferred tax assets for amounts when the realization is uncertain.Included in the balance at December 31, 2013 and 2012, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility.  Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period.

The Company prescribes a recognition threshold and a measurement attributable for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized.

The Company's policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periods ended December 31, 2013 and 2012, the Company did not recognize interest and penalties.

At December 31, 2013, the Company had net operating loss carry-forwards of approximately $21,059,100, which expire at various through dates that have not been determined. No tax benefit has been reported in the December 31, 2013 financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.

The income tax provision differs from the amount of income tax determined by applying the U.S. federal and state income tax rate to pretax income from continuing operations for the years ended December 31, 2013 and 2012 due to the following:

	2013			2012
Book income	$	(3,505,200	)	$	(4,228,000	)
Tax to book differences for deductible expenses		(17,600	)		106,200
Tax non deductible expenses		1,403,200			2,834,200
Valuation Allowance		2,119,600			1,287,600
Income tax expense	$	-		$	-

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

The net deferred tax assets and liabilities consist of the following components as of December 31,

	2013			2012
Deferred tax assets:
NOL carryover	$	8,423,640		$	6,051,100
Other carryovers		449,650			436,700
Deferred tax liabilites:
Depreciation		(49,600	)		(25,200	)
Less Valuation Allowance		(8,823,690	)		(6,462,600	)
Net deferred tax asset	$	-		$	-

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years.

XML

Options And Warrants

12 Months Ended

Dec. 31, 2013

Options And Warrants [Abstract]

OPTIONS AND WARRANTS

7.     OPTIONS AND WARRANTS

Options

The Board of Directors adopted the OriginOil, Inc., 2009 Incentive Stock Option Plan (the “2009 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for Five Hundred Thousand (500,000) shares of Common Stock.  

On May 25, 2012, the Board of Directors adopted a new OriginOil, Inc., 2012 Incentive Stock Option Plan (the “2012 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for One Million (1,000,000) shares of Common Stock.  Options granted under these Plans may be either incentive options or nonqualified options and shall be administered by the Company's Board.  Each Option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the Plan or of any option agreement, each Option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the effective date of grant.

On June 14, 2013, the Board of Directors adopted a new OriginOil, Inc., 2013 Incentive Stock Option Plan (the “2013 Plan”) for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for Four Million (4,000,000) shares of Common Stock.  Options granted under the Plan may be either incentive options or nonqualified options and shall be administered by the Company's Board.  Each Option shall state the number of shares to which it pertains. The exercise price will be determined by the holders percentage owned as follows: If the holder owns more than 10% of the total combined voting power or value of all classes of stock of the Company, then the exercise price will be no less than 110% of the fair market value of the stock as of the date of grant; if the person is not a 10% holder, then the exercise price will be no less than 100% of the fair market value of the stock as of the date of grant. Notwithstanding any other provision of the 2013 Plan or of any option agreement, each Option shall expire on the date specified in the option agreement, which date shall not be later than the tenth (10th) anniversary from the date of grant. If the status of an employee terminates for any reason other than disability or death, then the Optionee or their representative shall have the right to exercise the portion of any Options which were exercisable as of the date of such termination, in whole or in part, not less than 30 days nor more than three (3) months after such termination.

With respect to Non-statutory Options granted to employees, directors or consultants, the Board or Committee may specify such period for exercise that the Option shall automatically terminate following the termination of employment or services as to shares covered by the Option as the Board or Committee deems reasonable and appropriate.

During the year ended December 31, 2013, the Company granted 533,498 incentive stock options to employees with an estimated fair value of approximately $122,705 using the Black-Scholes-Merton calculation. The options are exercisable at $0.44/share, vest monthly after 90 days from grant date over a period of five (5) years and expire in ten (10) years from the date of grant. As of December 31, 2013, 483,498 incentive stock options were outstanding, due to forfeiture of 50,000 options. During the year ended December 31, 2013, the Company recognized compensation costs of $9,815 based on the fair value of options that vested.

During the year ended December 31, 2013, the Company granted 2,532,665 Non-statutory stock options under the 2013 Stock Option Plan to employees and members of the Board of Directors with an estimated fair value of approximately $597,974 using the Black-Scholes-Merton calculation. The options are exercisable at $0.38/share up to $0.44/share, vest over a period of five (5) years and expire in ten (10) years from the date of grant. As of December 31, 2013, 2,482,665 incentive stock options were outstanding, due to forfeiture of 50,000 options. During the year ended December 31, 2013, the Company recognized compensation costs of $71,772 based on the fair value of options that vested.

During the year ended December 31, 2013, the Company granted 500,000 options under the 2013 Stock Option Plan to an employee with an estimated fair value of approximately $70,000 using the Black-Scholes-Merton calculation. The options are exercisable at $0.43/share, vest immediately and expire in five (5) years from the date of grant. During the year ended December 31, 2013, the Company recognized compensation costs of $70,000 based on the fair value of options that vested.

During the year ended December 31, 2013, the Company recorded $95,890 of compensation cost based on the vesting of the options granted to employees, directors and consultants in prior periods. Future unamortized compensation expense on the unvested outstanding options at December 31, 2013 was approximately $855,243.

In fiscal 2012, the Board of Directors agreed to grant an officer of the Company options to purchase 759,645 shares of common stock at $0.43 per share.  Upon grant, the options vested immediately and will expire in 5 years.  Total fair value of the options granted amounted to $209,000 determined by using the Black-Scholes Option Pricing Model and was recorded in 2012 and was reflected as compensation cost and as due to officer which is included as part of accrued expenses in the accompanying 2012 balance sheet.  In April 2013, the Board formally approved the issuance of the 759,645 options and the amount was reclassified from due to officer to additional paid in capital.

	2013			2012
Risk free interest rate		0.28% - 0.49	%		0.87 - 1.58	%
Stock volatility factor		88.00% - 91.00	%		69.93 - 70.25	%
Weighted average expected option life	4 - 10 years			4 - 10 years
Expected dividend yield	None			None

A summary of the Company’s stock option activity and related information follows:

	December 31, 2013					December 31, 2012
				Weighted					Weighted
	Number			average		Number			average
	of			exercise		of			exercise
	Options			price		Options			price
Outstanding, beginning of year		465,294		$	1.67		351,130		$	6.14
Granted		4,325,808			0.41		384,000			0.90
Exercised		-			-		-			-
Forfeited/Expired		(106,459	)		0.39		(269,836	)		(6.40	)
Outstanding, end of year		4,684,643		$	0.53		465,294		$	1.67
Exercisable at the end of year		1,792,083		$	0.45		75,732		$	3.08
Weighted average fair value of
options granted during the year				$	0.41				$	0.68

As of December 31, 2013, the outstanding options had no intrinsic value. 

The weighted average remaining contractual life of options outstanding issued under the 2009 Plan, 2012 Plan, and 2013 Plan as of  December 31, 2013 was as follows:

						Weighted
						Average
		Stock		Stock		Remaining
Exercise		Options		Options		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	0.43 - 7.20		1,701,978		981,750		1.98 - 9.71
$	0.29 - 0.44		2,982,665		810,333		9.71
			4,684,643		1,792,083

Stock-based compensation expense recognized during the year is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the year ended December 31, 2013, included compensation expense for the stock-based payment awards granted prior to, but not yet vested, as of December 31, 2013 based on the grant date fair value estimated.

Warrants

During the year ended December 31, 2013, in conjunction with the Company’s issuance of shares of common stock for cash, the Company granted warrants to purchase a total of 37,427,384 shares of our common stock.  Each warrant is exercisable at a price per share between $0.15  to $0.25 subject to adjustment for stock splits, dividends, distributions, recapitalizations and the like and will expire in one up to five years from date of grant (see Note 6).

During the year ended December 31, 2013, the Company issued 332,960 shares of common stock in exchange for a cashless exercise of 454,911 purchase warrants. During the year ended December 31, 2013, the Company issued 779,298 shares of common stock upon exercise of the purchase warrants of 779,298 for cash in the amount of $194,826.

During the year ended December 31, 2013, the Company amended the exercise price of approximately 4,308,000 warrants issued in 2012, from $0.65 per share to $0.25 per share. The Company calculated the change in fair value of the warrants before and after the modification using the Black Scholes Pricing Option Model and recorded an expense in the statement of operations during the year ended December 31, 2013 amounting to $645,398.

		2013				2012
Risk free interest rate			0.17% - 0.44	%			.62% - .86	%
Stock volatility factor			83.00% - 88.00	%			68.56% - 70.61	%
Weighted average expected option life	5 years				5 years
Expected dividend yield	None				None

A summary of the Company’s warrant activity and related information follows:

	December 31, 2013					December 31, 2012
				Weighted					Weighted
				average					average
				exercise					exercise
	Options			price		Options			price
Outstanding -beginning of year		7,554,616		$	0.79		836,188		$	4.20
Granted		37,427,384			0.20		6,818,430			0.66
Exercised		(1,234,210	)		0.30		-			-
Forfeited		(1,714,194	)		1.26		(100,002	)		(4.10	)
Outstanding - end of year		42,033,596		$	0.31		7,554,616		$	0.79
Exercisable - end of year		41,782,058					7,098,104

 At December 31, 2013, the weighted average remaining contractual life of warrants outstanding:

						Weighted
						Average
						Remaining
Exercise		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	0.15 - 0.65		40,355,718		40,355,718		0.14 - 4.45
$	0.90 - 10.20		811,516		811,516		0.50 - 4.72
$	0.26 - 5.70		866,362		614,824		1.59 - 4.72
			42,033,596		41,782,058

At December 31, 2013 the aggregate intrinsic value of the warrants outstanding was $320,000.

XML

Derivative Liabilities

12 Months Ended

Dec. 31, 2013

Derivative Liabilities [Abstract]

DERIVATIVE LIABILITIES

9.    DERIVATIVE LIABILITIES

In June 2008, the FASB issued authoritative guidance on determining whether an instrument (or embedded feature) is indexed to an entity’s own stock. Under the authoritative guidance, effective January 1, 2009, instruments which did not have fixed settlement provisions were deemed to be derivative instruments. As a result, certain convertible notes issued related to the private placement described in Notes 4 do not have fixed settlement provisions because their conversion prices may be lowered if the Company issues securities at lower prices in the future. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.  At December, 31, 2012, the outstanding fair value of the convertible notes accounted as derivative liabilities amounted to $355,526.

During the year ended December 31, 2013, we determined that the fair value of the conversion feature of the convertible notes issued during the year at issuance was $3,063,210, based upon the weighted average Black-Sholes-Merton pricing model calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes. As the aggregate fair value of these liabilities of $3,063,210 exceeded the aggregate Note value of $2,106,873, the excess of the liability over the Note value of $956,337 was considered as a cost of the private placement and reported in the accompanying statement of operations.

During the year ended December 31, 2013, approximately $1,172,172 convertible notes were converted.  As a result of the conversion of these notes, the Company recorded a gain of $3,407,340 due to the extinguishment of the corresponding derivative liability.  Furthermore, during the year ended December 31, 2013, the Company recognized a change in fair value of $1,289,642 to account for the change in fair value of the derivative liabilities.  At December 31, 2013, the fair value of the derivative liability was $1,031,484.

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Black Scholes option valuation model. The significant assumptions used in the Probability Weighted Black Scholes valuation of the derivative are as follows:

Risk free interest rate	.05% - .72%
Stock volatility factor	86.88% - 101.0%
Weighted average expected option life	6 months - 4 years
Expected dividend yield	None

XML

Subsequent Events

12 Months Ended

Dec. 31, 2013

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

10.   SUBSEQUENT EVENTS

On January 1, 2014, the Company issued an aggregate of 400,000 shares of its common stock previously granted to Ivan Ivankovich and Anthony Fidaleo, both of whom received 200,000 shares of common stock each, for serving on the Company’s Board of Directors at time of issuance.  The fair value of these shares has been included in accrued expenses as of December 31, 2013.

Between January 6, 2014 and February 19, 2014, a Lender converted an aggregate principal and interest amount of $87,828 into 676,032 shares of common stock under the prior securities purchase agreement.

On January 10, 2014, the Company’s Board of Directors authorized the entering into of restricted stock grant agreements providing for the grant of an aggregate of 45,000,000 shares of common stock to certain officers and members of the Company’s management. The shares were eligible for issuance subject to the satisfaction of certain performance criteria and if such performance criteria were met, the shares then become eligible for vesting on a monthly basis. On April 5, 2014, and prior to the issuance or vesting of any of the shares, each of the grantees mutually agreed with the Company to the termination of the restricted stock grant agreements. Subsequently, on April 9, 2014, the Company’s Board of Directors authorized the entering into of restricted stock grant agreements providing for the grant of an aggregate of 40,000,000 shares of common stock to certain officers and members of the Company’s management. The shares are eligible for issuance subject to the satisfaction of certain performance criteria and if such performance criteria are met, the shares then become eligible for vesting on a monthly basis.

Between January 16, 2014 and March 31, 2014, holders of convertible notes, known in our filings as “Convertible Promissory Notes” converted an aggregate outstanding principal amount of $665,000, plus unpaid interest of $34,074 into an aggregate of 8,877,130 shares of the Company’s common stock.

On January 31, 2014, the Company’s Board of Directors appointed Mr. Byron Elton as director.  On February 10, 2014, in connection with Mr. Elton’s appointment, the Company issued to Mr. Elton 100,000 shares of its common stock and was recorded as compensation expense.

Between January 31, 2014 through March 31, 2014, the Company sold convertible promissory notes ("Notes") in the aggregate principal amount of $885,000. The Notes mature on various dates, nine months from the date of issuance and bear interest at 10% per annum. The Notes may be converted into shares of the Company’s common stock at a conversion price range of the lesser of $0.20 to $0.22 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Notes.  The Notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In the event of default, the Notes shall become immediately due and payable at the mandatory default amount. The mandatory default amount is 150% of the Notes amount and such mandatory default amount shall bear interest at 10% per annum.  In addition, for as long as the Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the Notes or such other convertible notes or a term was not similarly provided to the purchaser of the Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the Notes and such other convertible notes.

In March 2014, holders of warrants to purchase up to an aggregate of 3,000,000 shares of the Company’s common stock at an exercise price of $0.15 per share delivered notices of election to exercise the warrants in full on a cash basis resulting in the issuance of 3,000,000 shares of the Company’s common stock for an aggregate purchase price of $450,000.

During the subsequent period through April 7, 2014, in connection with certain one-time make good agreements, the Company issued an aggregate of 434,223 shares of its common stock at a fair value of $96,254 to certain holders of its common stock.

During the subsequent period through April 15, 2014, the Company issued 6,213,340 shares of common stock for services at a fair value of $1,300,920. Included in the issuance of those shares, on April 9, 2014, we agreed to issue 2,160,000 shares of our common stock to a consultant in lieu of cash consideration.  In addition, on April 9, 2014, our board of directors authorized the issuance to consultants of an aggregate of 3,020,000 shares of our common stock in lieu of cash consideration including 1,000,000 shares of common stock to each of Robert Rashti and Eng Cheh Hong who beneficially own more than 5% of the outstanding shares of our common stock.

XML

Options and Warrants (Details) (Employee Stock Option [Member])	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk free interest rate, minimum	0.28%	0.87%
Risk free interest rate, maximum	0.49%	1.58%
Stock volatility factor, minimum	88.00%	69.93%
Stock volatility factor, maximum	91.00%	70.25%
Expected dividend yield
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average expected option life	4 years	4 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average expected option life	10 years	10 years

XML

Options and Warrants (Tables)

12 Months Ended

Dec. 31, 2013

Options And Warrants [Abstract]

Schedule of valuation assumptions of stock options exercisable

	2013			2012
Risk free interest rate		0.28% - 0.49	%		0.87 - 1.58	%
Stock volatility factor		88.00% - 91.00	%		69.93 - 70.25	%
Weighted average expected option life	4 - 10 years			4 - 10 years
Expected dividend yield	None			None

Schedule of company's stock option activity and related information

	December 31, 2013					December 31, 2012
				Weighted					Weighted
	Number			average		Number			average
	of			exercise		of			exercise
	Options			price		Options			price
Outstanding, beginning of year		465,294		$	1.67		351,130		$	6.14
Granted		4,325,808			0.41		384,000			0.90
Exercised		-			-		-			-
Forfeited/Expired		(106,459	)		0.39		(269,836	)		(6.40	)
Outstanding, end of year		4,684,643		$	0.53		465,294		$	1.67
Exercisable at the end of year		1,792,083		$	0.45		75,732		$	3.08
Weighted average fair value of
options granted during the year				$	0.41				$	0.68

Schedule of weighted average remaining contractual life of options outstanding issued under the plan

						Weighted
						Average
		Stock		Stock		Remaining
Exercise		Options		Options		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	0.43 - 7.20		1,701,978		981,750		1.98 - 9.71
$	0.29 - 0.44		2,982,665		810,333		9.71
			4,684,643		1,792,083

Schedule of share based compensation, warrant, activity

		2013				2012
Risk free interest rate			0.17% - 0.44	%			.62% - .86	%
Stock volatility factor			83.00% - 88.00	%			68.56% - 70.61	%
Weighted average expected option life	5 years				5 years
Expected dividend yield	None				None

Schedule of company's warrant activity and related information

	December 31, 2013					December 31, 2012
				Weighted					Weighted
				average					average
				exercise					exercise
	Options			price		Options			price
Outstanding -beginning of year		7,554,616		$	0.79		836,188		$	4.20
Granted		37,427,384			0.20		6,818,430			0.66
Exercised		(1,234,210	)		0.30		-			-
Forfeited		(1,714,194	)		1.26		(100,002	)		(4.10	)
Outstanding - end of year		42,033,596		$	0.31		7,554,616		$	0.79
Exercisable - end of year		41,782,058					7,098,104

Schedule of weighted average remaining contractual life of warrants outstanding

						Weighted
						Average
						Remaining
Exercise		Warrants		Warrants		Contractual
Prices		Outstanding		Exercisable		Life (years)
$	0.15 - 0.65		40,355,718		40,355,718		0.14 - 4.45
$	0.90 - 10.20		811,516		811,516		0.50 - 4.72
$	0.26 - 5.70		866,362		614,824		1.59 - 4.72
			42,033,596		41,782,058

XML

Summary of Significant Accounting Policies (Details 1) (Fair Value, Measurements, Recurring, USD $)	Dec. 31, 2013	Dec. 31, 2012
(Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability
(Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability
(Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	$ 1,031,484	$ 355,526

XML

Derivative Liabilities (Details)	12 Months Ended
	Dec. 31, 2013
Significant assumptions used for black scholes valuation of the derivative
Expected dividend yield
Minimum [Member]
Significant assumptions used for black scholes valuation of the derivative
Risk free interest rate	0.05%
Stock volatility factor	86.88%
Weighted average expected option life	6 months
Maximum [Member]
Significant assumptions used for black scholes valuation of the derivative
Risk free interest rate	0.72%
Stock volatility factor	101.00%
Weighted average expected option life	4 years

XML

Statement of Shareholders' Deficit (USD $)	Preferred stock	Common stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2011		$ 770	$ 16,198,019	$ (16,997,083)	$ (798,294)
Balance (in shares) at Dec. 31, 2011		7,694,505
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for cash and subscriptions payable		243	1,576,649		1,576,892
Common stock issued for cash and subscriptions payable (in shares)		2,426,003
Common stock issued for conversion of debt		298	3,561,487		3,561,785
Common stock issued for conversion of debt (in shares)		2,980,037
Common stock issued for conversion of interest payable on debt		10	88,843		88,853
Common stock issued for conversion of interest payable on debt (in shares)		96,791
Common stock issued for services		124	1,683,924		1,684,048
Common stock issued for services (in shares)		1,246,558
Common stock issued with unsecured subordinated debt at fair value		141	(141)
Common stock issued with unsecured subordinated debt at fair value (in shares)		1,411,351
Common stock issued with for settlement of debt at fair value		185	1,605,457		1,605,642
Common stock issued with for settlement of debt at fair value (in shares)		1,850,019
Common stock issued upon exercise of warrants at fair value through a cashless exercise		26	(26)
Common stock issued upon exercise of warrants at fair value through a cashless exercise (in shares)		262,281
Original issue discount for convertible debenture			92,662		92,662
Cost of modification of warrants
Beneficial conversion feature on promissory notes			1,479,578		1,479,578
Options and warrant compensation expense			739,464		739,464
Stock issuance cost			(1,497)		(1,497)
Net loss				(10,570,029)	(10,570,029)
Balance at Dec. 31, 2012		1,797	27,024,419	(27,567,112)	(540,896)
Balance (in shares) at Dec. 31, 2012		17,967,544
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		1,227	2,266,315		2,267,542
Common stock issued (in shares)		12,270,172
Common stock issued for conversion of debt		1,986	2,973,240		2,975,226
Common stock issued for conversion of debt (in shares)		19,861,112
Common stock issued for services		245	901,868		902,113
Common stock issued for services (in shares)		2,448,976
Common stock issued with for settlement of debt at fair value
Common stock issued upon exercise of warrants at fair value through a cashless exercise		33	(33)
Common stock issued upon exercise of warrants at fair value through a cashless exercise (in shares)		332,960
Common stock issued for warrants		78	194,748		194,826
Common stock issued for warrants (in shares)		779,298
Issuance of shares of common stock			1,000		1,000
Issuance of shares of common stock (in shares)		4,444
Fair value of warrants issued with notes			88,370		88,370
Cost of modification of warrants			645,398		(645,398)
Beneficial conversion feature on promissory notes			161,422		161,422
Fair value of options issued in current year previously reflected in accrued expenses			209,000		209,000
Stock and warrant compensation cost			345,791		345,791
Net loss				(8,762,991)	(8,762,991)
Balance at Dec. 31, 2013		$ 5,366	$ 34,811,538	$ (36,330,103)	$ (1,513,199)
Balance (in shares) at Dec. 31, 2013		53,664,506

XML

Convertible Promissory Notes Payable

12 Months Ended

Dec. 31, 2013

Convertible Promissory Notes Payable [Abstract]

CONVERTIBLE PROMISSORY NOTES PAYABLE

4.    CONVERTIBLE PROMISSORY NOTES PAYABLE

Convertible promissory notes payable consist of the following as of December 31, 2013 and 2012:

Balance as of December 31,	2013			2012
Convertible Promisory Notes (a)	$	1,530,000		$	-
OID Notes (b)		273,125			573,330
Security Purchase Agreement (c)		122,828			100,000
Total Notes		1,925,953			673,330
Debt Discount		(971,964	)		(237,965	)
	$	953,989		$	435,365

(a)   Convertible Promissory Notes

During 2013, the Company issued $1,910,000 of unsecured convertible promissory notes to institutional investors (the “Convertible Promissory Notes” or “Notes”). The Convertible Promissory Notes mature on various dates ranging from six to nine months from the date of issuance and bear interest at 10% per annum. The Notes may be converted into shares of the Company’s common stock at a conversion price range of the lesser of $0.21 to $0.50 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Notes.  The Notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In the event of default, the Notes shall become immediately due and payable at the mandatory default amount. The mandatory default amount is 150% of the Notes amount and such mandatory default amount shall bear interest at 10% per annum.  In addition, for as long as the Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the Notes or such other convertible notes or a term was not similarly provided to the purchaser of the Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the Notes and such other convertible notes. The conversion feature of the Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes (see below).

During the year ended December 31, 2013, the Company converted $380,000 of the Notes principal due plus accrued interest of $19,923 into 3,909,121 shares of common stock. As of December 31, 2013, the remaining Notes of $1,530,000 are due at various times through August 26, 2014.

(b)   OID Notes

In prior years and during the year ended December 31, 2013, the Company issued unsecured convertible promissory notes (the “OID Notes”) to various investors (holders). Each OID Note bears an original issue discount and one time interest which are being amortized over the term of the OID Notes. The OID Notes were originally convertible into the common stock of the Company at conversion prices ranging from $0.4375 to $0.65. The original maturity date of the OID Notes is ninety (90) days from their effective date.  If the OID Notes are not repaid on maturity, then the maturity date is automatically extended for up to three further 30 day periods and an extension fee of 25% of the then outstanding principal is applied. Every extension period, interest and other fees are also added to the principal amount of the OID Notes at the end of each 30 day period that the OID Notes are still outstanding. In the event of default, such as failure to pay any principal and interest when due and payable (or payable upon conversion), the OID Notes immediately become due and payable at the mandatory default amount which is 150% or 200% of the OID Note amounts. The OID Notes’ mandatory default amount bear interest at 10% per annum.

OID Notes

The OID Notes are convertible into shares of the Company’s common stock at a conversion price range from the lesser of $0.4375 to $0.65 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 70% to 50% of the average of the three lowest closing prices in the 25 trading days previous to a conversion.  In addition, so long as the OID Notes or other convertible note transactions currently in effect between the Company and the holders are outstanding, upon any issuance by the Company of any security with any term more favorable to the holder of such security or with a term in favor of the holder of such security that was not similarly provided to the holders in these OID Notes, then such additional or more favorable term shall at the OID Notes holders’ option become a part of any or all of the outstanding OID Notes with the holders. The conversion feature of the OID Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the OID Notes (see below).

At December 31, 2012, the balance of the OID Notes amounted to $573,330 of which $237,234 represented Original Issue Discount (OID). During the year ended December 31, 2013, the Company issued new OID Notes to various investors in an aggregate principal amount of $235,000, with an OID of $78,333 ($313,333 total). The maturity dates of the new OID Notes are ninety (90) days from their effective issuance date. The new OID Notes have similar terms and conditions as the old OID Notes mentioned in the preceding paragraph.

During the year ended December 31, 2013, the majority of the OID Notes’ due dates were extended numerous times and extension fees, additional one time interest and defaults fees were charged by the OID Note holders totaling $1,073,974. During the year ended December 31, 2013, OID Notes that totaled $1,687,512 (composed of principal, interest and default fees) were converted into 12,480,520 shares of the Company’s common stock.  The balance of the OID Notes outstanding as of December 31, 2013 was $273,125, which is due in various amounts through July 14, 2014.

(c)    Securities Purchase Agreement

On June 20, 2012, the Company received an initial advance of $100,000, and subsequently issued warrants to purchase an aggregate of up to 153,846 shares of our common stock. The funds were received in consideration of the sale of a 10% unsecured convertible promissory note (the “Note”), with an aggregate sum of $400,000, plus warrants to purchase an aggregate of up to 615,385 shares of the Company’s common stock at a purchase price of $0.65 per share. The Note originally matured six months from the date of each purchase made under the Note, and bore interest at a rate of 10% per annum, which increased to 15% when the Note was not repaid by September 18, 2012. The Note was originally convertible into shares of the Company’s common stock at a conversion price of $0.65. The warrants may be exercised at any time for a period of four years from the date of issuance at an exercise price of $0.65.  The balance outstanding under the Note at December 31, 2012 was $100,000.

On February 15, 2013, the Company and the lender entered into an amendment to the Note providing for, among other things, an extension of the maturity date of the Note until July 21, 2013 and the amendment of the conversion price of the Note to the lesser of $0.65 or 70% of the average of the three lowest closing prices in the 25 trading days previous to a conversion. During the months of June and December, 2013, the lender advanced another $250,000 under the securities purchase agreement and was issued 307,692 warrants to acquire shares of our common stock, bringing the total principal received under the Note to $350,000. The warrants were valued at $88,370 and accounted for as a discount that is being amortized over the life of the Note. During the year ended December 31, 2013, the lender converted $227,172 of the Note, plus accrued interest of $30,000, into 1,189,417 shares of the Company’s common stock leaving a remaining principal balance of $122,828, which is due in August 2014. During the year ended December 31, 2013, the Company recognized interest expense of $37,500 relating to the Note.

The conversion feature of the Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note (see below).

 (d)   Other Convertible Note

On May 21, 2013, the Company entered into a convertible promissory note for the conversion of an accounts payable in the amount of $290,560. The note was non-interest bearing and was to mature on December 31, 2015. The Company had the ability to pay the note in full on or before the maturity date without penalty. The note may be converted into shares of the Company’s common stock at a conversion price of 75% of the average of the three (3) lowest sale prices during the 25 trading days immediately preceding the date of delivery. As the conversion price of the note was less than the market price of the Company’s common stock at the date of its issuance, the Company determined that the note contained a beneficial conversion feature of $161,422. The note’s beneficial conversion feature was considered as debt discount and was being amortized over the life of the note. As of the December 31, 2013, the note was converted into 1,788,034 shares of common stock of the Company and all remaining unamortized note discount was recorded as interest expense.

Conversion feature of the notes

The agreements governing the convertible notes (a), (b) and (c) discussed above include an anti-dilution provision that allows for the automatic reset of the conversion price upon any future sale of the Company’s common stock, warrants, options, convertible debt or any other equity-linked securities at an issuance, exercise or conversion price below the current conversion price of the Amended Notes or exercise price of the warrants issued with the Convertible Notes. The Company considered the current FASB guidance of “Determining Whether an Instrument Indexed to an Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability or whether or not within the issuers’ control, means the instrument is not indexed to the issuers own stock. Accordingly, the Company determined that the conversion prices of the Convertible Notes are not a fixed amount because they are subject to fluctuations based on the occurrence of future offerings or events. As a result, the Company determined that the conversion features are not considered indexed to the Company’s own stock and characterized the initial fair value of these warrants as derivative liabilities upon issuance. The Company determined the aggregate initial fair value of the embedded beneficial conversion feature of the Conversion Notes issued during the year ended December 31, 2013 to be $3,063,210. These amounts were determined by management with the use of a probability weighted average Black-Scholes Merton option pricing model. As the aggregate fair value of these liabilities of $3,063,210 exceeded the aggregate Note value of $2,106,873, the excess of the liability over the Note value of $956,337 was considered as a cost of the private placement and is reported in the accompanying statement of operations. As such, the Company recorded a $2,106,873 valuation discount upon issuance of the notes. The Company is amortizing this valuation discount to interest expense over the life of the notes. During the year ended December 31, 2013, the Company included $1,372,874 of interest relating to the amortization of these discounts, and as of December 31, 2013 and December 31, 2012, the unamortized balance of the note discount was $971,964 and $237,965, respectively.

XML

Summary of Significant Accounting Policies (Detail Textuals) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock Options Outstanding	4,684,643	465,294
Notes convertible into shares of common stock	12,037,206	841,663
Research and development Costs	$ 1,072,548	$ 980,170
Advertising costs	220,535	209,761
Impairment of patents	317,689
Impairment loss on patents	317,689
Bank deposits in excess of federally insured limits	571,448	257,355
Description of accounting for derivatives	The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Reclassification from current assets to long term assets	20,000
Prior to reclassification adjustment	$ 25,000
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Loss per share calculations warrants excluded	42,033,596	7,554,616

XML

Options and Warrants (Details 4) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Class Of Warrant Or Right [Roll Forward]
Warrants, outstanding - end of period	42,033,596	7,554,616
Warrant
Class Of Warrant Or Right [Roll Forward]
Warrants, outstanding -beginning of period	7,554,616	836,188
Warrants, granted	37,427,384	6,818,430
Warrants, exercised	(1,234,210)
Warrants, forfeited	(1,714,194)	(100,002)
Warrants, outstanding - end of period	42,033,596	7,554,616
Class Of Warrant Or Right, Weighted Average Exercise Price [Roll Forward]
Weighted average exercise price, outstanding - beginning of year	$ 0.79	$ 4.20
Weighted average exercise price, granted	$ 0.20	$ 0.66
Weighted average exercise price, exercised	$ 0.30
Weighted average exercise price, forfeited	$ 1.26	$ (4.10)
Weighted average exercise price, outstanding - end of year	$ 0.31	$ 0.79

XML

Convertible Promissory Notes Payable (Tables)

12 Months Ended

Dec. 31, 2013

Convertible Promissory Notes Payable [Abstract]

Schedule of convertible promissory notes payable

	2013			2012
Convertible Promisory Notes (a)	$	1,530,000		$	-
OID Notes (b)		273,125			573,330
Security Purchase Agreement (c)		122,828			100,000
Total Notes		1,925,953			673,330
Debt Discount		(971,964	)		(237,965	)
	$	953,989		$	435,365